Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
M Aviram, … , S L Primo-Parmo, B N La Du
M Aviram, … , S L Primo-Parmo, B N La Du
Published April 15, 1998
Citation Information: J Clin Invest. 1998;101(8):1581-1590. https://doi.org/10.1172/JCI1649.
View: Text | PDF
Research Article Article has an altmetric score of 6

Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.

  • Text
  • PDF
Abstract

HDL levels are inversely related to the risk of developing atherosclerosis. In serum, paraoxonase (PON) is associated with HDL, and was shown to inhibit LDL oxidation. Whether PON also protects HDL from oxidation is unknown, and was determined in the present study. In humans, we found serum HDL PON activity and HDL susceptibility to oxidation to be inversely correlated (r2 = 0.77, n = 15). Supplementing human HDL with purified PON inhibited copper-induced HDL oxidation in a concentration-dependent manner. Adding PON to HDL prolonged the oxidation lag phase and reduced HDL peroxide and aldehyde formation by up to 95%. This inhibitory effect was most pronounced when PON was added before oxidation initiation. When purified PON was added to whole serum, essentially all of it became HDL-associated. The PON-enriched HDL was more resistant to copper ion-induced oxidation than was control HDL. Compared with control HDL, HDL from PON-treated serum showed a 66% prolongation in the lag phase of its oxidation, and up to a 40% reduction in peroxide and aldehyde content. In contrast, in the presence of various PON inhibitors, HDL oxidation induced by either copper ions or by a free radical generating system was markedly enhanced. As PON inhibited HDL oxidation, two major functions of HDL were assessed: macrophage cholesterol efflux, and LDL protection from oxidation. Compared with oxidized untreated HDL, oxidized PON-treated HDL caused a 45% increase in cellular cholesterol efflux from J-774 A.1 macrophages. Both HDL-associated PON and purified PON were potent inhibitors of LDL oxidation. Searching for a possible mechanism for PON-induced inhibition of HDL oxidation revealed PON (2 paraoxonase U/ml)-mediated hydrolysis of lipid peroxides (by 19%) and of cholesteryl linoleate hydroperoxides (by 90%) in oxidized HDL. HDL-associated PON, as well as purified PON, were also able to substantially hydrolyze (up to 25%) hydrogen peroxide (H2O2), a major reactive oxygen species produced under oxidative stress during atherogenesis. Finally, we analyzed serum PON activity in the atherosclerotic apolipoprotein E-deficient mice during aging and development of atherosclerotic lesions. With age, serum lipid peroxidation and lesion size increased, whereas serum PON activity decreased. We thus conclude that HDL-associated PON possesses peroxidase-like activity that can contribute to the protective effect of PON against lipoprotein oxidation. The presence of PON in HDL may thus be a major contributor to the antiatherogenicity of this lipoprotein.

Authors

M Aviram, M Rosenblat, C L Bisgaier, R S Newton, S L Primo-Parmo, B N La Du

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1995 1969 Total
Citations: 4 7 12 16 19 23 26 25 31 33 33 54 61 47 48 41 57 50 33 44 22 39 25 38 29 26 23 6 1 1 874
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (874)

Title and authors Publication Year
Myricitrin Alleviates Hypercholesterolemia and Non-Alcoholic Fatty Liver Disease in High Cholesterol Diet-Fed Mice
Kim YJ, Park S, Kim H, Kim SR, Jung UJ
Nutrients 2025
High-density lipoprotein cholesterol: how studying the ‘good cholesterol’ could improve cardiovascular health
Diaz L, Bielczyk-Maczynska E
Open Biology 2025
The interaction between a leflunomide-response methylation site (cg17330251) and variant (rs705379) on response to leflunomide in patients with rheumatoid arthritis
Zhao F, Chen Y, Liu H, Jin L, Feng X, Dai B, Chen M, Wang Q, Yao Y, Liao R, Zhao J, Qu B, Song Y, Fu L
Frontiers in Pharmacology 2025
Investigating the role of the Pon1-rs854560 (L55M) SNP in colorectal Cancer susceptibility.
Wei X, Qin R, Yin L, Iqbal MA, Shaibu Z, Li G, Wu T
Journal of cancer research and clinical oncology 2025
Effect of fentanyl and remifentanil on neuron damage and oxidative stress during induction neurotoxicity.
Taghizadehghalehjoughi A, Naldan ME, Yeni Y, Genc S, Hacimuftuoglu A, Isik M, Necip A, Bolat İ, Yildirim S, Beydemir S, Baykan M
Journal of Cellular and Molecular Medicine 2024
Paraoxonase 1: evolution of the enzyme and of its role in protecting against atherosclerosis
Durrington P, Soran H
Current Opinion in Lipidology 2024
Dysfunctional HDL Diagnostic Metrics for Cardiovascular Disease Risk Stratification: Are we Ready to Implement in Clinics?
Kempegowda SN, Sugur K, Thimmulappa RK
Journal of cardiovascular translational research 2024
Exploring the Relationship between Canine Paraoxonase-1 (PON-1) Serum Activity and Liver Disease Classified by Clinico-Pathological Evaluation.
Meazzi S, Bristi SZT, Bianchini V, Scarpa P, Giordano A
Animals : an open access journal from MDPI 2024
The Molecular Bases of Anti-Oxidative and Anti-Inflammatory Properties of Paraoxonase 1
Jakubowski H
Antioxidants 2024
Molecular Structure of Paraoxonase-1 and Its Modifications in Relation to Enzyme Activity and Biological Functions—A Comprehensive Review
Lewoń-Mrozek D, Kurzynoga J, Jędrzejewski P, Kędzierska K, Partyka A, Kuriata-Kordek M, Ściskalska M
International Journal of Molecular Sciences 2024
Allostatic Load and Oxidative Stress Markers in Women With Early- and Late-Onset Preeclampsia
Montoya-Estrada A, García-Cerda MV, Guzmán-Grenfell AM, Figueroa-Damian R, Torres-Cosme JL, Laresgoiti-Servitje E, Beltrán-Montoya JJ, Romo-Yañez J, Reyes-Muñoz E
Cureus 2024
Highly Dynamic Gene Family Evolution Suggests Changing Roles for PON Genes Within Metazoa
Lucas SA, Graham AM, Presnell JS, Clark NL
Genome Biology and Evolution 2023
Paraoxonase 1 and atherosclerosis
Durrington PN, Bashir B, Soran H
Frontiers in Cardiovascular Medicine 2023
Modulatory Effect of Lifestyle-Related, Environmental and Genetic Factors on Paraoxonase-1 Activity: A Review.
Kunachowicz D, Ściskalska M, Kepinska M
International journal of environmental research and public health 2023
Biological Health Markers Associated with Oxidative Stress in Dairy Cows during Lactation Period.
Tufarelli V, Colonna MA, Losacco C, Puvača N
Metabolites 2023
Paraoxonases at the Heart of Neurological Disorders.
Khalaf FK, Connolly J, Khatib-Shahidi B, Albehadili A, Tassavvor I, Ranabothu M, Eid N, Dube P, Khouri SJ, Malhotra D, Haller ST, Kennedy DJ
International journal of molecular sciences 2023
Proteomic Exploration of Paraoxonase 1 Function in Health and Disease
Jakubowski H
International journal of molecular sciences 2023
Vutiglabridin Modulates Paraoxonase 1 and Ameliorates Diet-Induced Obesity in Hyperlipidemic Mice.
Sulaiman D, Choi LS, Lee HM, Shin J, Kim DH, Lee KW, Eftekhari P, Quartier A, Park HS, Reddy ST
Biomolecules 2023
The effects of dietary essential fatty acid ratios and energy level on growth performance, lipid metabolism, and inflammation in grow-finish pigs.
Becker SL, Humphrey DC, Karriker LA, Brown JT, Skoland KJ, Greiner LL
Journal of animal science 2023
Proteomic and functional analysis of HDL subclasses in humans and rats: a proof-of-concept study.
Huang C, Zhang J, Huang J, Li H, Wen K, Bao J, Wu X, Sun R, Abudukeremu A, Wang Y, He Z, Chen Q, Huang X, Wang H, Zhang Y
Lipids in Health and Disease 2023
Effects of Seven Weeks of Combined Physical Training on High-Density Lipoprotein Functionality in Overweight/Obese Subjects
Bacchetti T, Morresi C, Ferretti G, Larsson A, Åkerfeldt T, Svensson M
Metabolites 2023
Echinacea purpurea extract intervention for counteracting neurochemical and behavioral changes induced by bifenthrin.
Abdel-Wahhab KG, Sayed RS, El-Sahra DG, Hassan LK, Elqattan GM, Mannaa FA
Metabolic Brain Disease 2023
CRP/HDL-C and Monocyte/HDL-C ratios as Predictors of Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus.
Djesevic M, Hasic S, Lepara O, Jahic R, Kurtovic A, Fajkic A
2023
HDL Metabolism and Diseases
L Zheng
2022
The Functional Role of Lipoproteins in Atherosclerosis: Novel Directions for Diagnosis and Targeting Therapy
Yongzheng Lu, Xiaolin Cui, Li Zhang, Xu Wang, Yanyan Xu, Zhen Qin, Gangqiong Liu, Qiguang Wang, Kang Tian, Khoon S Lim, Chris J Charles, Jinying Zhang, Junnan Tang
Aging and disease 2022
HDL Composition, Heart Failure, and Its Comorbidities
A Diab, C Ripoll, Z Guo, A Javaheri
Frontiers in Cardiovascular Medicine 2022
HDL and Endothelial Function.
Wu Y, Xu Y, Chen J, Zhao M, Rye KA
Advances in experimental medicine and biology 2022
Alterations of HDL's to piHDL's Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies.
Vyletelová V, Nováková M, Pašková Ľ
Pharmaceuticals (Basel, Switzerland) 2022
Abnormal paraoxonase-1 (PON1) enzyme activity in idiopathic inflammatory myopathies.
Bae SS, Shahbazian A, Wang J, Golub I, Oganesian B, Dowd T, Vayngortin B, Wang R, Elashoff D, Reddy ST, Charles-Schoeman C
Rheumatology (Oxford, England) 2022
Sensitive Assay for the Lactonase Activity of Serum Paraoxonase 1 (PON1) by Harnessing the Fluorescence Turn-On Characteristics of Bioorthogonally Synthesized and Geometrically Controlled Chemical Probes.
Fang BK, Dai CY, Severance S, Hwang CC, Huang CH, Hou SY, Yeh BL, Gong MM, Chou YH, Wang JJ, Wang TP
Molecules (Basel, Switzerland) 2022
The Hydrolysis Rate of Paraoxonase-1 Q and R Isoenzymes: An In Silico Study Based on In Vitro Data.
Karabulut S, Mansour B, Casanola-Martin GM, Rasulev B, Gauld JW
Molecules (Basel, Switzerland) 2022
Ameliorations in dyslipidemia and atherosclerotic plaque by the inhibition of HMG-CoA reductase and antioxidant potential of phytoconstituents of an aqueous seed extract of Acacia senegal (L.) Willd in rabbits.
Charan J, Riyad P, Ram H, Purohit A, Ambwani S, Kashyap P, Singh G, Hashem A, Abd Allah EF, Gupta VK, Kumar A, Panwar A
PloS one 2022
Effect of Carotenoids on Paraoxonase-1 Activity and Gene Expression.
Otocka-Kmiecik A
Nutrients 2022
Obstructive Sleep Apnoea and Lipid Metabolism: The Summary of Evidence and Future Perspectives in the Pathophysiology of OSA-Associated Dyslipidaemia
Meszaros M, Bikov A
Biomedicines 2022
Paraoxonase 1 and atrial fibrillation: Is there a relationship?
Istratoaie S, Boroş B, Vesa ŞC, Maria Pop R, Cismaru G, Pop D, Vasile Milaciu M, Ciumărnean L, Văcăraş V, Dana Buzoianu A
Medicine 2022
HDL Isolated by Immunoaffinity, Ultracentrifugation, or Precipitation is Compositionally and Functionally Distinct
Holzer M, Ljubojevic-Holzer S, Souza Junior DR, Stadler JT, Rani A, Scharnagl H, Ronsein GE, Marsche G
Journal of lipid research 2022
Periconceptional Mediterranean diet during pregnancy on children's health.
Çobanoğullari H, Ergoren MC, Dundar M, Bertelli M, Tulay P
Journal of Preventive Medicine and Hygiene 2022
Association between Paraoxonase/Arylesterase Activity of Serum PON-1 Enzyme and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.
Erre GL, Bassu S, Giordo R, Mangoni AA, Carru C, Pintus G, Zinellu A
2022
Effect of Dialyzer Reuse on the Activity of Paraoxonase 1 in Patients on Hemodialysis.
Miguita R Jr, Matsumoto AK, Michelin AP, Morelli NR, Baltus THL, Delfino VDA, Barbosa DS
Indian journal of nephrology 2022
Endothelial Lipase Modulates Paraoxonase 1 Content and Arylesterase Activity of HDL
I Schilcher, JT Stadler, M Lechleitner, A Hrzenjak, A Berghold, G Pregartner, M Lhomme, M Holzer, M Korbelius, F Reichmann, A Springer, C Wadsack, T Madl, D Kratky, A Kontush, G Marsche, S Frank
International journal of molecular sciences 2021
High density lipoproteins and oxidative stress in breast cancer
G Mazzuferi, T Bacchetti, O Islam, G Ferretti
Lipids in Health and Disease 2021
Paraoxonase‐1 (PON1) Status Analysis Using Non‐Organophosphate Substrates
J Marsillach, RJ Richter, LG Costa, CE Furlong
2021
Mitochondrial Mutations and Genetic Factors Determining NAFLD Risk
SA Dabravolski, EE Bezsonov, MS Baig, TV Popkova, LV Nedosugova, AV Starodubova, AN Orekhov
International journal of molecular sciences 2021
Dietary Strategies to Improve Cardiovascular Health: Focus on Increasing High-Density Lipoprotein Functionality.
Stadler JT, Marsche G
Frontiers in Nutrition 2021
The Relevance of Noncoding DNA Variations of Paraoxonase Gene Cluster in Atherosclerosis-Related Diseases
A Wysocka, A Zwolak
International journal of molecular sciences 2021
Paraoxonase 1 concerning dyslipidaemia, cardiovascular diseases, and mortality in haemodialysis patients
AE Grzegorzewska, P Adamska, E Iwańczyk-Skalska, K Ostromecka, L Niepolski, W Marcinkowski, A Mostowska, W Warchoł, C Żaba, PP Jagodziński
Scientific Reports 2021
Anabolic treatments in bovines: quantification of plasma protein markers of dexamethasone administration
R Stella, D Bovo, E Mastrorilli, M Pezzolato, E Bozzetta, G Biancotto
PROTEOMICS 2021
Paraoxonase 1 gene variants concerning cardiovascular mortality in conventional cigarette smokers and non-smokers treated with hemodialysis
AE Grzegorzewska, K Ostromecka, MK Świderska, P Adamska, A Mostowska, PP Jagodziński
Scientific Reports 2021
EPA’s pleiotropic mechanisms of action: a narrative review
JR Nelson, MJ Budoff, OR Wani, V Le, DK Patel, A Nelson, RL Nemiroff
Postgraduate Medicine 2021
Paraoxonase 1 gene (PON1) variants concerning hepatitis C virus (HCV) spontaneous clearance in hemodialysis individuals: a case–control study
AE Grzegorzewska, A Mostowska, W Warchoł, PP Jagodziński
BMC Infectious Diseases 2021
The effect of grape products containing polyphenols on oxidative stress: a systematic review and meta-analysis of randomized clinical trials
S Sarkhosh-Khorasani, ZS Sangsefidi, M Hosseinzadeh
Nutrition Journal 2021
The Role of Oxidative Stress in Sarcoidosis
SS Fois, S Canu, AG Fois
International journal of molecular sciences 2021
Hepatic paraoxonase 1 ameliorates dysfunctional high-density lipoprotein and atherosclerosis in scavenger receptor class B type I deficient mice
XJ Zhao, LC Liu, C Guo, WW Shen, J Cao, F Du, DF Wu, H Yu
Annals of translational medicine 2021
Serum Paroxonase 1 level may be an Indicator and Predictor of the Severity of Androgenetic Alopecia.
Tantawy M, Khabir AA, Mahsoub N, Zohdy M
International journal of trichology 2021
Artichoke and Bergamot Phytosome Alliance: A Randomized Double Blind Clinical Trial in Mild Hypercholesterolemia.
Riva A, Petrangolini G, Allegrini P, Perna S, Giacosa A, Peroni G, Faliva MA, Naso M, Rondanelli M
Nutrients 2021
Repetitions of Strenuous Exercise Consistently Increase Paraoxonase 1 Concentration and Activity in Plasma of Average-Trained Men.
Otocka-Kmiecik A, Orłowska-Majdak M, Stawski R, Szkudlarek U, Kosielski P, Padula G, Gałczyński S, Nowak D
Oxidative medicine and cellular longevity 2021
PON1 (Paraoxonase 1) Q192R Gene Polymorphism in Ischemic Stroke among North Indian Population.
Gupta A, Saluja A, Saraswathy KN, Imnameren L, Yadav S, Dhamija RK
Annals of Indian Academy of Neurology 2021
Association Between PON1 (L55M and Q192R) Genetic Polymorphism and Recurrent Pregnancy Loss in North Indian Women Exposed to Pesticides.
Jaiswar SP, Priyadarshini A, Singh A, Ahmad MK, Deo S, Sankhwar P
2021
Effects of disease activity on lipoprotein levels in patients with early arthritis: can oxidized LDL cholesterol explain the lipid paradox theory?
AM Fernández-Ortiz, AM Ortiz, S Pérez, E Toledano, L Abásolo, MA González-Gay, S Castañeda, I González-Álvaro
Arthritis Research & Therapy 2020
HDL Proteome and Alzheimer’s Disease: Evidence of a Link
J Marsillach, MP Adorni, F Zimetti, B Papotti, G Zuliani, C Cervellati
Antioxidants 2020
The Structure and Function of Paraoxonase-1 and Its Comparison to Paraoxonase-2 and -3
A Taler-Verčič, M Goličnik, A Bavec
Molecules (Basel, Switzerland) 2020
Association of combined genetic variations in SOD3, GPX3, PON1, and GSTT1 with hypertension and severity of coronary artery disease
N Decharatchakul, C Settasatian, N Settasatian, N Komanasin, U Kukongviriyapan, P Intharapetch, V Senthong, K Sawanyawisuth
Heart and Vessels 2020
Biological Activities of Egg Yolk Lipids: A Review
N Xiao, Y Zhao, Y Yao, N Wu, M Xu, H Du, Y Tu
Journal of Agricultural and Food Chemistry 2020
African Walnuts (Tetracarpidium conophorum) Modulate Hepatic Lipid Accumulation in Obesity via Reciprocal Actions on HMG-CoA Reductase and Paraoxonase
DE Uti, IJ Atangwho, EU Eyong, GU Umoru, GE Egbung, SO Rotimi, VU Nna
Endocrine, metabolic & immune disorders drug targets 2020
Benzenesulfonamide derivatives containing imine and amine groups: Inhibition on human paraoxonase and molecular docking studies
M Işık, Ş Beydemir, Y Demir, M Durgun, C Türkeş, A Nasır, A Necip, M Akkuş
International Journal of Biological Macromolecules 2020
Metabolome and proteome changes in skeletal muscle and blood of pre-weaning calves fed leucine and threonine supplemented diets
K Yu, M Matzapetakis, A Horvatić, M Terré, A Bach, J Kuleš, N Yeste, N Gómez, L Arroyo, E Rodríguez-Tomàs, R Peña, N Guillemin, AM de Almeida, PD Eckersall, A Bassols
Journal of Proteomics 2020
Vasculoprotective Effects of Vildagliptin. Focus on Atherogenesis
M Wiciński, K Górski, E Wódkiewicz, M Walczak, M Nowaczewska, B Malinowski
International journal of molecular sciences 2020
Oxidative Stress Biomarkers and Peripheral Endothelial Dysfunction in Rheumatoid Arthritis: A Monocentric Cross-Sectional Case-Control Study
S Bassu, A Zinellu, S Sotgia, AA Mangoni, A Floris, G Farina, G Passiu, C Carru, GL Erre
Molecules (Basel, Switzerland) 2020
Serial measurements of Paraoxonase-1 (PON-1) activity in horses with experimentally induced endotoxemia
D Scavone, M Sgorbini, AS Borges, JP Oliveira-Filho, V Vitale, S Paltrinieri
BMC veterinary research 2020
Effect of Roux-en-Y Gastric Bypass on Lipoprotein Metabolism and Markers of HDL Functionality in Morbid Obese Patients
EL Chiappe, M Martin, AI Molli, A Millan, W Tetzlaff, E Botta, F Ferraro, MS Sáez, MV Gonzalez, L Boero, P Sorroche, A Beskow, M Gutierrez, G Cerrone, S Gutt, G Frechtel, F Brites
Obesity Surgery 2020
Preanalytical variables affecting the measurement of serum paraoxonase-1 activity in horses
G Rossi, A Richardson, H Jamaludin, C Secombe
Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc 2020
Paraoxonase single nucleotide variants show associations with polycystic ovary syndrome: a meta-analysis
A Kunjantarachot, N Pabalan, H Jarjanazi, DM Christofolini, E Montagna, CP Barbosa, B Bianco
Reproductive Biology and Endocrinology 2020
High-Density Lipoprotein-Targeted Therapies for Heart Failure
M Mishra, BD Geest
Biomedicines 2020
The effect of resveratrol supplementation on serum levels of asymmetric de‐methyl‐arginine and paraoxonase 1 activity in patients with type 2 diabetes: A randomized, double‐blind controlled trial
M Tabatabaie, S Abdollahi, A SalehiAbargouei, CC Clark, E KarimiNazari, H Fallahzadeh, M Rahmanian, H MozaffariKhosravi
Phytotherapy research : PTR 2020
Baicalein maintains redox balance in experimental hyperlipidemic rats
SS Tripathi, R Kumar, A Bissoyi, SI Rizvi
Archives Of Physiology And Biochemistry 2020
Handbook of Dietary Phytochemicals
J Xiao, SD Sarker, Y Asakawa
2020
ABCA1 gene R1587K polymorphism could be associated with metabolic syndrome and increased plasma triglyceride concentration in adults from northern Mexico
MP Quijada, ZR Castillo, OR Pellegrini, EA Ochoa, SY Camarena, MM Corral, MN Vásquez
Nutrición hospitalaria 2020
Paraoxonase 1 gene polymorphisms concerning non-insulin-dependent diabetes mellitus nephropathy in hemodialysis patients
AE Grzegorzewska, K Ostromecka, P Adamska, A Mostowska, W Warchoł, PP Jagodziński
Journal of Diabetes and its Complications 2020
Cholesterol homeostasis: researching a dialogue between the brain and peripheral tissues
M Gliozzi, V Musolino, F Bosco, M Scicchitano, F Scarano, S Nucera, MC Zito, S Ruga, C Carresi, R Macrì, L Guarnieri, J Maiuolo, A Tavernese, AR Coppoletta, C Nicita, R Mollace, E Palma, C Muscoli, C Belzung, V Mollace
Pharmacological research : the official journal of the Italian Pharmacological Society 2020
Simultaneous Cross-Linking and Cross-Polymerization of Enzyme Responsive Polyethylene Glycol Nanogels in Confined Aqueous Droplets for Reduction of Low-Density Lipoprotein Oxidation
S Basak, HA Khare, M Roursgaard, PJ Kempen, JH Lee, S Bazban-Shotorbani, M Kræmer, S Chernyy, TL Andresen, K Almdal, N Kamaly
Biomacromolecules 2020
İnsan Serum Paraoksonaz-1 (PON1) Üzerine Zoledronik Asit’in İn Vitro İnhibisyon Etkisi
H SÖYÜT, Y ULUTAŞ, E KÖKSAL
2020
Paraoxonase-1 as a Regulator of Glucose and Lipid Homeostasis: Impact on the Onset and Progression of Metabolic Disorders
Meneses, Silvestre, SL, Macedo
International journal of molecular sciences 2019
Evaluating the link between Paraoxonase-1 levels and Alzheimer's disease development
C Cervellati, G Valacchi, V Tisato, G Zuliani, J Marsillach
Minerva medica 2019
Comparative analysis of plasma total antioxidant capacity in patients with hyperglycemia and hyperglycemia plus dyslipidemia
V Vichaibun, K Khananurak, T Sophonnithiprasert
Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2019
Interaction between MTHFR 677C>T, PON1 192Q>R and PON1 55L>M polymorphisms and its effect on non-recurrent spontaneous abortion in Mexican women
J Blanco-Muñoz, M Lacasaña, R Gamboa, C Huesca-Gómez, JÁ Hernández-Mariano, C Aguilar-Garduño
Gene 2019
Hepatoprotective immune response during Trichinella spiralis infection in mice
AS FARID, EM FATH, S MIDO, N NONAKA, Y HORII
Journal of Veterinary Medical Science 2019
Epimedium koreanum Extract and Its Flavonoids Reduced Atherosclerotic Risk via Suppressing Modification of Human HDL
JY Kim, SH Shim
Nutrients 2019
Paraoxonase 1 Activity, Polymorphism and Atherosclerosis Risk Factors in Patients Undergoing Coronary Artery Surgery
A Wysocka, M Cybulski, A P.Wysokiński, H Berbeć, J Stążka, T Zapolski
Journal of Clinical Medicine 2019
Organochlorine and organophosphorous pesticides may induce colorectal cancer; A case-control study
M Abolhassani, G Asadikaram, P Paydar, H Fallah, M Aghaee-Afshar, V Moazed, H Akbari, SD Moghaddam, A Moradi
Ecotoxicology and Environmental Safety 2019
Association of paraoxonase-1 L55M and Q192R polymorphisms with PCOS risk and potential risk factors for atherosclerosis
HS Nalkiran, SB Sahin, T Ayaz, I Nalkiran, AI Guzel, T Eldes, Y Yildiz
Biomarkers in Medicine 2019
Paraoxonases Activities and Polymorphisms in Elderly and Old-Age Diseases: An Overview
D Levy, CO Reichert, SP Bydlowski
Antioxidants 2019
Low Serum Paraoxonase-1 Activity Associates with Incident Cardiovascular Disease Risk in Subjects with Concurrently High Levels of High-Density Lipoprotein Cholesterol and C-Reactive Protein
JP Corsetti, CE Sparks, RW James, SJ Bakker, RP Dullaart
Journal of Clinical Medicine 2019
Lipoproteins in Atherosclerosis Process
V Arnao, A Tuttolomondo, M Daidone, A Pinto
Current medicinal chemistry 2019
Antibiotics Used in Patients after Surgery and Effects of Human Serum Paraoxonase-I (PON1) Enzyme Activity
A Yılmaz, E Dilek
Protein and peptide letters 2019
Intravenous laser wavelength radiation effect on LCAT, PON1, catalase, and FRAP in diabetic rats
A Amjadi, H Mirmiranpour, SO Sobhani, NM Goudarzi
Lasers in Medical Science 2019
Investigation of Potential Paraoxonase-I Inhibitors by Kinetic and Molecular Docking Studies: Chemotherapeutic Drugs
C Türkeş
Protein and peptide letters 2019
Antibiyotik Olarak Kullanılan Sultamisilin, Sefdinir, Vankomisin Hidroklorür ve Kolistin Etken Maddelerinin İnsan Serum Paraoksonaz1 Enzim Aktivitesi Üzerine in vitro Etkilerinin İncelenmesi
E Dilek, MB ÖZÇELİK, S YILDIRIM
2019
PON1 arylesterase activity, HDL functionality and their correlation in malnourished children
MR Mogarekar, MG Dhabe, MM Palmate
Journal of Pediatric Endocrinology and Metabolism 2019
Influence of Surgical Procedures on Serum Paraoxonase-1-Related Variables and Markers of Inflammation in Hospitalized Patients
S Iftimie, A Escribano, A Díez-Sans, I Albiciuc, A Hernández-Aguilera, I Fort-Gallifa, AF López-Azcona, J Camps, J Joven, A Castro
Journal of Investigative Surgery 2019
High-Density Lipoproteins as Biomarkers and Therapeutic Tools: Volume 1. Impacts of Lifestyle, Diseases, and Environmental Stressors on HDL
KH Cho
2019
Associations between nine candidate genetic polymorphisms with coronary heart disease: A meta-analysis
Q Li, Q Du
Herz 2019
Anti-inflammatory, anti-oxidant and hepatoprotective effects of lactoferrin in rats
AS Farid, MA Shemy, E Nafie, AM Hegazy, EY Abdelhiee
Drug and Chemical Toxicology 2019
Aspirinin insan kaynaklı hepatoma hücrelerinde paraoksonaz enzimlerinin protein düzeylerine ve arilesteraz aktivitesine etkisi
E Özgün, GS Özgün
2019
Bazı antrakinonların insan paraoksonaz 1 (hPON1) üzerine etkilerinin incelenmesi
B GÖKÇE
2019
In Vitro and In Silico Studies on the Toxic Effects of Antibacterial Drugs as Human Serum Paraoxonase 1 Inhibitor
C Türkeş, Ş Beydemir, Öİ Küfrevioğlu
ChemistrySelect 2019
Relationship between Paraoxonase-1 and Arylesterase Enzyme Activities and SYNTAX I and II Scores in Patients with ST-Elevation Myocardial Infarction
Erdoğan Sökmen, Mustafa Çelik, Serkan Sivri, Kenan Güçlü
The Journal of Tehran University Heart Center 2019
The effect of coenzyme Q and selenium on kidney in rats with partial unilateral ureteral obstruction
MK Kirdag, D Tuglu, E Yuvanc, U Kisa, M Balci, E Batislam, E Yilmaz
Türk Üroloji Dergisi/Turkish Journal of Urology 2019
High-Density Lipoproteins
A Haghikia, U Landmesser
Cardiology Clinics 2018
Functional features of the “finger” domain of the DEG/ENaC channels MEC-4 and UNC-8
C Matthewman, CK Johnson, DM Miller, L Bianchi
American journal of physiology. Cell physiology 2018
Distribution of Paraoxonase-1 (PON-1) and Lipoprotein Phospholipase A2 (Lp-PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes
A Passaro, GB Vigna, A Romani, JM Sanz, C Cavicchio, G Bonaccorsi, G Valacchi, C Cervellati
Oxidative medicine and cellular longevity 2018
Decreases in Paraoxonase-1 Activities Promote a Pro-inflammatory Effect of Lipids Peroxidation Products in Non-smoking and Smoking Patients with Acute Pancreatitis
G Marek, M Ściskalska, Z Grzebieniak, H Milnerowicz
International journal of medical sciences 2018
Paraoxonase activity in metabolic syndrome in children and adolescents
Adhe-Rojekar A, Mogarekar MR, Rojekar MV
Caspian Journal of Internal Medicine 2018
Effect of Atorvastatin on Serum Para-Oxonase-1 and C-Reactive Protein in Wistar Rats
A Marathe, B Ganaraja, KA Shenoy, KA Prabhu, M Nandini
Indian Journal of Clinical Biochemistry 2018
A Possible Mechanism: Vildagliptin Prevents Aortic Dysfunction through Paraoxonase and Angiopoietin-Like 3
Q Zhang, X Xiao, J Zheng, M Li, M Yu, F Ping, T Wang, X Wang
BioMed Research International 2018
Biomechanistic insights into the roles of oxidative stress in generating complex neurological disorders
M Yusuf, M Khan, MA Robaian, RA Khan
Biological Chemistry 2018
Oxidative Stress in Spinocerebellar Ataxia Type 7 Is Associated with Disease Severity
Y Torres-Ramos, A Montoya-Estrada, B Cisneros, K Tercero-Pérez, G León-Reyes, N Leyva-García, O Hernández-Hernández, JJ Magaña
The Cerebellum 2018
Oxidative modifications of foetal LDL-c and HDL-c lipoproteins in preeclampsia
G León-Reyes, SE y Sosa, R Medina-Navarro, AM Guzmán-Grenfell, AX Medina-Urrutia, S Fuentes-García, GJ Hicks, YD Torres-Ramos
Lipids in Health and Disease 2018
Alterations in haemolymph proteome of Mytilus galloprovincialis mussel after an induced injury
L Franco-Martínez, S Martínez-Subiela, D Escribano, S Schlosser, K Nöbauer, E Razzazi-Fazeli, D Romero, JJ Cerón, A Tvarijonaviciute
Fish & Shellfish Immunology 2018
Decreased serum PON1 arylesterase activity in familial hypercholesterolemia patients with a mutated LDLR gene
M Idrees, AR Siddiq, M Ajmal, M Akram, RR Khalid, A Hussain, R Qamar, H Bokhari
Genetics and molecular biology 2018
Slim Body Weight Is Highly Associated With Enhanced Lipoprotein Functionality, Higher HDL-C, and Large HDL Particle Size in Young Women
KH Park, D Yadav, SJ Kim, JR Kim, KH Cho
Frontiers in Endocrinology 2018
Ethnic Disparities in Endothelial Function and Its Cardiometabolic Correlates: The Pathobiology of Prediabetes in A Biracial Cohort Study
I Owei, N Umekwe, H Mohamed, S Ebenibo, J Wan, S Dagogo-Jack
Frontiers in Endocrinology 2018
Terminalia pallida fruit ethanolic extract ameliorates lipids, lipoproteins, lipid metabolism marker enzymes and paraoxonase in isoproterenol-induced myocardial infarcted rats
AH Shaik, NR Shaik, AK Mohammed, SY Omar, A Mohammad, TA Mohaya, LD Kodidhela
Saudi Journal of Biological Sciences 2018
Lipid associated antioxidants: arylesterase and paraoxonase-1 in benign prostatic hyperplasia treatment-naïve patients
GA Asare, SE Andam, H Asare-Anane, S Ammanquah, Y Anang-Quartey, DK Afriyie, I Musah
Prostate International 2018
Significant association between paraoxonase 1 rs662 polymorphism and coronary heart disease: A meta-analysis in the Chinese population
Z Deng, H Xiang, W Gao
Herz 2018
Therapeutic potentials of propolis and pollen on biochemical changes in reproductive function of L-NAME induced hypertensive male rats
MF Gulhan
Clinical and Experimental Hypertension 2018
Associations of the PON1 rs662 polymorphism with circulating oxidized low-density lipoprotein and lipid levels: a systematic review and meta-analysis
Z Luo, L Pu, I Muhammad, Y Chen, X Sun
Lipids in Health and Disease 2018
Long-Term Supplementation of Black Elderberries Promotes Hyperlipidemia, but Reduces Liver Inflammation and Improves HDL Function and Atherosclerotic Plaque Stability in Apolipoprotein E-Knockout Mice
CL Millar, GH Norris, C Jiang, J Kry, A Vitols, C Garcia, YK Park, JY Lee, CN Blesso
Molecular Nutrition & Food Research 2018
Exogenous (Pomegranate Juice) or Endogenous (Paraoxonase1) Antioxidants Decrease Triacylglycerol Accumulation in Mouse Cardiovascular Disease-Related Tissues
O Rom, N Volkova, H Jeries, C Grajeda-Iglesias, M Aviram
Lipids 2018
The Role of Acetylcholinesterase, Paraxonase, and Oxidative Stress in Breast Tumors
P Paydar, G Asadikaram, HZ Nejad, V Moazed, B Poursayedi, MH Nematollahi, H Akbari, M Abolhassani, FK Shadmani
International Journal of Cancer Management 2018
Pulmonary Health and Disorders
M Pokorski
2018
Pulmonary Health and Disorders
M Pokorski
2018
Pulmonary Health and Disorders
M Pokorski
2018
Design, synthesis and evaluation of antitumor acylated monoaminopyrroloquinazolines
B Chao, BX Li, X Xiao
Bioorganic & Medicinal Chemistry Letters 2017
Paraoxonase and atherosclerosis-related cardiovascular diseases
DA Chistiakov, AA Melnichenko, AN Orekhov, YV Bobryshev
Biochimie 2017
Is hyperhomocysteinemia a causal factor for heart failure? The impact of the functional variants of MTHFR and PON1 on ischemic and non-ischemic etiology
E Strauss, W Supinski, A Radziemski, G Oszkinis, AL Pawlak, J Gluszek
International Journal of Cardiology 2017
Active Site Hydrophobicity and the Convergent Evolution of Paraoxonase Activity in Structurally Divergent Enzymes: The Case of Serum Paraoxonase 1
D Blaha-Nelson, DM Krüger, K Szeler, M Ben-David, SC Kamerlin
Journal of the American Chemical Society 2017
Could high-density lipoprotein cholesterol predict increased cardiovascular risk?:
TI Chang, E Streja, H Moradi
Current opinion in endocrinology, diabetes, and obesity 2017
Paraoxonase-1 activity is related to Trichinella spiralis -induced hepatitis in rats
AS Farid, EM Fath, S Mido, N Nonaka, Y Horii
European Journal of Clinical Investigation 2017
The Application of a Modified d-ROMs Test for Measurement of Oxidative Stress and Oxidized High-Density Lipoprotein
F Ito, T Ito, C Suzuki, T Yahata, K Ikeda, K Hamaoka
International journal of molecular sciences 2017
The Search for Dietary Supplements to Elevate or Activate Circulating Paraoxonases
J Lou-Bonafonte, C Gabás-Rivera, M Navarro, J Osada
International journal of molecular sciences 2017
Interaction between prenatal pesticide exposure and a common polymorphism in the PON1 gene on DNA methylation in genes associated with cardio-metabolic disease risk—an exploratory study
K Declerck, S Remy, C Wohlfahrt-Veje, KM Main, GV Camp, G Schoeters, WV Berghe, HR Andersen
Clinical Epigenetics 2017
Oxidative profiles of LDL and HDL isolated from women with preeclampsia
G León-Reyes, RF Maida-Claros, AX Urrutia-Medina, E Jorge-Galarza, AM Guzmán-Grenfell, S Fuentes-García, R Medina-Navarro, MA Moreno-Eutimio, JL Muñoz-Sánchez, JJ Hicks, YD Torres-Ramos
Lipids in Health and Disease 2017
Disparities in Cardiovascular Disease and Type 2 Diabetes Risk Factors in Blacks and Whites: Dissecting Racial Paradox of Metabolic Syndrome
K Osei, T Gaillard
Frontiers in Endocrinology 2017
Phytochemical Constituents, Health Benefits, and Industrial Applications of Grape Seeds: A Mini-Review
Z Ma, H Zhang
Antioxidants 2017
High-density lipoprotein-associated paraoxonase 1: a possible prognostic biomarker for heart failure?: Editorial comment
O Rom, M Aviram
European Journal of Heart Failure 2017
Atherogenicity of amino acids in the lipid-laden macrophage model system in vitro and in atherosclerotic mice: A key role for triglyceride metabolism
O Rom, C Grajeda-Iglesias, M Najjar, N Abu-Saleh, N Volkova, DE Dar, T Hayek, M Aviram
The Journal of Nutritional Biochemistry 2017
Paraoxonases and infectious diseases
J Camps, S Iftimie, A García-Heredia, A Castro, J Joven
Clinical Biochemistry 2017
Type 2 Diabetes in Young Females Results in Increased Serum Amyloid A and Changes to Features of High Density Lipoproteins in Both HDL 2 and HDL 3
K Griffiths, A Pazderska, M Ahmed, A McGowan, AP Maxwell, J McEneny, J Gibney, GJ McKay
Journal of Diabetes Research 2017
Correlation of PON1 polymorphisms with ankylosing spondylitis susceptibility: A case–control study in Chinese Han population
H Xu, Y Qu
Medicine 2017
The value of time-averaged serum high-sensitivity C-reactive protein in prediction of mortality and dropout in peritoneal dialysis patients
SH Liu, CY Chen, YJ Li, HH Wu, CY Lin, YC Chen, MY Chang, HH Hsu, CL Ku, YC Tian
Therapeutics and Clinical Risk Management 2017
Paraoxonase and arylesterase activity in bladder cancer
MM Utangac, E Yeni, M Savas, A Altunkol, H Ciftci, K Gumus, M Demir
Türk Üroloji Dergisi/Turkish Journal of Urology 2017
Type 2 Diabetes in Young Females Results in Increased Serum Amyloid A and Changes to Features of High Density Lipoproteins in Both HDL 2 and HDL 3
K Griffiths, A Pazderska, M Ahmed, A McGowan, AP Maxwell, J McEneny, J Gibney, GJ McKay
Journal of Diabetes Research 2017
Similar Active Sites and Mechanisms Do Not Lead to Cross-Promiscuity in Organophosphate Hydrolysis: Implications for Biotherapeutic Engineering
M Purg, M Elias, SC Kamerlin
Journal of the American Chemical Society 2017
Low-dose grape pomace and omija fruit extract is more effective than high-dose in lowering oxidative stress and fat-pad mass in db/db mice
SJ Cho, HJ Kim, JY Choi, EY Kwon, YJ Kim, R Ryu, MS Choi, YB Park
Food Science and Biotechnology 2017
Alteration of paraoxonase, arylesterase and lactonase activities in people around fluoride endemic area of Tamil Nadu, India
M Arulkumar, R Vijayan, S Penislusshiyan, P Sathishkumar, J Angayarkanni, T Palvannan
Clinica Chimica Acta 2017
ATHEROTHROMBOSIS AND OXIDATIVE STRESS: MECHANISMS AND MANAGEMENT IN ELDERLY
F Violi, L Loffredo, R Carnevale, P Pignatelli, D Pastori
Antioxidants & Redox Signaling 2017
Serum paraoxonase activity in patients with ischaemic and nonischaemic dilated cardiomyopathy
F Gungoren, T Senturk, A Ozturk, K Koz, E Sarandol, D Yesilbursa, S Gullulu, G Ozkaya, A Aydinlar
Acta Cardiologica 2017
Paraoxonase 1 (PON1) and stroke; the dilemma of genetic variation
A Tajbakhsh, M Rezaee, M Rivandi, F Forouzanfar, F Afzaljavan, A Pasdar
Clinical Biochemistry 2017
Paraoxonase, arylesterase and lactonase activities of paraoxonase-1 (PON1) in obese and severely obese women
C Cervellati, G Bonaccorsi, A Trentini, G Valacchi, JM Sanz, M Squerzanti, M Spagnolo, L Massari, I Crivellari, P Greco, R Parladori, A Passaro, G Ricci
Scandinavian Journal of Clinical & Laboratory Investigation 2017
The role of paraoxonase in cancer
T Bacchetti, G Ferretti, A Sahebkar
Seminars in Cancer Biology 2017
A case-control study: The association of serum paraoxonase 1 activity and concentration with the development of type 2 diabetes mellitus
JA Crow, EC Meek, RW Wills, JE Chambers
Diabetes/Metabolism Research and Reviews 2017
SERUM PARAOXONASE ACTIVITY IN RENAL TRANSPLANT RECIPIENTS
S Gadicherla, S M.N, P Doddamani
2017
Combined Effects of Curcumin and Lycopene or Bixin in Yoghurt on Inhibition of LDL Oxidation and Increases in HDL and Paraoxonase Levels in Streptozotocin-Diabetic Rats.
Assis RP, Arcaro CA, Gutierres VO, Oliveira JO, Costa PI, Baviera AM, Brunetti IL
International journal of molecular sciences 2017
Paradoxical effects of SAA on lipoprotein oxidation suggest a new antioxidant function for SAA
S Jayaraman, C Haupt, O Gursky
Journal of lipid research 2016
Paraoxonase 1-treated oxLDL promotes cholesterol efflux from macrophages by stimulating the PPARγ-LXRα-ABCA1 pathway
S Ikhlef, H Berrougui, OK Simo, A Khalil
FEBS Letters 2016
HDL—A molecule with a multi-faceted role in coronary artery disease
S Arora, SK Patra, R Saini
Clinica Chimica Acta 2016
A Genetic Biomarker of Oxidative Stress, the Paraoxonase-1 Q192R Gene Variant, Associates with Cardiomyopathy in CKD: A Longitudinal Study
E Dounousi, I Bouba, B Spoto, K Pappas, G Tripepi, I Georgiou, A Tselepis, M Elisaf, D Tsakiris, C Zoccali, K Siamopoulos
Oxidative medicine and cellular longevity 2016
Concentration of Smaller High‐Density Lipoprotein Particle (HDL‐P) Is Inversely Correlated With Carotid Intima Media Thickening After Confounder Adjustment: The Multi Ethnic Study of Atherosclerosis (MESA)
DS Kim, YK Li, GA Bell, AA Burt, T Vaisar, PM Hutchins, CE Furlong, JD Otvos, JF Polak, MK Arnan, JD Kaufman, RL McClelland, WT Longstreth, GP Jarvik
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2016
iTRAQ-based proteomic analysis of plasma reveals abnormalities in lipid metabolism proteins in chronic kidney disease-related atherosclerosis
M Luczak, D Formanowicz, Ł Marczak, J Suszyńska-Zajczyk, E Pawliczak, M Wanic-Kossowska, M Stobiecki
Scientific Reports 2016
Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases
M Castellazzi, A Trentini, A Romani, G Valacchi, T Bellini, G Bonaccorsi, E Fainardi, C Cavicchio, A Passaro, G Zuliani, C Cervellati
The International Journal of Biochemistry & Cell Biology 2016
Caenorhabditis elegans paraoxonase-like proteins control the functional expression of DEG/ENaC mechanosensory proteins
Y Chen, S Bharill, Z Altun, R OHagan, B Coblitz, EY Isacoff, M Chalfie
Molecular biology of the cell 2016
Metrics of High-Density Lipoprotein Function and Hospital Mortality in Acute Heart Failure Patients
I Potočnjak, V Degoricija, M Trbušić, SD Terešak, B Radulović, G Pregartner, A Berghold, B Tiran, G Marsche, S Frank, L Calabresi
PloS one 2016
A review of paraoxonase 1 properties and diagnostic applications
M Kulka
Polish Journal of Veterinary Sciences 2016
Increased presence of oxidized low‐density lipoprotein in the left ventricular blood of subjects with cardiovascular disease
CA Narasimhulu, D Litvinov, B Sengupta, D Jones, C SaiSudhakar, M Firstenberg, B Sun, S Parthasarathy
Physiological Reports 2016
Protective Role of Dietary Curcumin in the Prevention of the Oxidative Stress Induced by Chronic Alcohol with respect to Hepatic Injury and Antiatherogenic Markers
R Varatharajalu, M Garige, LC Leckey, K Reyes-Gordillo, R Shah, MR Lakshman
Oxidative medicine and cellular longevity 2016
Meta-markers for the differential diagnosis of lung cancer and lung disease
YI Kim, JM Ahn, HJ Sung, SS Na, J Hwang, Y Kim, JY Cho
Journal of Proteomics 2016
A study of paraoxonase1 (PON1) activities, HDL cholesterol and its association with vascular complication in type 2 diabetes mellitus
MR Mogarekar, MG Dhabe, CC Gujrathi
International Journal of Diabetes in Developing Countries 2016
The contribution of paraoxonase 1 and myeloperoxidase to HDL-cholesterol functionality
M Malara, A Kęska, G Lutosławska
Biomedical Human Kinetics 2016
Water-Soluble Components of Sesame Oil Reduce Inflammation and Atherosclerosis
CA Narasimhulu, K Selvarajan, KY Burge, D Litvinov, B Sengupta, S Parthasarathy
Journal of Medicinal Food 2016
Paraoxonase 1 (PON1) and pomegranate influence circadian gene expression and period length
U Loizides-Mangold, M Koren-Gluzer, S Skarupelova, AM Makhlouf, T Hayek, M Aviram, C Dibner
Chronobiology International 2016
Association of serum amyloid A and oxidative stress with paraoxonase 1 in sarcoidosis patients
J Ivanišević, J Kotur-Stevuljević, A Stefanović, S Spasić, VV Mihailović, JV Ivanov, Z Jelić-Ivanović
European Journal of Clinical Investigation 2016
Effects of improved fat meat products consumption on emergent cardiovascular disease markers of male volunteers at cardiovascular risk
P Celada, FJ Sánchez-Muniz, G Delgado-Pando, S Bastida, ME Rodilla, F Jiménez-Colmenero, B Olmedilla-Alonso
Journal of Physiology and Biochemistry 2016
Atherosclerosis — do we know enough already to prevent it?
CA Narasimhulu, I Fernandez-Ruiz, K Selvarajan, X Jiang, B Sengupta, A Riad, S Parthasarathy
Current Opinion in Pharmacology 2016
Plasma protein thiols: an early marker of oxidative stress in asthma and chronic obstructive pulmonary disease
A Zinellu, AG Fois, S Sotgia, E Zinellu, F Bifulco, G Pintus, AA Mangoni, C Carru, P Pirina
European Journal of Clinical Investigation 2016
Antioxidative Activity after Rosuvastatin Treatment in Patients with Stable Ischemic Heart Disease and Decreased High Density Lipoprotein Cholesterol
DS Park, KH Yun, HY Park, SJ Rhee, NH Kim, SK Oh, JW Jeong
Korean Circulation Journal 2016
Assessing the stoichiometric efficacy of mammalian expressed paraoxonase-1 variant I-F11 to afford protection against G-type nerve agents
DG Mata, P Sabnekar, CA Watson, PE Rezk, N Chilukuri
Chemico-Biological Interactions 2016
Ethnic differences in serum lipids and lipoproteins in overweight/obese African-American and white American women with pre-diabetes: significance of NMR-derived lipoprotein particle concentrations and sizes
T Gaillard, K Osei
BMJ Open Diabetes Research & Care 2016
Serum Paraoxonase activity in relation to lipid profile in Age-related Macular Degeneration patients
K AnandBabu, SR Bharathidevi, S Sripriya, P Sen, VJ Prakash, A Bindu, N Viswanathan, N Angayarkanni
Experimental Eye Research 2016
The Early Effect of Carotid Artery Stenting on Antioxidant Capacity and Oxidative Stress in Patients with Carotid Artery Stenosis
S Michalak, W Ambrosius, E Wysocka, M Dziarmaga, R Juszkat, A Wykretowicz, W Kozubski
Oxidative medicine and cellular longevity 2016
High morning blood pressure surge is associated with oxidative stress and paraoxonase 1 activity in newly diagnosed hypertensive patients
O Kaypaklı, M Gür, H Harbalıoğlu, T Şeker, Ş Selek
Clinical and Experimental Hypertension 2016
In vitro effects of exogenous carbon monoxide on oxidative stress and lipid metabolism in macrophages
L Petrick, M Rosenblat, M Aviram
Toxicology and industrial health 2016
Paraoxonase 1 (PON1) Q192R genotypes and their interaction with smoking strongly increase atherogenicity and the Framingham risk score
A Souza-Nogueira, AE Camargo, FA Remondi, MM Paoliello, RJ Richter, CE Furlong, DS Barbosa, M Maes, EG Moreira
Archives of Endocrinology and Metabolism 2016
Investigation of ischemia-modified albumin levels and some atherosclerosis-related serum parameters in patients with diabetic foot
S MUHTAROĞLU, DB KETİ, K ÜNLÜHİZARCI
TURK J MED SCI 2016
Effects of aerobic training on serum paraoxonase activity and its relationship with PON1-192 phenotypes in women
GR Nalcakan, SR Varol, F Turgay, M Nalcakan, MZ Ozkol, SO Karamizrak
Journal of Sport and Health Science 2016
ASSESSMENT OF PARAOXONASE-1 ACTIVITY IN DIABETES MELLITUS
R Mathivanan, S Natarajan, S Subramaniyam
2016
Paraoxonase 1 (PON1) Q192R genotypes and their interaction with smoking strongly increase atherogenicity and the Framingham risk score.
Souza-Nogueira A, Camargo AE, Remondi FA, Paoliello MM, Richter RJ, Furlong CE, Barbosa DS, Maes M, Moreira EG
Archives of Endocrinology and Metabolism 2016
Anthocyanin-rich black elderberry extract improves markers of HDL function and reduces aortic cholesterol in hyperlipidemic mice
N Farrell, G Norris, SG Lee, OK Chun, CN Blesso
Food & Function 2015
Oxidative stress in chronic vascular disease: From prediction to prevention
F Santilli, D D'Ardes, G Davì
Vascular Pharmacology 2015
The chemistry and pharmacology of privileged pyrroloquinazolines
B Chao, BX Li, X Xiao
MedChemComm 2015
Dysfunctional High-Density Lipoprotein: An Innovative Target for Proteomics and Lipidomics
J Salazar, LC Olivar, E Ramos, M Chávez-Castillo, J Rojas, V Bermúdez
Cholesterol 2015
Identification of Critical Paraoxonase 1 Residues Involved in High Density Lipoprotein Interaction
X Gu, Y Huang, BS Levison, G Gerstenecker, AJ DiDonato, LB Hazen, J Lee, V Gogonea, JA DiDonato, SL Hazen
The Journal of biological chemistry 2015
PLTP activity inversely correlates with CAAD: effects of PON1 enzyme activity and genetic variants on PLTP activity
DS Kim, AA Burt, JE Ranchalis, S Vuletic, T Vaisar, WF Li, EA Rosenthal, W Dong, JF Eintracht, AG Motulsky, JD Brunzell, JJ Albers, CE Furlong, GP Jarvik
Journal of lipid research 2015
Cholesterol Metabolism in CKD
AB Reiss, I Voloshyna, JD Leon, N Miyawaki, J Mattana
American Journal of Kidney Diseases 2015
Human paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological roles
M Mackness, B Mackness
Gene 2015
Molecular Strategies for Targeting Antioxidants to Mitochondria: Therapeutic Implications
N Apostolova, VM Victor
Antioxidants & Redox Signaling 2015
Shift of the interconnection from the reaction system of paraoxonase 1 to the peroxidation reaction system of myeloperoxidase with HDL-C levels: A marker of atherosclerosis in patients with normal cholesterol levels
F Wang, Y Liu, Y Cong, P Li, Y Li, Z Yan, Y Tang, Y Cheng, Y Zheng
Clinica Chimica Acta 2015
Serum paraoxonase and arylesterase activities of paraoxonase-1 (PON-1), mild cognitive impairment, and 2-year conversion to dementia: A pilot study
C Cervellati, A Trentini, A Romani, T Bellini, C Bosi, B Ortolani, A Zurlo, A Passaro, D Seripa, G Zuliani
Journal of Neurochemistry 2015
Effect of statin therapy on paraoxonase-1 status: A systematic review and meta-analysis of 25 clinical trials
G Ferretti, T Bacchetti, A Sahebkar
Progress in Lipid Research 2015
Paraoxonase-2 (PON2) protects oral squamous cell cancer cells against irradiation-induced apoptosis
M Krüger, AM Pabst, B Al-Nawas, S Horke, M Moergel
Journal of Cancer Research and Clinical Oncology 2015
Therapeutic Potential of Ocimum tenuiflorum as MPO Inhibitor with Implications for Atherosclerosis Prevention
CA Narasimhulu, S Vardhan
Journal of Medicinal Food 2015
Paraoxonase-1 Enzyme Activity Assay for Clinical Samples: Validation and Correlation Studies
A Younis
Medical science monitor : international medical journal of experimental and clinical research 2015
Paraoxonase and Arylesterase Activities in Dipper and Non-Dipper Prehypertensive Subjects:
M Yuksel, A Yildiz, E Tekbas, E Gunduz, A Ekinci, MZ Bilik, N Ozaydogdu, Z Atilgan
Medicine 2015
Markers of Oxidative Stress and Neuroprogression in Depression Disorder
M Vaváková, Z Ďuračková, J Trebatická
Oxidative medicine and cellular longevity 2015
Transduced PEP-1-PON1 proteins regulate microglial activation and dopaminergic neuronal death in a Parkinson's disease model
MJ Kim, M Park, DW Kim, MJ Shin, O Son, HS Jo, HJ Yeo, SB Cho, JH Park, CH Lee, DS Kim, OS Kwon, J Kim, KH Han, J Park, WS Eum, SY Choi
Biomaterials 2015
PON1 polymorphisms are predictors of ability to attain HDL-C goals in statin-treated patients
JA de Souza, A Menin, LO Lima, L Smiderle, MH Hutz, CR van der Sand, LC van der Sand, ME Ferreira, RC Pires, S Almeida, M Fiegenbaum
Clinical Biochemistry 2015
Association Between Paraoxonase Gene Polymorphisms and Intracerebral Hemorrhage in a Korean Population
HJ Park, SK Kim, HK Park, JH Chung
Journal of Molecular Neuroscience 2015
Addressing the link between paraoxonase-1 gene variants and the incidence of early onset myocardial infarction
MF Rahman, IM Hashad, K Abou-Aisha, SM Abdel-Maksoud, MZ Gad
Archives of Medical Science : AMS 2015
Atherosclerosis: Risks, Mechanisms, and Therapies
HJ Pownall, C Rosales, BK Gillard, AM Gotto
Atherosclerosis: Risks, Mechanisms, and Therapies 2015
Glucomannan and glucomannan plus spirulina added to pork significantly block dietary cholesterol effects on lipoproteinemia, arylesterase activity, and CYP7A1 expression in Zucker fa/fa rats
L González-Torres, M Vázquez-Velasco, R Olivero-David, S Bastida, J Benedí, RR González, MJ González-Muñoz, FJ Sánchez-Muniz
Journal of Physiology and Biochemistry 2015
Cardiovascular protective effect of glabridin: Implications in LDL oxidation and inflammation
MR Kang, KH Park, SJ Oh, J Yun, CW Lee, MY Lee, SB Han, JS Kang
International Immunopharmacology 2015
Environmental Factors in Neurodevelopmental and Neurodegenerative Disorders
P Factor-Livak
Environmental Factors in Neurodevelopmental and Neurodegenerative Disorders 2015
Effects of Anaerobic Training on Paraoxonase-1 Enzyme (PON1) Activities of High Density Lipoprotein Subgroups and Its Relationship with PON1-Q192R Phenotype
F Turgay, AR Şişman, AÇ Aksu
Journal of Atherosclerosis and Thrombosis 2015
Serum paraoxonase and arylesterase activities in patients with chronic otitis media
M Turan, R Ucler, M Aslan, F Kalkan, A Taskın, MF Garca, H Cankaya
Redox Report 2015
Transcriptional regulation of human paraoxonase 1 by PXR and GR in human hepatoma cells
N Ponce-Ruiz, AE Rojas-García, BS Barrón-Vivanco, G Elizondo, YY Bernal-Hernández, A Mejía-García, IM Medina-Díaz
Toxicology in Vitro 2015
Relation of Paraoxonase1, Arylesterase and Lipid Profile in Ischemic Stroke Patients
SS Chawhan
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH 2015
Oxidative Stress and Paraoxonase 1 Activity Predict Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
A Börekçi, M Gür, C Türkoğlu, M Çaylı, Ş Selek, O Kaypaklı, H Uçar, M Coşkun, T Şeker, M Koç, T Gökdeniz, MY Gözükara
Angiology 2015
Anti-atherogenic properties of high-density lipoproteins in psychiatric patients before and after two months of atypical anti-psychotic therapy
O Hussein, L Izikson, Y Bathish, E Dabur, A Hanna, J Zidan
Journal of Psychopharmacology (Oxford, England) 2015
Silicon-Enriched Restructured Pork Affects the Lipoprotein Profile, VLDL Oxidation, and LDL Receptor Gene Expression in Aged Rats Fed an Atherogenic Diet
A Garcimartín, JA Santos-López, S Bastida, J Benedí, FJ Sánchez-Muniz
The Journal of nutrition 2015
SERUM PARAOXONASE ACTIVITY AND ITS RELATION TO SERUM LIPIDS IN CORONARY ARTERY DISEASE
RS Nair, SS Nair, SB M
2015
L-4F Inhibits Lipopolysaccharide-Mediated Activation of Primary Human Neutrophils
OF Sharifov, X Xu, A Gaggar, EM Tabengwa, CR White, MN Palgunachari, GM Anantharamaiah, H Gupta
Inflammation 2014
Regulation of Endothelial Nitric Oxide Synthase and High-Density Lipoprotein Quality by Estradiol in Cardiovascular Pathology
KE Kypreos, S Zafirovic, PI Petropoulou, P Bjelogrlic, I Resanovic, A Traish, ER Isenovic
Journal of cardiovascular pharmacology and therapeutics 2014
Impairment of High-Density Lipoprotein Resistance to Lipid Peroxidation and Adipose Tissue Inflammation in Obesity Complicated by Obstructive Sleep Apnea
R Yadav, M France, R Aghamohammadzadeh, Y Liu, S Hama, S Kwok, J Schofield, P Turkington, AA Syed, R Malik, P Pemberton, A Greenstein, P Durrington, B Ammori, M Gibson, M Jeziorska, H Soran
The Journal of clinical endocrinology and metabolism 2014
HDL-3 is a Superior Predictor of Carotid Artery Disease in a Case-Control Cohort of 1725 Participants
DS Kim, AA Burt, EA Rosenthal, JE Ranchalis, JF Eintracht, TS Hatsukami, CE Furlong, S Marcovina, JJ Albers, GP Jarvik
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2014
Anthocyanin Supplementation Improves HDL-Associated Paraoxonase 1 Activity and Enhances Cholesterol Efflux Capacity in Subjects With Hypercholesterolemia
Y Zhu, X Huang, Y Zhang, Y Wang, Y Liu, R Sun, M Xia
The Journal of clinical endocrinology and metabolism 2014
The regulation of hepatic Pon1 by a maternal high-fat diet is gender specific and may occur through promoter histone modifications in neonatal rats
RS Strakovsky, X Zhang, D Zhou, YX Pan
The Journal of Nutritional Biochemistry 2014
Advances in Experimental Medicine and Biology
A Devarajan, D Shih, ST Reddy
Advances in experimental medicine and biology 2014
Role of Oxidative Stress in Chronic Diseases
M Ghashghaeinia, T Wieder, M Duszenko
Role of Oxidative Stress in Chronic Diseases 2014
Protective Effects of Sea Spaghetti-Enriched Restructured Pork Against Dietary Cholesterol: Effects on Arylesterase and Lipoprotein Profile and Composition of Growing Rats
AR Moreira, R Olivero-David, M Vázquez-Velasco, L González-Torres, J Benedí, S Bastida, FJ Sánchez-Muniz
Journal of Medicinal Food 2014
Association of chemerin with oxidative stress, inflammation and classical adipokines in non-diabetic obese patients
P Fülöp, I Seres, H Lőrincz, M Harangi, S Somodi, G Paragh
Journal of Cellular and Molecular Medicine 2014
Paraoxonase (PON1) activity in patients with subclinical thoracic aortic atherosclerosis
M Gür, M Çaylı, H Uçar, Z Elbasan, DY Şahin, MY Gözükara, Ş Selek, NY Koyunsever, T Şeker, C Türkoğlu, O Kaypaklı, N Aksoy
The International Journal of Cardiovascular Imaging 2014
Does Pomegranate intake attenuate cardiovascular risk factors in hemodialysis patients?
L Shema-Didi, B Kristal, S Sela, R Geron, L Ore
Nutrition Journal 2014
Study on total antioxidant status in relation to oxidative stress in type 2 diabetes mellitus
AJ Rani, SV Mythili
Journal of Clinical and Diagnostic Research : JCDR 2014
Paraoxonase1, its Q192R polymorphism and HDL-cholesterol in relation to intensive cardiac care unit stay in ischemic heart disease
MH Hampe, MR Mogarekar
Indian journal of human genetics 2014
Age-Dependent Paraoxonase 1 (PON1) Activity and LDL Oxidation in Wistar Rats during Their Entire Lifespan
D Kumar, SI Rizvi
The Scientific World JOURNAL 2014
Association of cholesteryl ester transfer protein genotypes with paraoxonase-1 activity, lipid profile and oxidative stress in type 2 diabetes mellitus: A study in San Luis, Argentina
S Siewert, II Gonzalez, RO Lucero, MS Ojeda
Journal of Diabetes Investigation 2014
HDL-cholesterol in coronary artery disease risk: Function or structure?
Ó Pérez-Méndez, HG Pacheco, C Martínez-Sánchez, M Franco
Clinica Chimica Acta 2014
Novel Study on N-Nitrosamines as Risk Factors of Cardiovascular Diseases
SA Sheweita, HA El-Bendery, MH Mostafa
BioMed Research International 2014
An assessment of antioxidant status in patients with carbon monoxide poisoning
S Zengin, B A, S Karta, B Can, M Orkmez, A Taskin, U Lok, B Gulen, C Yildirim, S Taysi
World Journal of Emergency Medicine 2014
Serum myeloperoxidase/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease
Y Haraguchi, R Toh, M Hasokawa, H Nakajima, T Honjo, K Otsui, K Mori, M Miyamoto-Sasaki, M Shinohara, K Nishimura, T Ishida, K Hirata
Atherosclerosis 2014
HDL3 stimulates paraoxonase 1 antiatherogenic catalytic and biological activities in a macrophage model system: In vivo and in vitro studies: HDL3 Stimulates PON1 Antiatherogenic Properties
M Rosenblat, N Volkova, M Aviram
BioFactors 2014
Effect of calcium channel blockers on paraoxonase-1 (PON1) activity and oxidative stress
C Türkeş, H Söyüt, Ş Beydemir
Pharmacological Reports 2014
Human serum paraoxonase-1 (hPON1): in vitro inhibition effects of moxifloxacin hydrochloride, levofloxacin hemihidrate, cefepime hydrochloride, cefotaxime sodium and ceftizoxime sodium
C Türkeş, H Söyüt, Ş Beydemir
Journal of Enzyme Inhibition and Medicinal Chemistry 2014
Paraoxonase1 Genetic Polymorphisms in a Mixed Ancestry African Population
M Macharia, AP Kengne, DM Blackhurst, RT Erasmus, TE Matsha
Mediators of Inflammation 2014
PON1 status evaluation in patients with chronic arterial occlusion of lower limbs due to atherosclerosis obliterans
MP Kasprzak, M Iskra, W Majewski, M Budzyń-Napierała, B Gryszczyńska, K Strzyżewski, J Kasprzak
Archives of Medical Science : AMS 2014
Anti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis
H El-Banna, A Jiman-Fatani
BMC musculoskeletal disorders 2014
Adherence to Mediterranean diet during pregnancy and serum lipid, lipoprotein and homocysteine concentrations at birth
E Gesteiro, S Bastida, BR Bernal, FJ Sánchez-Muniz
European Journal of Nutrition 2014
Comparative Study of Glucose Homeostasis, Lipids and Lipoproteins, HDL Functionality, and Cardiometabolic Parameters in Modestly Severely Obese African Americans and White Americans With Prediabetes: Implications for the Metabolic Paradoxes
SJ Healy, K Osei, T Gaillard
Diabetes care 2014
Effects of dietary components on high-density lipoprotein measures in a cohort of 1,566 participants
D Kim, AA Burt, JE Ranchalis, LE Jarvik, JF Eintracht, CE Furlong, GP Jarvik
Nutrition & Metabolism 2014
Vitamin B6 Supplementation Improves Oxidative Stress and Enhances Serum Paraoxonase/Arylesterase Activities in Streptozotocin-Induced Diabetic Rats
S Taş, E Sarandöl, M Dirican
The Scientific World JOURNAL 2014
Affective and inflammatory responses among orchestra musicians in performance situation
A Pilger, H Haslacher, E Ponocny-Seliger, T Perkmann, K Böhm, A Budinsky, A Girard, K Klien, G Jordakieva, L Pezawas, O Wagner, J Godnic-Cvar, R Winker
Brain, Behavior, and Immunity 2014
The salt stimulation property of serum paraoxonase (PON1) could be a valuable factor in evaluating the enzyme status in ischemic stroke: The role of activity-determined PON1 192Q/R phenotypes
A Mahrooz, A Alizadeh, G Gohari
Journal of the Neurological Sciences 2014
Plasma paraoxonase and arylesterase activities in smokers and smokeless tobacco users as Maraş powder
N Kurtul, S Söylemez, M Çelik
Inhalation Toxicology 2014
Identification by a proteomic approach of a plasma protein as a possible biomarker of illicit dexamethasone treatment in veal calves
C Guglielmetti, M Mazza, M Pagano, S Carrella, S Sciuto, S Nodari, M Pezzolato, GB Richelmi, E Baioni, M Caramelli, PL Acutis, E Bozzetta
Food Additives & Contaminants: Part A 2014
Paraoxonase-1 activity and oxidative stress in patients with anterior ST elevation myocardial infarction undergoing primary percutaneous coronary intervention with and without no-reflow
M Gür, C Türkoğlu, A Taşkın, H Uçar, A Börekçi, T Şeker, MY Gözükara, O Kaypaklı, S Akyol, Ş Selek, DY Şahin, Z Elbasan, M Çaylı
Atherosclerosis 2014
Measurement of serum paraoxonase activity and MDA concentrations in patients suffering with oral squamous cell carcinoma
UU Malik, IA Siddiqui, Z Hashim, S Zarina
Clinica Chimica Acta 2014
Onion extract ( Allium cepa L.), quercetin and catechin up-regulate paraoxonase 1 activity with concomitant protection against low-density lipoprotein oxidation in male Wistar rats subjected to oxidative stress: Up-regulation of PON1 activity and protection of LDL oxidation by onion extract and flavonoids
N Jaiswal, SI Rizvi
Journal of the Science of Food and Agriculture 2014
Activation of paraoxonase 1 is associated with HDL remodeling ex vivo
A Gugliucci
Clinica Chimica Acta 2014
The effects of metformin on endothelial dysfunction, lipid metabolism and oxidative stress in women with polycystic ovary syndrome
D Kocer, F Bayram, H Diri
Gynecological Endocrinology 2014
Decreased serum paraoxonase and arylesterase activities in patients with rosacea
Z Takci, SG Bilgili, AS Karadag, ME Kucukoglu, S Selek, M Aslan
Journal of the European Academy of Dermatology and Venereology 2014
Lowered plasma paraoxonase (PON)1 activity is a trait marker of major depression and PON1 Q192R gene polymorphism–smoking interactions differentially predict the odds of major depression and bipolar disorder
CC Bortolasci, HO Vargas, A Souza-Nogueira, DS Barbosa, EG Moreira, SO Nunes, M Berk, S Dodd, M Maes
Journal of Affective Disorders 2014
High-density lipoproteins as modulators of endothelial cell functions: alterations in patients with coronary artery disease
A Kratzer, H Giral, U Landmesser
Cardiovascular Research 2014
Association between butyrylcholinesterase activity and phenotypes, paraoxonase192 rs662 gene polymorphism and their enzymatic activity with severity of rheumatoid arthritis: Correlation with systemic inflammatory markers and oxidative stress, preliminary report
S Shahmohamdnejad, A Vaisi-Raygani, Y Shakiba, A Kiani, Z Rahimi, T Pourmotabbed
Clinical Biochemistry 2014
Relationship between paraoxonase 1 activity and high density lipoprotein concentration during naturally occurring babesiosis in dogs
G Rossi, J Kuleš, RB Rafaj, V Mrljak, S Lauzi, A Giordano, S Paltrinieri
Research in Veterinary Science 2014
Associations of High Density Lipoprotein Cholesterol and Framingham Cardiovascular Risk with Diabetic Retinopathy in African Type 2 Diabetics
B Longo-Mbenza, MM Muaka, T Gombet, IL Phemba, S Cook, EM Mengome
World Journal of Cardiovascular Diseases 2014
Decreased HDL-Dependent Paraoxonase and Arylesterase Enzyme Activity May Indicate a Worse Prognosis in Multiple Myeloma
HY Ellidag, O Aydin, E Eren, N Yilmaz, M Ergin
Asian Pacific Journal of Cancer Prevention 2014
Paraoxonase responses to exercise and niacin therapy in men with metabolic syndrome
JK Taylor, EP Plaisance, AJ Mahurin, ML Mestek, J Moncada-Jimenez, PW Grandjean
Redox Report 2014
Paraoxonase (PON)1 Q192R functional genotypes and PON1 Q192R genotype by smoking interactions are risk factors for the metabolic syndrome, but not overweight or obesity
CC Bortolasci, HO Vargas, A Souza-Nogueira, EG Moreira, SO Nunes, M Berk, S Dodd, DS Barbosa, M Maes
Redox Report 2014
Using oxidant and antioxidant levels to predict the duration of both acute peripheral and mesenteric ischemia
S Yazici, S Demirtas, O Guclu, O Karahan, C Yavuz, A Caliskan, B Mavitas
Perfusion 2014
Multiple Myeloma: Relationship to Antioxidant Esterases
HY Ellidag, E Eren, O Aydin, M Yildirim, C Sezer, N Yilmaz
Medical Principles and Practice 2014
Breaking the chain at the membrane: paraoxonase 2 counteracts lipid peroxidation at the plasma membrane
H Hagmann, A Kuczkowski, M Ruehl, T Lamkemeyer, S Brodesser, S Horke, S Dryer, B Schermer, T Benzing, PT Brinkkoetter
The FASEB Journal 2014
Gamma Glutamyl Transferase Activity is Associated With Both Paraoxonase Activity and Aortic Stiffness in Hypertensive Patients: GGT and Hypertension
MY Gözükara, A Börekçi, M Gür, N Aksoy, T Şeker, O Kaypaklı, H Uçar, C Türkoğlu, M Koç, İ Makca, S Akyol, Ş Selek, M Çaylı
Journal of Clinical Laboratory Analysis 2014
Free Radicals in Human Health and Disease
V Rani, UC Yadav
2014
An assessment of antioxidant status in patients with carbon monoxide poisoning
S Zengin, B A, S Karta, B Can, M Orkmez, A Taskın, U Lok, B Gulen, C Yildirim, S Taysi
World Journal of Emergency Medicine 2014
Myeloperoxidase, paraoxonase-1 and HDL form a functional ternary complex
Ying Huang, Zhiping Wu, Meliana Riwanto, Shengqiang Gao, Bruce Levison, Xiaodong Gu, Xiaoming Fu, Matthew Wagner, Christian Besler, Gary Gerstenecker, Renliang Zhang, Xin-Min Li, Anthony DiDonato, Valentin Gogonea, W.H. Wilson Tang, Jonathan D. Smith, Edward F. Plow, Paul L. Fox, Diana Shih, Aldons Lusis, Edward A Fisher, Joseph DiDonato, Ulf Landmesser, Stanley L. Hazen
Journal of Clinical Investigation 2013
Anti-inflammatory mechanisms of apolipoprotein a-I mimetic Peptide in acute respiratory distress syndrome secondary to sepsis
OF Sharifov, X Xu, A Gaggar, WE Grizzle, VK Mishra, J Honavar, SH Litovsky, MN Palgunachari, CR White, GM Anantharamaiah, H Gupta
PloS one 2013
Cytochrome P450 2E1: Its Role in Disease and Drug Metabolism
A Dey
2013
Cytochrome P450 2E1: Its Role in Disease and Drug Metabolism
A Dey
2013
High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease
M Riwanto, U Landmesser
2013
Redox signaling in cardiovascular health and disease
NR Madamanchi, MS Runge
Free radical biology & medicine 2013
HDL and cholesterol: life after the divorce?
KC Vickers, AT Remaley
Journal of lipid research 2013
Aging affects high-density lipoprotein composition and function
M Holzer, M Trieb, V Konya, C Wadsack, A Heinemann, G Marsche
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2013
Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond
AS Shah, L Tan, JL Long, WS Davidson
Journal of lipid research 2013
Effects of three different fibrates on intrahepatic cholestasis experimentally induced in rats
A El-Sisi, S Hegazy, E El-Khateeb
PPAR Research 2013
Abundance of Plasma Antioxidant Proteins Confers Tolerance to Acute Hypobaric Hypoxia Exposure
G Padhy, NK Sethy, L Ganju, K Bhargava
High Altitude Medicine & Biology 2013
Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease
DS Kim, J Marsillach, CE Furlong, GP Jarvik
Pharmacogenomics 2013
High-density lipoprotein impedes glycation of low-density lipoprotein
NN Younis, H Soran, V Charlton-Menys, R Sharma, S Hama, P Pemberton, MM Elseweidy, PN Durrington
Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease 2013
Effects on transcriptional regulation and lipid droplet characteristics in the liver of female juvenile pigs after early postnatal feed restriction and refeeding are dependent on birth weight
C Nebendahl, R Krüger, S Görs, E Albrecht, K Martens, S Hennig, N Storm, W Höppner, R Pfuhl, BU Metzler-Zebeli, HM Hammon, CC Metges
PloS one 2013
Paraoxonase 1 in neurological disorders
T Menini, A Gugliucci
Redox Report 2013
Cord-blood lipoproteins, homocysteine, insulin sensitivity/resistance marker profile, and concurrence of dysglycaemia and dyslipaemia in full-term neonates of the Mérida Study
E Gesteiro, S Bastida, FJ Sánchez-Muniz
European Journal of Pediatrics 2013
Functional paraoxonase 1 variants modify the risk of Parkinson's disease due to organophosphate exposure
PC Lee, SL Rhodes, JS Sinsheimer, J Bronstein, B Ritz
Environment International 2013
The Q192R polymorphism of the paraoxonase 1 gene is a risk factor for coronary artery disease in Saudi subjects
MA Hassan, OS Al-Attas, T Hussain, NM Al-Daghri, MS Alokail, AK Mohammed, B Vinodson
Molecular and Cellular Biochemistry 2013
Serum lactonase and arylesterase activities in alcoholic hepatitis and hepatitis B
MR Mogarekar, SJ Talekar
Indian Journal of Gastroenterology 2013
Cationic peptide mR18L with lipid lowering properties inhibits LPS-induced systemic and liver inflammation in rats
OF Sharifov, G Nayyar, VV Ternovoy, VK Mishra, SH Litovsky, MN Palgunachari, DW Garber, GM Anantharamaiah, H Gupta
Biochemical and Biophysical Research Communications 2013
Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis
E D’Amico, P Factor-Litvak, RM Santella, H Mitsumoto
Free radical biology & medicine 2013
Enzymatic assessment of paraoxonase 1 activity on HDL subclasses: A practical zymogram method to assess HDL function
A Gugliucci, R Caccavello, K Kotani, N Sakane, S Kimura
Clinica Chimica Acta 2013
Distinct composition of human fetal HDL attenuates its anti-oxidative capacity
I Sreckovic, R Birner-Gruenberger, B Obrist, T Stojakovic, H Scharnagl, M Holzer, M Scholler, S Philipose, G Marsche, U Lang, G Desoye, C Wadsack
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2013
Association between PON1 genetic polymorphisms and miscarriage in Mexican women exposed to pesticides
J Blanco-Muñoz, C Aguilar-Garduño, R Gamboa-Avila, M Rodríguez-Barranco, O Pérez-Méndez, C Huesca-Gómez, B González-Alzaga, M Lacasaña
Science of The Total Environment 2013
Niacin Administration Significantly Reduces Oxidative Stress in Patients With Hypercholesterolemia and Low Levels of High-Density Lipoprotein Cholesterol:
S Hamoud, M Kaplan, E Meilin, A Hassan, R Torgovicky, R Cohen, T Hayek
The American Journal of the Medical Sciences 2013
Soy Protein, Genistein, and Daidzein Improve Serum Paraoxonase Activity and Lipid Profiles in Rheumatoid Arthritis in Rats
M Mohammadshahi, F Haidari, AA Saei, B Rashidi, S Mahboob, MR Rashidi
Journal of Medicinal Food 2013
Enhanced HDL-cholesterol-associated anti-oxidant PON-1 activity in prostate cancer patients
M Eroglu, N Yilmaz, S Yalcinkaya, N Ay, O Aydin, C Sezer
The Kaohsiung Journal of Medical Sciences 2013
Atherosclerosis and arteriosclerosis parameters in stroke patients associate with paraoxonase polymorphism and esterase activities
S Shenhar-Tsarfaty, N Waiskopf, K Ofek, L Shopin, S Usher, S Berliner, I Shapira, NM Bornstein, Y Ritov, H Soreq, EB Assayag
European Journal of Neurology 2013
Oxidant/Antioxidant Status in Cases of Snake Bite
S Zengin, B Al, P Yarbil, S Taysi, H Bilinc, C Yildirim, N Aksoy
The Journal of Emergency Medicine 2013
Targeting paraoxonase-1 in atherosclerosis
M Mackness, B Mackness
Expert Opinion on Therapeutic Targets 2013
PON1 gene polymorphisms and plasma PON1 activities in Takayasu's arteritis disease
C Huesca-Gómez, ME Soto, V Castrejón-Téllez, O Pérez-Méndez, R Gamboa
Immunology Letters 2013
Paraoxonase 1 (PON1) reduces macrophage inflammatory responses
S Aharoni, M Aviram, B Fuhrman
Atherosclerosis 2013
Modulation of the endogenous antioxidants paraoxonase-1 and urate by pesticide exposure and genetic variants of xenobiotic-metabolizing enzymes
AF Hernández, F Gil, M Lacasaña, M Rodríguez-Barranco, A Gómez, D Lozano, A Pla
Food and Chemical Toxicology 2013
Paraoxonase1 (PON1) reduces insulin resistance in mice fed a high-fat diet, and promotes GLUT4 overexpression in myocytes, via the IRS-1/Akt pathway
M Koren-Gluzer, M Aviram, T Hayek
Atherosclerosis 2013
Interleukin-6 upregulates paraoxonase 1 gene expression via an AKT/NF-κB-dependent pathway
CC Cheng, CM Hsueh, CY Chen, TH Chen, SL Hsu
Biochemical and Biophysical Research Communications 2013
Paraoxonase 1 activities, regulation, and interactions with atherosclerotic lesion:
M Aviram, J Vaya
Current Opinion in Lipidology 2013
Serum paraoxonase 1 activity in dogs: preanalytical and analytical factors and correlation with C-reactive protein and alpha-2-globulin
G Rossi, A Giordano, F Pezzia, M Kjelgaard-Hansen, S Paltrinieri
Veterinary Clinical Pathology 2013
Endothelial dysfunction – a major mediator of diabetic vascular disease
CM Sena, AM Pereira, R Seiça
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2013
Oxidative stress, hematological and biochemical alterations in farmers exposed to pesticides
T Wafa, K Nadia, N Amel, C Ikbal, T Insaf, K Asma, MA Hedi, H Mohamed
Journal of Environmental Science and Health, Part B 2013
Effect of vitamins, probiotics and protein level on semen traits and seminal plasma biochemical parameters of post-moult male broiler breeders
RU Khan, ZU Rahman, I Javed, F Muhammad
British Poultry Science 2013
Biological markers of oxidative stress: Applications to cardiovascular research and practice
E Ho, KK Galougahi, CC Liu, R Bhindi, GA Figtree
Redox Biology 2013
Molecular dynamics simulation of human serum paraoxonase 1 in DPPC bilayer reveals a critical role of transmembrane helix H1 for HDL association
MC Patra, SN Rath, SK Pradhan, J Maharana, S De
European Biophysics Journal 2013
Integrated glycoproteomics demonstrates fucosylated serum paraoxonase 1 alterations in small cell lung cancer
JM Ahn, HJ Sung, YH Yoon, BG Kim, WS Yang, C Lee, HM Park, BJ Kim, BG Kim, SY Lee, HJ An, JY Cho
Molecular & cellular proteomics : MCP 2013
Oxytocin induced oxidative stress in lactating Bubalis bubalis (Nili Ravi)
Z Iqbal, ZU Rahman, F Muhammad, T Khaliq, H Anwar, MM Awais, S Sadaf
BMC veterinary research 2013
Pomegranate for your cardiovascular health
M Aviram, M Rosenblat
Rambam Maimonides Medical Journal 2013
The determination of Q192R polymorphism of paraoxonase 1 by using non-toxic substrate p-nitrophenylacetate
MR Mogarekar, SS Chawhan
Indian journal of human genetics 2013
Elucidation of mechanisms of actions of thymoquinone-enriched methanolic and volatile oil extracts from Nigella sativa against cardiovascular risk parameters in experimental hyperlipidemia
S Ahmad, ZH Beg
Lipids in Health and Disease 2013
Association between paraoxonase gene and stroke in the Han Chinese population
G Zhang, W Li, Z Li, H Lv, Y Ren, R Ma, X Li, X Kang, Y Shi, Y Sun
BMC Medical Genetics 2013
The effects of atorvastatin on oxidative stress in L-NAME-treated rats
V Sozer, H Uzun, R Gelisgen, M Kaya, R Kalayci, O Tabak, N Arican, D Konukoglu
Scandinavian Journal of Clinical & Laboratory Investigation 2013
L-arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in plasma and synovial fluid of patients with knee osteoarthritis
V Pascale, W Pascale, V Lavanga, V Sansone, P Ferrario, VD Colonna
Medical science monitor : international medical journal of experimental and clinical research 2013
Plasma paraoxonase 1 arylesterase activity in d-galactose-induced aged rat model: correlation with LDL oxidation and redox status
D Kumar, SI Rizvi
Aging clinical and experimental research 2013
Lipoproteinemia and arylesterase activity in Zucker Fa/Fa rats fed glucomannan/spirulina-enriched squid-surimi: Glucomannan squid-surimi and cholesterolemia
M Vázquez-Velasco, L González-Torres, R Olivero-David, S Bastida, J Benedí, MI Sánchez-Reus, MJ González-Muñoz, FJ Sánchez-Muniz
European Journal of Lipid Science and Technology 2013
Paraoxonase 1 and oxidative stress in paediatric non-alcoholic steatohepatitis
S Desai, SS Baker, W Liu, DA Moya, RW Browne, L Mastrandrea, RD Baker, L Zhu
Liver International 2013
Effect of the nutritional supplement ALAnerv® on the serum PON1 activity in post-acute stroke patients
BN Manolescu, M Berteanu, D Cintezã
Pharmacological Reports 2013
Deleterious effect of glycation on the ability of HDL to counteract the inhibitory effect of oxidized LDL on endothelium-dependent vasorelaxation: HDL Glycation Impairs Vasorelaxation
MC Brindisi, L Duvillard, S Monier, B Vergès, L Perségol
Diabetes/Metabolism Research and Reviews 2013
Paraoxonase is reduced in patients with growth hormone deficiency: A novel risk factor for atherosclerosis
F Bayram, G Baskol, F Tanriverdi, M Baskol, D Kocer, A Caniklioğlu
Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences 2013
Paraoxonase-1 Suppresses Experimental Colitis via the Inhibition of IFN-  Production from CD4 T Cells
J Yamashita, C Iwamura, T Ito, M Narita, Y Hara, T Sasaki, D Masuda, M Takahashi, M Tsuchiya, K Hada, M Ishikawa, T Matsuo, Y Ohno, H Tanaka, H Maruyama, Y Ogawa, T Nakayama
Journal of immunology (Baltimore, Md. : 1950) 2013
Effect of exercise on plasma paraoxonase1 activity in rugby players: Dependance on training experience
A Otocka-Kmiecik, K Bortnik, U Szkudlarek, D Nowak, M Orłowska-Majdak
Redox Report 2013
Prognostic value of serum paraoxonase and arylesterase activity in patients with sepsis
Y Li, R Zhai, H Li, X Mei, G Qiu
J INT MED RES 2013
Effects on Transcriptional Regulation and Lipid Droplet Characteristics in the Liver of Female Juvenile Pigs after Early Postnatal Feed Restriction and Refeeding Are Dependent on Birth Weight
C Nebendahl, R Krüger, S Görs, E Albrecht, K Martens, S Hennig, N Storm, W Höppner, R Pfuhl, BU Metzler-Zebeli, HM Hammon, CC Metges, JJ Li
PloS one 2013
Association between C-reactive protein, pro-oxidant-antioxidant balance and traditional cardiovascular risk factors in an Iranian population
A Razavi, MR Baghshani, AA Rahsepar, HM Ardabili, MS Andalibi, SM Parizadeh, S Tavallaie, S Mousavi, M Ghayour-Mobarhan, G Ferns
Annals of Clinical Biochemistry 2013
Novel biological functions of high-density lipoprotein cholesterol
C Mineo, PW Shaul
Circulation research 2012
Myeloperoxidase-derived chlorinating species induce protein carbamylation through decomposition of thiocyanate and urea: Novel pathways generating dysfunctional high-density lipoprotein
M Holzer, K Zangger, D El-Gamal, V Binder, S Curcic, V Konya, R Schuligoi, A Heinemann, G Marsche
Antioxidants & Redox Signaling 2012
Psoriasis alters HDL composition and cholesterol efflux capacity
M Holzer, P Wolf, S Curcic, R Birner-Gruenberger, W Weger, M Inzinger, D El-Gamal, C Wadsack, A Heinemann, G Marsche
Journal of lipid research 2012
Low Levels of Serum Paraoxonase Activities are Characteristic of Metabolic Syndrome and May Influence the Metabolic-Syndrome-Related Risk of Coronary Artery Disease
N Martinelli, R Micaglio, L Consoli, P Guarini, E Grison, F Pizzolo, S Friso, E Trabetti, PF Pignatti, R Corrocher, O Olivieri, D Girelli
Experimental Diabetes Research 2012
Regulation of paraoxonase 1 (PON1) in PCB 126-exposed male Sprague Dawley rats
H Shen, LW Robertson, G Ludewig
Toxicology Letters 2012
Diet-Induced Weight Loss in Overweight or Obese Women and Changes in High-Density Lipoprotein Levels and Function
BO Aicher, EK Haser, LA Freeman, AV Carnie, JA Stonik, X Wang, AT Remaley, GJ Kato, RO Cannon
Obesity 2012
Lipid peroxidation and paraoxonase activity in nocturnal cyclic and sustained intermittent hypoxia
HK Okur, Z Pelin, M Yuksel, S Yosunkaya
Sleep and Breathing 2012
High Density Lipoprotein and it’s Dysfunction
E Eren, N Yilmaz, O Aydin
The open biochemistry journal 2012
PPARs in Regulation of Paraoxonases: Control of Oxidative Stress and Inflammation Pathways
J Camps, A García-Heredia, A Rull, C Alonso-Villaverde, G Aragonès, R Beltrán-Debón, E Rodríguez-Gallego, J Joven
PPAR Research 2012
Relationship between paraoxonase and homocysteine: crossroads of oxidative diseases
N Yilmaz
Archives of Medical Science : AMS 2012
Evaluating Oxidative Stress in Human Cardiovascular Disease: Methodological Aspects and Considerations
R Lee, M Margaritis, KM Channon, C Antoniades
Current medicinal chemistry 2012
Assessment of paraoxonase 1, xanthine oxidase and glutathione peroxidase activities, nitric oxide and thiol levels in women with polycystic ovary syndrome : Oxidative stress in polycystic ovary syndrome
G Baskol, E Aygen, F Erdem, A Caniklioğlu, F Narin, Y Şahin, T Kaya
Acta Obstetricia et Gynecologica Scandinavica 2012
Association between reactive oxygen metabolites and paraoxonase 1 activity during a physical activity increase intervention with older people : d-ROMs and PON1 in physical activity
K Kotani, R Caccavello, T Mutou, T Yamada, N Taniguchi, A Gugliucci
Australasian Journal on Ageing 2012
The Past and Present of Paraoxonase Enzyme: Its Role in the Cardiovascular System and Some Diseases
S Aydin, İ Sahin, S Aydin, A Aksoy, C Citil
Journal of Medical Biochemistry 2012
Trichinella spiralis: Infection changes serum paraoxonase-1 levels, lipid profile, and oxidative status in rats
S Mido, EM Fath, AS Farid, N Nonaka, Y Oku, Y Horii
Experimental Parasitology 2012
Ontogeny of mammalian metabolizing enzymes in humans and animals used in toxicological studies
SA Saghir, SA Khan, AT McCoy
Critical Reviews in Toxicology 2012
Altered expression of apoA-I, apoA-IV and PON-1 activity in CBS deficient homocystinuria in the presence and absence of treatment: Possible implications for cardiovascular outcomes
H Jiang, SP Stabler, RH Allen, KN Maclean
Molecular Genetics and Metabolism 2012
Impacts of some antibiotics on human serum paraoxonase 1 activity
EB Dilek, Öİ Küfrevioğlu, Ş Beydemir
Journal of Enzyme Inhibition and Medicinal Chemistry 2012
Relationship of PON1 192 and 55 gene polymorphisms to calcific valvular aortic stenosis
LM Moura, S Faria, M Brito, FJ Pinto, SD Kristensen, IM Barros, N Rajamannan, F Rocha-Gonçalves
American Journal of Cardiovascular Disease 2012
Dysfunctional HDL: A novel important diagnostic and therapeutic target in cardiovascular disease?
A Otocka-Kmiecik, DP Mikhailidis, SJ Nicholls, M Davidson, J Rysz, M Banach
Progress in Lipid Research 2012
Paraoxonase-1 activity and oxidative status in patients with knee osteoarthritis and their relationship with radiological and clinical parameters
C Ertürk, MA Altay, Ş Selek, A Koçyiğit
Scandinavian Journal of Clinical & Laboratory Investigation 2012
Purification, characterization, and investigation of in vitro inhibition by metals of paraoxonase from different sheep breeds
K Erol, N Gençer, M Arslan, O Arslan
Artificial Cells, Blood Substitutes and Biotechnology 2012
The growing importance of PON1 in cardiovascular health: a review
M Macharia, MS Hassan, D Blackhurst, RT Erasmus, TE Matsha
Journal of Cardiovascular Medicine 2012
Oxidative Stress and Disease: Bioavailability and Function
A Weseler, A Bast
Oxidative Stress and Disease 2012
Genistein as a potential inducer of the anti-atherogenic enzyme paraoxonase-1: studies in cultured hepatocytes in vitro and in rat liver in vivo
C Schrader, IM Ernst, H Sinnecker, ST Soukup, SE Kulling, G Rimbach
Journal of Cellular and Molecular Medicine 2012
Hyperlipidemia, oxidative stress, and intima media thickness in children with chronic kidney disease
J Kotur-Stevuljević, A Peco-Antić, S Spasić, A Stefanović, D Paripović, M Kostić, D Vasić, A Vujović, Z Jelić-Ivanović, V Spasojević-Kalimanovska, D Kornic-Ristovski
Pediatric Nephrology 2012
R-carrying genotypes of serum paraoxonase (PON1) 192 polymorphism and higher activity ratio are related to susceptibility against ischemic stroke
A Mahrooz, G Gohari, MB Hashemi, M Zargari, H Musavi, M Abedini, A Alizadeh
Molecular Biology Reports 2012
Association of a protective paraoxonase 1 (PON1) polymorphism in Parkinson's disease
AC Belin, C Ran, A Anvret, S Paddock, M Westerlund, A Håkansson, H Nissbrandt, P Söderkvist, N Dizdar, A Ahmadi, M Anvret, T Willows, O Sydow, D Galter
Neuroscience Letters 2012
Evaluation of paraoxonase and arylesterase activities in Egyptian patients with ankylosing spondylitis
SM Olama, MM Elarman
Rheumatology International 2012
Synthesis and paroxonase activities of novel bromophenols
Y Akbaba, C Türkeş, L Polat, H Söyüt, E Şahin, A Menzek, S Göksu, Ş Beydemir
Journal of Enzyme Inhibition and Medicinal Chemistry 2012
HDL functionality:
H Soran, S Hama, R Yadav, PN Durrington
Current Opinion in Lipidology 2012
Evaluation of endothelial dysfunction, lipid metabolism in women with polycystic ovary syndrome: relationship of paraoxonase 1 activity, malondialdehyde levels, low-density lipoprotein subfractions, and endothelial dysfunction
F Bayram, D Kocer, M Ozsan, S Muhtaroglu
Gynecological Endocrinology 2012
Reduction of paraoxonase-1 activity may contribute the qualitative impairment of HDL particles in patients with type 2 diabetes
H Murakami, J Tanabe, N Tamasawa, K Matsumura, M Yamashita, K Matsuki, H Murakami, J Matsui, T Suda
Diabetes Research and Clinical Practice 2012
Hypolipidemic and antioxidant activities of thymoquinone and limonene in atherogenic suspension fed rats
S Ahmad, ZH Beg
Food Chemistry 2012
The Antioxidant Status Response to Low-Fat and Walnut Paste–Enriched Meat Differs in Volunteers at High Cardiovascular Risk Carrying Different PON-1 Polymorphisms
FJ Sánchez-Muniz, A Canales, M Nus, S Bastida, M Guillén, D Corella, B Olmedilla-Alonso, F Granado-Lorencio, J Benedí
Journal of the American College of Nutrition 2012
Psoriasis alters HDL composition and cholesterol efflux capacity[S]
M Holzer, P Wolf, S Curcic, R Birner-Gruenberger, W Weger, M Inzinger, D El-Gamal, C Wadsack, A Heinemann, G Marsche
Journal of lipid research 2012
Imbalance in superoxide dismutase/thioredoxin reductase activities in hypercholesterolemic subjects: relationship with low density lipoprotein oxidation
PR Augusti, AR Ruviaro, A Quatrin, S Somacal, GM Conterato, JT Vicentini, MM Duarte, T Emanuelli
Lipids in Health and Disease 2012
Antioxidant and anti-inflammatory role of paraoxonase 1: implication in arteriosclerosis diseases
D Litvinov, H Mahini, M Garelnabi
North American Journal of Medical Sciences 2012
Association of lipids with oxidative stress biomarkers in subclinical hypothyroidism
A Santi, MM Duarte, CC de Menezes, VL Loro
International Journal of Endocrinology 2012
Vasculitis, Atherosclerosis, and Altered HDL Composition in Heme-Oxygenase-1-Knockout Mice
K Ishikawa, M Navab, AJ Lusis
International Journal of Hypertension 2012
Regulation of Hepatic Paraoxonase-1 Expression
B Fuhrman
Journal of Lipids 2012
Paraoxonase 1 in Chronic Kidney Failure
A Gugliucci, K Kotani, S Kimura
Journal of Lipids 2012
Paraoxonase Activity and Expression Is Modulated by Therapeutics in Experimental Rat Nonalcoholic Fatty Liver Disease
O Hussein, J Zidan, KA Jabal, I Shams, S Szvalb, M Grozovski, I Bersudsky, R Karry, M Aviram
International Journal of Hepatology 2012
Paraoxonase 1 Polymorphism and Prenatal Pesticide Exposure Associated with Adverse Cardiovascular Risk Profiles at School Age
HR Andersen, C Wohlfahrt-Veje, C Dalgård, L Christiansen, KM Main, C Nellemann, K Murata, TK Jensen, NE Skakkebæk, P Grandjean, D Amre
PloS one 2012
Paraoxonase-1 Gene Q192R Polymorphism and Reactive Oxygen Metabolites
K Kotani, K Tsuzaki, N Sakane
J INT MED RES 2012
Inflammation, paraoxonase-1 activity and HDL physico-chemical properties: a comparison between Prader-Willi syndrome and obese subjects
G Ferretti, T Bacchetti, S Masciangelo, G Grugni, V Bicchiega
Disease models & mechanisms 2012
Blood pressure, lipid levels and apolipoprotein A1 and paraoxonase 1 gene polymorphisms in patients with abdominal obesity
, OO Bolshakova, OD Belyaeva, OA Berkovich, VI Larionova, EI Baranova
2012
Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease
Christian Besler, Kathrin Heinrich, Lucia Rohrer, Carola Doerries, Meliana Riwanto, Diana M. Shih, Angeliki Chroni, Keiko Yonekawa, Sokrates Stein, Nicola Schaefer, Maja Mueller, Alexander Akhmedov, Georgios Daniil, Costantina Manes, Christian Templin, Christophe Wyss, Willibald Maier, Felix C. Tanner, Christian M. Matter, Roberto Corti, Clement E. Furlong, Aldons J. Lusis, Arnold von Eckardstein, Alan M. Fogelman, Thomas F. Lüscher, Ulf Landmesser
Journal of Clinical Investigation 2011
Targeted deletion of endothelial lipase increases HDL particles with anti-inflammatory properties both in vitro and in vivo
T Hara, T Ishida, Y Kojima, H Tanaka, T Yasuda, M Shinohara, R Toh, K Hirata
Journal of lipid research 2011
Evolving Concepts of the Role of High-Density Lipoprotein in Protection from Atherosclerosis
JA Farmer, J Liao
Current Atherosclerosis Reports 2011
Effects of APOA5 S19W polymorphism on growth, insulin sensitivity and lipoproteins in normoweight neonates
E Gesteiro, S Bastida, M Vázquez-Velasco, D Corella, M Guillén, JM Ordovas, FJ Sánchez-Muniz
European Journal of Pediatrics 2011
Oxidative Stress and Disease
I Paur, M Carlsen, B Halvorsen, R Blomhoff
Herbal Medicine 2011
Advances in Clinical Chemistry
M Mahler
Advances in Clinical Chemistry Volume 54 2011
Effects of Nori- and Wakame-enriched meats with or without supplementary cholesterol on arylesterase activity, lipaemia and lipoproteinaemia in growing Wistar rats
R Olivero-David, A Schultz-Moreira, M Vázquez-Velasco, L González-Torres, S Bastida, J Benedí, MI Sanchez-Reus, MJ González-Muñoz, FJ Sánchez-Muniz
British Journal of Nutrition 2011
Paraoxonase Arg 192 allele is an independent risk factor for three-vessel stenosis of coronary artery disease
A Vaisi-Raygani, H Ghaneialvar, Z Rahimi, H Tavilani, T Pourmotabbed, E Shakiba, A Vaisi-Raygani, A Kiani, M Aminian, R Alibakhshi, C Bartels
Molecular Biology Reports 2011
Synergism between paraoxonase Arg 192 and the angiotensin converting enzyme D allele is associated with severity of coronary artery disease
A Vaisi-Raygani, Z Rahimi, H Tavilani, H Vaisi-Raygani, A Kiani, M Aminian, E Shakiba, Y Shakiba, T Pourmotabbed
Molecular Biology Reports 2011
Serum Paraoxonase/Arylesterase Activity Affects Outcome in Ischemic Stroke Patients
S Michalak, R Kazmierski, A Hellmann, E Wysocka, D Kocialkowska-Adamczewska, A Wencel-Warot, WL Nowinski
Cerebrovascular Diseases 2011
Evaluation of serum oxidative and antioxidative status in patients with erectile dysfunction
M Aldemir, E Okulu, S Neşelioğlu, O Erel, K Ener, Ö Kayıgil
Andrologia 2011
The effects of rosuvastatin alone or in combination with fenofibrate or omega 3 fatty acids on inflammation and oxidative stress in patients with mixed dyslipidemia
AP Agouridis, V Tsimihodimos, TD Filippatos, AA Dimitriou, CC Tellis, MS Elisaf, DP Mikhailidis, AD Tselepis
Expert Opinion on Pharmacotherapy 2011
Pomegranate juice increases levels of paraoxonase1 (PON1) expression and enzymatic activity in streptozotocin-induced diabetic mice fed with a high-fat diet
G Betanzos-Cabrera, JA Guerrero-Solano, MM Martínez-Pérez, ZG Calderón-Ramos, H Belefant-Miller, JC Cancino-Diaz
Food Research International 2011
Effect of atorvastatin therapy on oxidant-antioxidant status and atherosclerotic plaque formation
ED Sezer, EY Sozmen, D Nart, T Onat
Vascular Health and Risk Management 2011
Ascorbic acid partly antagonizes resveratrol mediated heme oxygenase-1 but not paraoxonase-1 induction in cultured hepatocytes - role of the redox-regulated transcription factor Nrf2
AE Wagner, C Boesch-Saadatmandi, D Breckwoldt, C Schrader, C Schmelzer, F Döring, K Hashida, O Hori, S Matsugo, G Rimbach
BMC complementary and alternative medicine 2011
The three-gene paraoxonase family: Physiologic roles, actions and regulation
LP Précourt, D Amre, MC Denis, JC Lavoie, E Delvin, E Seidman, E Levy
Atherosclerosis 2011
The antioxidant HDL-associated paraoxonase-1 (PON1) attenuates diabetes development and stimulates β-cell insulin release
M Koren-Gluzer, M Aviram, E Meilin, T Hayek
Atherosclerosis 2011
Association of L55M and Q192R Polymorphisms of Paraoxonase-1 Gene with Preeclampsia
M Yaghmaei, M Hashemi, A Azarian, A Moazeni-Roodi, M Mokhtari, A Naghavai, S Salimi, M Mohammadi, M Taheri, S Ghavami
Archives of Medical Research 2011
Association between bipolar I disorder and the L55M and Q192R polymorphisms of the paraoxonase 1 (PON1) gene
A Ezzaher, DH Mouhamed, A Mechri, F Neffati, J Rejeb, A Omezzine, W Douki, A Bouslama, L Gaha, MF Najjar
Journal of Affective Disorders 2011
Four genetic polymorphisms of paraoxonase gene and risk of coronary heart disease: A meta-analysis based on 88 case–control studies
M Wang, X Lang, L Zou, S Huang, Z Xu
Atherosclerosis 2011
Paraoxonase 1 gene polymorphisms, paraoxonase/arylesterase activities and oxidized low-density lipoprotein levels in patients with migraine
S Yıldırım, S Akar, M Kuyucu, A Yıldırım, Ş Dane, R Aygül
Cell Biochemistry and Function 2011
Paraoxonase 1 protects macrophages from atherogenicity of a specific triglyceride isolated from human carotid lesion
H Tavori, M Aviram, S Khatib, R Musa, D Mannheim, R Karmeli, J Vaya
Free radical biology & medicine 2011
Predictive role of multilocus genetic polymorphisms in cardiovascular disease and inflammation-related genes on chronic kidney disease in Type 2 diabetes--an 8-year prospective cohort analysis of 1163 patients
Y Wang, AO Luk, RC Ma, WY So, CH Tam, MC Ng, X Yang, V Lam, PC Tong, JC Chan
Nephrology Dialysis Transplantation 2011
Role of JNK and c-Jun signaling pathway in regulation of human serum paraoxonase 1 gene transcription by berberine in human HepG2 cells
CC Cheng, CM Hsueh, KW Liang, CT Ting, CL Wen, SL Hsu
European Journal of Pharmacology 2011
Increased levels of total oxidant status and decreased activity of arylesterase in migraineurs
N Yilmaz, O Aydin, A Yegin, A Tiltak, E Eren
Clinical Biochemistry 2011
Hemodynamics and Metabolism at Low versus Moderate Altitudes
AC de León, MC Pérez, DA González, BB Díaz, SD Coello, AG Hernández, AA C
High Altitude Medicine & Biology 2011
Paraoxonase 1 (PON1) inhibits monocyte-to-macrophage differentiation
M Rosenblat, N Volkova, J Ward, M Aviram
Atherosclerosis 2011
Polyphenols and Human Health: A Prospectus
F Visioli, CA de la Lastra, C Andres-Lacueva, M Aviram, C Calhau, A Cassano, M D’Archivio, A Faria, G Favé, V Fogliano, R Llorach, P Vitaglione, M Zoratti, M Edeas
Critical Reviews in Food Science and Nutrition 2011
Semen Traits and Seminal Plasma Biochemical Parameters in White Leghorn Layer Breeders
RU Khan, V Laudadio, V Tufarelli
Reproduction in Domestic Animals 2011
Formaldehyde induces neurotoxicity to PC12 cells involving inhibition of paraoxonase-1 expression and activity
XQ Tang, YK Ren, RQ Chen, YY Zhuang, HR Fang, JH Xu, CY Wang, B Hu
Clinical and Experimental Pharmacology and Physiology 2011
Naringenin is an inhibitor of human serum paraoxonase (PON1): an in vitro study
A Mahrooz, MR Rashidi, M Nouri
Journal of Clinical Laboratory Analysis 2011
<i>In vitro</i> efficacy of some cattle drugs on bovine serum paraoxonase 1 (PON1) activity
M Arslan, N Gencer, O Arslan, OO Guler
Journal of Enzyme Inhibition and Medicinal Chemistry 2011
Paraoxonase-1, an organophosphate detoxifier and cardioprotective enzyme, is inhibited by anesthetics: An in vitro and in vivo insight
M Şentürk, D Ekinci, HA Alıcı, Ş Beydemir
Pesticide Biochemistry and Physiology 2011
Association between PON1 activity and coronary heart disease risk: A meta-analysis based on 43 studies
Y Zhao, Y Ma, Y Fang, L Liu, S Wu, D Fu, X Wang
Molecular Genetics and Metabolism 2011
Autoimmune-Mediated Reduction of High-Density Lipoprotein-Cholesterol and Paraoxonase-1 Activity in SLE-Prone gld Mice
R Srivastava, S Yu, BW Parks, LL Black, JH Kabarowski
Arthritis & Rheumatism 2011
Lovastatin enhances paraoxonase enzyme activity and quells low-density lipoprotein susceptibility to oxidation in type 2 diabetic nephropathy
N Nezami, A Ghorbanihaghjo, H Argani, J Safa, N Rashtchizadeh, AM Vatankhah, B Salari, B Hajhosseini
Clinical Biochemistry 2011
Effect of dietary lipids on paraoxonase-1 activity and gene expression
G Ferretti, T Bacchetti
Nutrition Metabolism and Cardiovascular Diseases 2011
Injection of paraoxonase 1 (PON1) to mice stimulates their HDL and macrophage antiatherogenicity
M Rosenblat, N Volkova, M Aviram
BioFactors 2011
Lipid status, paraoxonase-1 activity and metabolic parameters in serum of heifers and lactating cows related to oxidative stress
M Antončić-Svetina, R Turk, A Svetina, D Gereš, B Rekić, D Juretić
Research in Veterinary Science 2011
The human paraoxonase gene cluster as a target in the treatment of atherosclerosis
ZG She, HZ Chen, Y Yan, H Li, DP Liu
Antioxidants & Redox Signaling 2011
Effect of vitamin e and selenium supplement on paraoxonase-1 activity, oxidized low density lipoprotein and antioxidant defense in diabetic rats
T Ghaffari, M Nouri, E Irannejad, MR Rashidi
BioImpacts : BI 2011
HDL Dysfunctionality (Paraoxonase) Is Worse in Nondiabetic, Postmenopausal African American Than in White Women
T Gaillard, S Parthasarathy, K Osei
Diabetes care 2011
The concentration of thiobarbituric acid reactive substances (TBARS) and paraoxonase activity in blood of patients with osteoarthrosis after endoprosthesis implantation
DM Olszewska-Słonina, D Mątewski, R Czajkowski, KJ Olszewski, A Woźniak, G Odrowąż-Sypniewska, K Lis, D Musiałkiewicz, B Kowaliszyn
Medical science monitor : international medical journal of experimental and clinical research 2011
Effects of exercise intensity on HDL-C subparticles and atherogenic index
성기운, S Kim, YS Lee
Exercise Science 2011
Smoking is associated with reduced serum paraoxonase, antioxidants and increased oxidative stress in normolipidaemic acute myocardial infarct patients
Arun Kumar, Utpal Kumar Biswas
Heart Asia 2011
Pleiotropic Effects of Thyroid Hormones: Learning from Hypothyroidism
M Franco, E Chávez, O Pérez-Méndez
Journal of Thyroid Research 2011
The relationship of PON1 QR 192 and LM 55 polymorphisms with serum paraoxonase activities of Turkish diabetic patients
D Altuner, I Ates, SH Suzen, GV Koc, Y Aral, A Karakaya
Toxicology and industrial health 2011
Serum Levels of Lipids, Lipoproteins and Paraoxonase Activity in Pre-Eclampsia
B Demir, S Demir, Y Atamer, S Guven, A Atamer, Y Kocyigit, A Hekimoglu, G Toprak
J INT MED RES 2011
Nitric oxide and oxidative stress in vascular disease
U Förstermann
Pflügers Archiv - European Journal of Physiology 2010
Oxidative Modification and Poor Protective Activity of HDL on LDL Oxidation in Thalassemia
S Unchern, N Laohareungpanya, Y Sanvarinda, K Pattanapanyasat, P Tanratana, U Chantharaksri, N Sibmooh
Lipids 2010
Relationship between Paraoxonase 1 (PON1) gene polymorphisms and susceptibility of stroke: a meta-analysis
I Banerjee
European Journal of Epidemiology 2010
The genetics of vascular complications in diabetes mellitus
D Farbstein, AP Levy
Cardiology Clinics 2010
Paraoxonase 1 interactions with atherosclerotic lesions and arterial macrophages protect against foam cell formation and atherosclerosis development
H Tavori, M Rosenblat, J Vaya, M Aviram
Clinical Lipidology 2010
Genetic Association Between Single Nucleotide Polymorphisms in the Paraoxonase 1 (PON1) Gene and Small-for-Gestational-Age Birth in Related and Unrelated Subjects
C Infante-Rivard
American Journal of Epidemiology 2010
Paraoxonase: Its antiatherogenic role in chronic renal failure
M Prakash, NM Phani, R Kavya, M Supriya
Indian journal of nephrology 2010
Paraoxonase 1 R/Q alleles are associated with differential accumulation of saturated versus 20:5n3 fatty acid in human adipose tissue
A Zafiropoulos, M Linardakis, EH Jansen, AM Tsatsakis, A Kafatos, GN Tzanakakis
Journal of lipid research 2010
Estradiol enhances cell-associated paraoxonase 1 (PON1) activity in vitro without altering PON1 expression
S Ahmad, JE Scott
Biochemical and Biophysical Research Communications 2010
A homogeneous cell-based assay for measurement of endogenous paraoxonase 1 activity
S Ahmad, JJ Carter, JE Scott
Analytical Biochemistry 2010
Risk Factors Preceding Type 2 Diabetes and Cardiomyopathy
S Singh, S Dhingra, DD Ramdath, S Vasdev, V Gill, PK Singal
Journal of Cardiovascular Translational Research 2010
An atherogenic lipid profile with low serum paraoxonase-1 activity during nematode infection in rats
AS Farid, S Mido, BK Linh, T Hayashi, Y Horii
European Journal of Clinical Investigation 2010
Betaine Protects Chronic Alcohol and ω-3 PUFA-Mediated Down-Regulations of PON1 Gene, Serum PON1 and Homocysteine Thiolactonase Activities With Restoration of Liver GSH
R Varatharajalu, M Garige, LC Leckey, M Gong, MR Lakshman
Alcoholism, clinical and experimental research 2010
Molecular Mechanisms of HDL-Cholesterol Elevation by Statins and Its Effects on HDL Functions
S Yamashita, K Tsubakio-Yamamoto, T Ohama, Y Nakagawa-Toyama, M Nishida
Journal of Atherosclerosis and Thrombosis 2010
Effect of single bout of maximal excercise on plasma antioxidant status and paraoxonase activity in young sportsmen
A Otocka-Kmiecik, M Lewandowski, R Stolarek, U Szkudlarek, D Nowak, M Orlowska-Majdak
Redox Report 2010
Comparative modeling of PON2 and analysis of its substrate binding interactions using computational methods
S Barathi, M Charanya, S Muthukumaran, N Angayarkanni, V Umashankar
Journal of Ocular Biology, Diseases, and Informatics 2010
Studies on protective effects of human paraoxonases 1 and 3 on atherosclerosis in apolipoprotein E knockout mice
C Zhang, W Peng, M Wang, J Zhu, Y Zang, W Shi, J Zhang, J Qin
Gene Therapy 2010
High-density lipoproteins: Marker of cardiovascular risk and therapeutic target
PP Toth, MH Davidson
Journal of Clinical Lipidology 2010
Paraoxonase 1 (PON1) deficiency in mice is associated with reduced expression of macrophage SR-BI and consequently the loss of HDL cytoprotection against apoptosis
B Fuhrman, A Gantman, M Aviram
Atherosclerosis 2010
Impact of apolipoprotein E genotype and dietary quercetin on paraoxonase 1 status in apoE3 and apoE4 transgenic mice
C Boesch-Saadatmandi, J Niering, AM Minihane, I Wiswedel, A Gardeman, S Wolffram, G Rimbach
Atherosclerosis 2010
Paraoxonase 1 (PON1) expression in hepatocytes is upregulated by pomegranate polyphenols: A role for PPAR-γ pathway
J Khateeb, A Gantman, AJ Kreitenberg, M Aviram, B Fuhrman
Atherosclerosis 2010
Pomegranate juice polyphenols increase recombinant paraoxonase-1 binding to high-density lipoprotein: Studies in vitro and in diabetic patients
B Fuhrman, N Volkova, M Aviram
Nutrition 2010
Purification and kinetic properties of rabbit liver paraoxonase 1
T Bayrak, A Bayrak, E Demirpençe, K Kılınç
Journal of Chromatography B 2010
Some cardiovascular therapeutics inhibit paraoxonase 1 (PON1) from human serum
MM İşgör, Ş Beydemir
European Journal of Pharmacology 2010
Adenovirus-mediated human paraoxonase1 gene transfer to provide protection against the toxicity of the organophosphorus pesticide toxicant diazoxon
EG Duysen, K Parikh, V Aleti, V Manne, O Lockridge, N Chilukuri
Gene Therapy 2010
Consumption of polyphenolic-rich beverages (mostly pomegranate and black currant juices) by healthy subjects for a short term increased serum antioxidant status, and the serum’s ability to attenuate macrophage cholesterol accumulation
M Rosenblat, N Volkova, J Attias, R Mahamid, M Aviram
Food & Function 2010
Effects of hydroxytyrosol-enriched sunflower oil consumption on CVD risk factors
M Vázquez-Velasco, LE Díaz, R Lucas, S Gómez-Martínez, S Bastida, A Marcos, FJ Sánchez-Muniz
British Journal of Nutrition 2010
Anti-atherogenic property of ferulic acid in apolipoprotein E-deficient mice fed Western diet: Comparison with clofibrate
EY Kwon, GM Do, YY Cho, YB Park, SM Jeon, MS Choi
Food and Chemical Toxicology 2010
Plasma levels of lipoprotein-associated phospholipase A2 are increased in patients with β-thalassemia
AD Tselepis, G Hahalis, CC Tellis, EC Papavasiliou, PT Mylona, A Kourakli, DC Alexopoulos
Journal of lipid research 2010
Quercetin & Ethanol Attenuate the Progression of Atherosclerotic Plaques with Concomitant Up Regulation of Paraoxonase1 (PON1) Gene Expression and PON1 Activity in LDLR-/- Mice
LC Leckey, M Garige, R Varatharajalu, M Gong, T Nagata, CF Spurney, RM Lakshman
Alcoholism, clinical and experimental research 2010
Low Plasma Hdl Cholesterol and Elevated C Reactive Protein further Increase Cardiovascular Disease Risk in Latinos with Type 2 Diabetes
MC Calle, S Vega-López, S Segura-Pérez, JS Volek, R Pérez-Escamilla, ML Fernandez
Journal of diabetes &#x0026; metabolism 2010
The HDL Handbook
NJ Hime
The HDL Handbook 2010
The L55M polymorphism of paraoxonase-1 is a risk factor for rheumatoid arthritis
M Hashemi, AK Moazeni-Roodi, A Fazaeli, M Sandoughi, M Taheri, GR Bardestani, Z Zakeri, DM Kordi-Tamandani, S Ghavami
Genetics and Molecular Research 2010
Lack of association between paraoxonase-1 Q192R polymorphism and rheumatoid arthritis in southeast Iran
M Hashemi, AK Moazeni-Roodi, A Fazaeli, M Sandoughi, GR Bardestani, DM Kordi-Tamandani, S Ghavami
Genetics and Molecular Research 2010
Frying of Food: Oxidation, Nutrient and Non-Nutrient Antioxidants, Biologically Active Compounds and High Temperatures, Second Edition
F Snchez-Muniz, J Benedi, S Bastida, R Olivero-David
Frying of Food: Oxidation, Nutrient and Non-Nutrient Antioxidants, Biologically Active Compounds and High Temperatures, Second Edition 2010
The Role of Polymorphisms Within Paraoxonases (192 Gln/Arg in PON1 and 311Ser/Cys in PON2) in the Modulation of Cardiovascular Risk: A Pilot Study
A Gluba, T Pietrucha, M Banach, G Piotrowski, J Rysz
Angiology 2010
Resveratrol commonly displays hormesis: Occurrence and biomedical significance
EJ Calabrese, MP Mattson, V Calabrese
Human & Experimental Toxicology 2010
Targeted deletion of endothelial lipase increases HDL particles with anti-inflammatory properties both in vitro and in vivo
T Hara, T Ishida, Y Kojima, H Tanaka, T Yasuda, M Shinohara, R Toh, K Hirata
Journal of lipid research 2010
Plasma levels of lipoprotein-associated phospholipase A 2 are increased in patients with β-thalassemia
AD Tselepis, G Hahalis, CC Tellis, EC Papavasiliou, PT Mylona, A Kourakli, DC Alexopoulos
Journal of lipid research 2010
Paraoxonase 1 R/Q alleles are associated with differential accumulation of saturated versus 20:5n3 fatty acid in human adipose tissue
A Zafiropoulos, M Linardakis, EH Jansen, AM Tsatsakis, A Kafatos, GN Tzanakakis
Journal of lipid research 2010
Asymptomatic Atherosclerosis
M Naghavi
2010
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
Oxidative risk for atherothrombotic cardiovascular disease
JA Leopold, J Loscalzo
Free radical biology & medicine 2009
Is alcohol beneficial or harmful for cardioprotection?
R Lakshman, M Garige, M Gong, L Leckey, R Varatharajalu, S Zakhari
Genes & Nutrition 2009
Islet Endothelial Activation and Oxidative Stress Gene Expression Is Reduced by IL-1Ra Treatment in the Type 2 Diabetic GK Rat
G Lacraz, MH Giroix, N Kassis, J Coulaud, A Galinier, C Noll, M Cornut, F Schmidlin, JL Paul, N Janel, JC Irminger, M Kergoat, B Portha, MY Donath, JA Ehses, F Homo-Delarche, K Maedler
PloS one 2009
Measurement of serum paraoxonase-1 activity in the evaluation of liver function
J Camps, J Marsillach, J Joven
World journal of gastroenterology : WJG 2009
Paraoxonases in Inflammation, Infection, and Toxicology
ST Reddy
Paraoxonases in Inflammation, Infection, and Toxicology 2009
Paraoxonases in Inflammation, Infection, and Toxicology
ST Reddy
Paraoxonases in Inflammation, Infection, and Toxicology 2009
Paraoxonases in Inflammation, Infection, and Toxicology
ST Reddy
Paraoxonases in Inflammation, Infection, and Toxicology 2009
Paraoxonases in Inflammation, Infection, and Toxicology
ST Reddy
Paraoxonases in Inflammation, Infection, and Toxicology 2009
Paraoxonases in Inflammation, Infection, and Toxicology
ST Reddy
Paraoxonases in Inflammation, Infection, and Toxicology 2009
Paraoxonases in Inflammation, Infection, and Toxicology
ST Reddy
Paraoxonases in Inflammation, Infection, and Toxicology 2009
Paraoxonases in Inflammation, Infection, and Toxicology
ST Reddy
Paraoxonases in Inflammation, Infection, and Toxicology 2009
The roles of PON1 and PON2 in cardiovascular disease and innate immunity
DM Shih, AJ Lusis
Current Opinion in Lipidology 2009
The paraoxonases: role in human diseases and methodological difficulties in measurement
J Camps, J Marsillach, J Joven
Critical Reviews in Clinical Laboratory Sciences 2009
Autism
H Jyonouchi
Autism 2009
The paraoxonase gene family and atherosclerosis
D Seo, P Goldschmidt-Clermont
Current Atherosclerosis Reports 2009
Paraoxonase Variants Relate to 10-Year Risk in Coronary Artery Disease
JJ Regieli, JW Jukema, PA Doevendans, AH Zwinderman, JJ Kastelein, DE Grobbee, Y der Graaf
Journal of the American College of Cardiology 2009
Sequence identification, chromosomal mapping and tissue specific expression of the porcine paraoxonase 1 (PON1) gene
S Xie, J Li, Y Chen, C Wang, H Zhang, D Mo
Molecular Biology Reports 2009
Synergistic effect of polymorphisms of paraoxonase gene cluster and arsenic exposure on electrocardiogram abnormality
YT Liao, WF Li, CJ Chen, RJ Prineas, WJ Chen, ZM Zhang, CW Sun, SL Wang
Toxicology and Applied Pharmacology 2009
Serum paraoxonase and arylesterase activities in patients with epithelial ovarian cancer
H Camuzcuoglu, DT Arioz, H Toy, S Kurt, H Celik, O Erel
Gynecologic Oncology 2009
Decreased Paraoxonase and Arylesterase Activities in the Pathogenesis of Future Atherosclerotic Heart Disease in Women with Gestational Diabetes Mellitus
H Camuzcuoglu, H Toy, H Cakir, H Celik, O Erel
Journal of Women's Health 2009
Variation in paraoxonase-1 activity and atherosclerosis
H Soran, NN Younis, V Charlton-Menys, P Durrington
Current Opinion in Lipidology 2009
Genetic Polymorphism in Paraoxonase 1 (PON1): Population Distribution of PON1 Activity
G Ginsberg, P Neafsey, D Hattis, KZ Guyton, DO Johns, B Sonawane
Journal of Toxicology and Environmental Health, Part B 2009
Analysis of paraoxonase 1 (PON1) genetic polymorphisms and activities as risk factors for ischemic stroke in Turkish population
BC Demirdöğen, SÌ Demirkaya, A Türkanoğlu, S Bek, E Arınç, O Adalı
Cell Biochemistry and Function 2009
In vivo administration of BL-3050: highly stable engineered PON1-HDL complexes
L Gaidukov, D Bar, S Yacobson, E Naftali, O Kaufman, R Tabakman, DS Tawfik, E Levy-Nissenbaum
BMC clinical pharmacology 2009
Evaluation of polymorphisms in paraoxonase 2 (PON2) gene and their association with cardiovascular-renal disease risk in Mexican Americans
F Thameem, X He, VS Voruganti, SD Nath, P Fanti, J Blangero, JW Maccluer, AG Comuzzie, NH Arar, HE Abboud
Kidney & blood pressure research 2009
Studies on HDL associated enzymes under experimental hypercholesterolemia: possible modulation on selenium supplementation
HD Kaur, MP Bansal
Lipids in Health and Disease 2009
Human carotid atherosclerotic plaque increases oxidative state of macrophages and low-density lipoproteins, whereas paraoxonase 1 (PON1) decreases such atherogenic effects
H Tavori, M Aviram, S Khatib, R Musa, S Nitecki, A Hoffman, J Vaya
Free radical biology & medicine 2009
Di-oleoyl phosphatidylcholine (PC-18:1) stimulates paraoxonase 1 (PON1) enzymatic and biological activities: In vitro and in vivo studies
M Efrat, M Rosenblat, S Mahmood, J Vaya, M Aviram
Atherosclerosis 2009
Serum lipid profile, oxidative status, and paraoxonase 1 activity in hyperemesis gravidarum
H Aksoy, AN Aksoy, A Ozkan, H Polat
Journal of Clinical Laboratory Analysis 2009
Involvement of paraoxonase 1 genetic variants in Alzheimer���s disease neuropathology
V Leduc, L Th��roux, D Dea, Y Robitaille, J Poirier
European Journal of Neuroscience 2009
Paraoxonase: A multifaceted biomolecule
B Goswami, D Tayal, N Gupta, V Mallika
Clinica Chimica Acta 2009
Relation of PON1 and CYP1A1 genetic polymorphisms to clinical findings in a cross-sectional study of a Greek rural population professionally exposed to pesticides
AM Tsatsakis, A Zafiropoulos, MN Tzatzarakis, GN Tzanakakis, A Kafatos
Toxicology Letters 2009
Hydrogen sulfide destroys lipid hydroperoxides in oxidized LDL
MK Muellner, SM Schreier, H Laggner, M Hermann, H Esterbauer, M Exner, BM Gmeiner, S Kapiotis
Biochemical Journal 2009
Purification of PON1 from Human Serum and Assessment of Enzyme Kinetics Against Metal Toxicity
D Ekinci, Ş Beydemir
Biological Trace Element Research 2009
Pitavastatin induces PON1 expression through p44/42 mitogen-activated protein kinase signaling cascade in Huh7 cells
K Arii, T Suehiro, K Ota, Y Ikeda, Y Kumon, F Osaki, M Inoue, S Inada, N Ogami, H Takata, K Hashimoto, Y Terada
Atherosclerosis 2009
Grapes, Wines, Resveratrol, and Heart Health
AA Bertelli, DK Das
Journal of Cardiovascular Pharmacology 2009
Rosiglitazone modifies HDL structure and increases HDL-apo AI synthesis and catabolic rates
E Carreón-Torres, K Rendón-Sauer, M Monter-Garrido, P Toledo-Ibelles, R Gamboa, M Menjivar, R López-Marure, G Luc, C Fievet, D Cruz, G Vargas-Alarcón, O Pérez-Méndez
Clinica Chimica Acta 2009
Purification human PON1Q192 and PON1R192 isoenzymes by hydrophobic interaction chromatography and investigation of the inhibition by metals
N Gençer, O Arslan
Journal of Chromatography B 2009
Current understanding of the mechanisms involved in metabolic detoxification of warfare nerve agents
M Jokanović
Toxicology Letters 2009
Protective effect of paraoxonase 1 of high-density lipoprotein in type 2 diabetic patients with nephropathy
C Li, Q Gu
Nephrology 2009
Paraoxonases role in the prevention of cardiovascular diseases
M Rosenblat, M Aviram
BioFactors 2009
Altered Flow-Mediated Vasodilatation, Low Paraoxonase-1 Activity, and Abnormal High-Density Lipoprotein Subclass Distribution in Takayasu's Arteritis
N Espinola-Zavaleta, ME Soto-López, E Carreón-Torres, R Gamboa, AM Mejía, R Márquez-Velasco, R Bojalil, C Huesca-Gomez, PA Reyes, O Pérez-Méndez
Circulation Journal 2009
Expression and activity of paraoxonase 1 in human cataractous lens tissue
Z Hashim, A Ilyas, A Saleem, A Salim, S Zarina
Free radical biology & medicine 2009
Evaluation of the impacts of antibiotic drugs on PON 1; a major bioscavenger against cardiovascular diseases
D Ekinci, Ş Beydemir
European Journal of Pharmacology 2009
Is Plasma Homocysteine Level Associated With Metabolic Syndrome Components in Adolescents?
NB Ph.D., CY M.D., AÖ Ph.D., FB M.D., MM M.D., SK M.D.
Metabolic Syndrome and Related Disorders 2009
Paraoxonase 1 gene promoter polymorphisms are associated with the extent of stenosis in coronary arteries
M Najafi, LH Gohari, M Firoozrai
Thrombosis Research 2009
Protecting effect of vitamin E supplementation on submaximal exercise-induced oxidative stress in sedentary dogs as assessed by erythrocyte membrane fluidity and paraoxonase-1 activity
S Motta, C Letellier, M Ropert, C Motta, JJ Thiébault
The Veterinary Journal 2009
Arylesterase and paraoxonase activity of paraoxonase (PON1) affected by ischemia in the plasma of patients with arterial occlusion of the lower limbs
M Kasprzak, M Iskra, W Majewski, T Wielkoszyński
Clinical Biochemistry 2009
Schistosoma mansoni: Effect of dietary zinc supplement on egg granuloma in Swiss mice treated with praziqantel
MM Helmy, SS Mahmoud, ZH Fahmy
Experimental Parasitology 2009
Handbook of Toxicology of Chemical Warfare Agents
DR Varma, S Mulay, S Chemtob
Handbook of Toxicology of Chemical Warfare Agents 2009
Homocysteine and lipids: S-Adenosyl methionine as a key intermediate
R Obeid, W Herrmann
FEBS Letters 2009
Anti-ulcer Activity of Curcumin on Experimental Gastric Ulcer in Rats and Its Effect on Oxidative Stress/Antioxidant, IL-6 and Enzyme Activities
M Tuorkey, K Karolin
Biomedical and Environmental Sciences 2009
Effect of atorvastatin on paraoxonase1 (PON1) and oxidative status
A Nagila, T Permpongpaiboon, S Tantrarongroj, P Porapakkham, K Chinwattana, S Deakin, S Porntadavity
Pharmacological Reports 2009
Both Paraoxonase-1 Genotype and Activity Do Not Predict the Risk of Future Coronary Artery Disease; the EPIC-Norfolk Prospective Population Study
RS Birjmohun, M Vergeer, ES Stroes, MS Sandhu, SL Ricketts, MW Tanck, NJ Wareham, JW Jukema, JJ Kastelein, KT Khaw, SM Boekholdt, F Kronenberg
PloS one 2009
Measurement of serum paraoxonase-1 activity in the evaluation of liver function
J Camps, J Marsillach, J Joven
World journal of gastroenterology : WJG 2009
Q192R and L55M polymorphism in paraoxonase 1 gene in patients with coronary heart disease of different age and sex
GD Perales, AN Voitovich, MA Bogdanova, AY Anisenkova, MI Badmaeva, VL Stepanova, BI Smirnov, TN Ryabkova, VV Isakov, SI Yagashkina, ON Semenova, DV Cherkashin, SA Boitsov, YR Kovalev, OA Berkovich, EV Shlyakhto, NV Kirillova, VI Larionova
2009
Paraoxonase 1 (PON1) attenuates diabetes development in mice through its antioxidative properties
O Rozenberg, M Shiner, M Aviram, T Hayek
Free radical biology & medicine 2008
Effects of red wine polyphenolic compounds on paraoxonase-1 and lectin-like oxidized low-density lipoprotein receptor-1 in hyperhomocysteinemic mice
C Noll, J Hamelet, E Matulewicz, JL Paul, JM Delabar, N Janel
The Journal of Nutritional Biochemistry 2008
Laboratory Assessment of HDL Heterogeneity and Function
R Movva, DJ Rader
Clinical chemistry 2008
Advanced Protocols in Oxidative Stress I
D Armstrong
2008
Advanced Protocols in Oxidative Stress I
D Armstrong
2008
Advanced Protocols in Oxidative Stress I
D Armstrong
2008
Advanced Protocols in Oxidative Stress I
D Armstrong
2008
Advanced Protocols in Oxidative Stress I
D Armstrong
2008
Advanced Protocols in Oxidative Stress I
D Armstrong
2008
Recent Advances in Retinal Degeneration
RE Anderson, MM LaVail, JG Hollyfield
2008
Recent Advances in Retinal Degeneration
RE Anderson, MM LaVail, JG Hollyfield
2008
The Influence of PON1 192 Polymorphism on Endothelial Function in Diabetic Subjects with or without Hypertension
C IRACE, C CORTESE, E FIASCHI, F SCAVELLI, L LIBERATOSCIOLI, G FEDERICI, A GNASSO
Hypertension Research 2008
Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies
U Förstermann
Nature Clinical Practice Cardiovascular Medicine 2008
Relationship of adiponectin to serum paraoxonase 1
L Bajnok, E Csongradi, I Seres, Z Varga, S Jeges, A Peti, Z Karanyi, A Juhasz, E Mezosi, EV Nagy, G Paragh
Atherosclerosis 2008
Association of paraoxonase activity and coronary blood flow
A Yildiz, M Gur, R Yilmaz, R Demirbag, M Polat, S Selek, H Celik, O Erel
Atherosclerosis 2008
High-density lipoprotein cholesterol and paraoxonase 1 (PON1) genetics and serum PON1 activity in prepubertal children in Spain
C Garcés, L López-Simón, R Rubio, M Benavente, B Cano, H Ortega, M Oya
Clinical Chemistry and Laboratory Medicine 2008
Effect of Atorvastatin on Paraoxonase Activity in Patients with Hyperlipidemia
JK Shetty, M Prakash, S Tripathy, M Verma, P Vikram
Asian Journal of Biochemistry 2008
Lipid peroxidation in stroke patients
G Ferretti, T Bacchetti, S Masciangelo, L Nanetti, L Mazzanti, M Silvestrini, M Bartolini, L Provinciali
Clinical Chemistry and Laboratory Medicine 2008
Association of paraoxonase activity and coronary collateral flow
A Yildiz, Y Sezen, M Gur, R Yilmaz, R Demirbag, O Erel
Coronary Artery Disease 2008
Paraoxonase 1: Genetics and Activities During Aging
F Marchegiani, M Marra, F Olivieri, M Cardelli, RW James, M Boemi, C Franceschi
Rejuvenation Research 2008
Comparison of the ability of paraoxonases 1 and 3 to attenuate the in vitro oxidation of low-density lipoprotein and reduce macrophage oxidative stress
Y Liu, B Mackness, M Mackness
Free radical biology & medicine 2008
Genetic polymorphisms in the Paraoxonase 1 gene and risk of ovarian epithelial carcinoma
G Lurie, LR Wilkens, PJ Thompson, KE McDuffie, ME Carney, KY Terada, MT Goodman
Cancer epidemiology, biomarkers & prevention 2008
Determination of paraoxonase 1 status without the use of toxic organophosphate substrates
RJ Richter, GP Jarvik, CE Furlong
Circulation. Cardiovascular genetics 2008
Induction of paraoxonase 1 and apolipoprotein A-I gene expression by aspirin
P Jaichander, K Selvarajan, M Garelnabi, S Parthasarathy
Journal of lipid research 2008
Paraoxonase (PON1) is associated with familial combined hyperlipidemia
TM van Himbergen, LJ van Tits, E Avest, M Roest, HA Voorbij, J Graaf, AF Stalenhoef
Atherosclerosis 2008
Small dense LDL oxidation in hypertensives and diabetics and prediction of Metabolic Syndrome
J Nishtha, I Naseem, J Ahmad
Diabetes and Metabolic Syndrome: Clinical Research and Reviews 2008
The paraoxonase gene polymorphism in stroke patients and lipid profile
BS Shin, SY Oh, YS Kim, KW Kim
Acta Neurologica Scandinavica 2008
Long-term effects of resveratrol supplementation on suppression of atherogenic lesion formation and cholesterol synthesis in apo E-deficient mice
GM Do, EY Kwon, HJ Kim, SM Jeon, TY Ha, T Park, MS Choi
Biochemical and Biophysical Research Communications 2008
Macrophage paraoxonase 1 (PON1) binding sites
M Efrat, M Aviram
Biochemical and Biophysical Research Communications 2008
Effects of plasma homocysteine levels on serum HTase/PON activity in patients with type 2 diabetes
G Weijun, L Juming, Y Guoqing, D Jingtao, G Qinghua, M Yiming, P Changyu
Advances in Therapy 2008
The ontogeny of drug metabolism enzymes and implications for adverse drug events
RN Hines
Pharmacology & Therapeutics 2008
Paraoxonase activity and coronary heart disease risk in healthy middle-aged males: The PRIME study
JA Troughton, JV Woodside, JW Yarnell, D Arveiler, P Amouyel, J Ferrières, P Ducimetière, CC Patterson, G Luc
Atherosclerosis 2008
Determination of rat and mice arylesterase activity using serum mimetics
M Nus, FJ Sánchez-Muniz, JV Gago, E López-Oliva, JM Sánchez-Montero
Enzyme and microbial technology 2008
Pharmacologic Management of Isolated Low High-Density Lipoprotein Syndrome
V Bermúdez, R Cano, C Cano, F Bermúdez, N Arraiz, L Acosta, F Finol, MR Pabón, A Amell, N Reyna, J Hidalgo, P Kendall, V Manuel, R Hernández
American Journal of Therapeutics 2008
Purification of Human Serum Paraoxonase and Effect of Acetylsalicylic Acid on Paraoxonase Activity
N Demir, H Nadaroğlu, Y Demir
Pharmaceutical Biology 2008
Beneficial effects of curcumin on hyperlipidemia and insulin resistance in high-fat–fed hamsters
EM Jang, MS Choi, UJ Jung, MJ Kim, HJ Kim, SM Jeon, SK Shin, CN Seong, MK Lee
Metabolism 2008
Effect of spermine on lipid profile and HDL functionality in the streptozotocin-induced diabetic rat model
A Jafarnejad, SZ Bathaie, M Nakhjavani, MZ Hassan
Life Sciences 2008
PON1 status is influenced by oxidative stress and inflammation in coronary heart disease patients
J Kotur-Stevuljevic, S Spasic, Z Jelic-Ivanovic, V Spasojevic-Kalimanovska, A Stefanovic, A Vujovic, L Memon, D Kalimanovska-Ostric
Clinical Biochemistry 2008
Paraoxonase and arylesterase activities in untreated dipper and non-dipper hypertensive patients
A Yildiz, M Gur, R Demirbag, R Yilmaz, S Akyol, M Aslan, O Erel
Clinical Biochemistry 2008
Determination of rat serum esterase activities by an HPLC method using S-acetylthiocholine iodide and p-nitrophenyl acetate
M Koitka, J Höchel, D Obst, A Rottmann, H Gieschen, HH Borchert
Analytical Biochemistry 2008
Iron overload alters glucose homeostasis, causes liver steatosis, and increases serum triacylglycerols in rats
M Silva, ME Silva, H Paula, CM Carneiro, ML Pedrosa
Nutrition Research 2008
Paraoxonase 1 activities and polymorphisms in autism spectrum disorders
SP Paşca, E Dronca, B Nemeş, T Kaucsár, E Endreffy, F Iftene, I Benga, R Cornean, M Dronca
Journal of Cellular and Molecular Medicine 2008
Paraoxonase and Arylesterase Activities in Patients with Preeclampsia
Ayse Nur Aksoy, Nurinnisa Ozturk, Hulya Aksoy, Fatih Akcay
The Eurasian Journal of Medicine 2008
A common haplotype within the PON1 promoter region is associated with sporadic ALS
JE Landers, L Shi, TJ Cho, JD Glass, CE Shaw, PN Leigh, F Diekstra, M Polak, I Rodriguez-Leyva, S Niemann, BJ Traynor, D Mckenna-Yasek, PC Sapp, A Al-Chalabi, AM Wills, RH Brown
Amyotrophic Lateral Sclerosis 2008
Effects of Origanum onites on Endothelial Function and Serum Biochemical Markers in Hyperlipidaemic Patients
B Özdemir, A Ekbul, NB Topal, E Sarandöl, S Sağ, KH Başer, J Cordan, S Güllülü, E Tuncel, İ Baran, A Aydinlar
J INT MED RES 2008
Induction of paraoxonase 1 and apolipoprotein A-I gene expression by aspirin
P Jaichander, K Selvarajan, M Garelnabi, S Parthasarathy
Journal of lipid research 2008
The Paraoxonases: Their Role in Disease Development and Xenobiotic Metabolism
B Mackness, M Mackness, M Aviram, G Paragh
2008
Antiatherogenicity of extra virgin olive oil and its enrichment with green tea polyphenols in the atherosclerotic apolipoprotein-E-deficient mice: enhanced macrophage cholesterol efflux
M Rosenblat, N Volkova, R Coleman, Y Almagor, M Aviram
The Journal of Nutritional Biochemistry 2008
Recent Advances in Retinal Degeneration
RE Anderson, MM LaVail, JG Hollyfield
2008
Genetic Polymorphisms in the Paraoxonase 1 Gene and Risk of Ovarian Epithelial Carcinoma
G Lurie, LR Wilkens, PJ Thompson, KE McDuffie, ME Carney, KY Terada, MT Goodman
Cancer epidemiology, biomarkers & prevention 2008
Dyslipidemia inhibits Toll-like receptor-induced activation of CD8alpha-negative dendritic cells and protective Th1 type immunity
AT Shamshiev, F Ampenberger, B Ernst, L Rohrer, BJ Marsland, M Kopf
Journal of Experimental Medicine 2007
Cholinergic status modulations in human volunteers under acute inflammation
K Ofek, KS Krabbe, T Evron, M Debecco, AR Nielsen, H Brunnsgaad, R Yirmiya, H Soreq, BK Pedersen
Journal of Molecular Medicine 2007
Decreased Obesity and Atherosclerosis in Human Paraoxonase 3 Transgenic Mice
DM Shih, YR Xia, XP Wang, SS Wang, N Bourquard, AM Fogelman, AJ Lusis, ST Reddy
Circulation research 2007
Convergence of genes implicated in Alzheimer's disease on the cerebral cholesterol shuttle: APP, cholesterol, lipoproteins, and atherosclerosis
CJ Carter
Neurochemistry International 2007
Paraoxonase activity in patients with erectile dysfunction
H Ciftci, E Yeni, M Savas, A Verit, H Celik
International Journal of Impotence Research 2007
High-density lipoprotein mass, cholesteryl ester transport protein, and macrophage reverse cholesterol transport: from the bedside back to the bench
Y Levy
Cardiovascular Research 2007
Assessment of paraoxonase and arylesterase activities in patients with iron deficiency anemia
M Aslan, M Kosecik, M Horoz, S Selek, H Celik, O Erel
Atherosclerosis 2007
Ingestion of moderately thermally oxidized polyunsaturated fat decreases serum resistance to oxidation in men with coronary artery disease
WH Sutherland, MJ Williams, SA de Jong, MP McCormick
Nutrition Research 2007
Frequency of Paraoxonase 192/55 Polymorphism in an Iranian Population
F Sepahvand, P Rahimi-Moghaddam, M Shafiei, SM Ghaffari, M Rostam-Shirazi, M Mahmoudian
Journal of Toxicology and Environmental Health, Part A 2007
Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population
ET Elkiran, N Mar, B Aygen, F Gursu, A Karaoglu, S Koca
BMC Cancer 2007
Serum paraoxonase-1 activity and concentration are influenced by human immunodeficiency virus infection
S Parra, C Alonso-Villaverde, B Coll, N Ferré, J Marsillach, G Aragonès, M Mackness, B Mackness, L Masana, J Joven, J Camps
Atherosclerosis 2007
Serum paraoxonase and arylesterase activities for the evaluation of patients with chronic hepatitis
M Aslan, M Horoz, Y Nazligul, C Bolukbas, FF Bolukbas, S Selek, N Aksoy, O Erel
International Journal of Clinical Practice 2007
Serum PON1 arylesterase activity in relation to hyperhomocysteinaemia and oxidative stress in young adult central retinal venous occlusion patients
N Angayarkanni, S Barathi, T Seethalakshmi, R Punitham, R Sivaramakrishna, G Suganeswari, S Tarun
Eye 2007
Decreased paraoxonase-1 activity is a risk factor for ischemic stroke in Koreans
NS Kim, K Kang, MH Cha, BJ Kang, J Moon, BK Kang, BC Yu, YS Kim, SM Choi, OS Bang
Biochemical and Biophysical Research Communications 2007
Oxidative stress and systemic inflammation in patients with sleep apnea: Role of obesity
L LAVIE, A VISHNEVSKY, P LAVIE
Sleep and Biological Rhythms 2007
Paraoxonase and arylesterase activities in patients with cardiac syndrome X, and their relationship with oxidative stress markers
M Gur, A Yildiz, R Demirbag, R Yilmaz, M Aslan, I Ozdogru, O Erel
Coronary Artery Disease 2007
HIGH-DOSE TAURINE SUPPLEMENTATION INCREASES SERUM PARAOXONASE AND ARYLESTERASE ACTIVITIES IN EXPERIMENTAL HYPOTHYROIDISM
M Dirican, S Taş, E Sarandöl
Clinical and Experimental Pharmacology and Physiology 2007
Paraoxonase Phenotype Distribution in a Healthy Iranian Population
F Sepahvand, M Shafiei, SM Ghaffari, P Rahimi-Moghaddam, M Mahmoudian
Basic & Clinical Pharmacology & Toxicology 2007
Effect of rosuvastatin versus atorvastatin treatment on paraoxonase-1 activity in men with established cardiovascular disease and a low HDL-cholesterol
SC Bergheanu, AV Tol, GM Dallinga-Thie, A Liem, PH Dunselman, JG van der Bom, JW Jukema
Current Medical Research and Opinion 2007
Accelerated atherosclerosis in apolipoprotein E-deficient mice fed Western diets containing palm oil compared with extra virgin olive oils: A role for small, dense high-density lipoproteins
JM Arbonés-Mainar, MA Navarro, R Carnicer, N Guillén, JC Surra, S Acín, MA Guzmán, AJ Sarría, C Arnal, MP Aguilera, A Jiménez, G Beltrán, M Uceda, J Osada
Atherosclerosis 2007
Synergistic Effects between Q192R Polymorphism of Paraoxonase 1 Gene and Some Conventional Risk Factors in Premature Coronary Artery Disease
A Balcerzyk, I Zak, J Krauze
Archives of Medical Research 2007
Macrophage paraoxonase 2 (PON2) expression is up-regulated by pomegranate juice phenolic anti-oxidants via PPARγ and AP-1 pathway activation
M Shiner, B Fuhrman, M Aviram
Atherosclerosis 2007
Macrophage NADPH oxidase activation, impaired cholesterol fluxes, and increased cholesterol biosynthesis in diabetic mice: A stimulatory role for d-glucose
T Hayek, M Kaplan, R Kerry, M Aviram
Atherosclerosis 2007
The effect of atorvastatin therapy on lecithin:cholesterol acyltransferase, cholesteryl ester transfer protein and the antioxidant paraoxonase
A Kassai, L Illyés, HZ Mirdamadi, I Seres, T Kalmár, M Audikovszky, G Paragh
Clinical Biochemistry 2007
Oxidative stress and antioxidant defenses in serum of patients with non-alcoholic steatohepatitis
G Baskol, M Baskol, D Kocer
Clinical Biochemistry 2007
Chemical Warfare Agents: Chemistry, Pharmacology, Toxicology, and Therapeutics
N Chilukuri, C Luo, B Doctor, A Saxena, D Maxwell
Chemical Warfare Agents: Chemistry, Pharmacology, Toxicology, and Therapeutics 2007
Coronary artery disease risk factors in patients with schizophrenia: effects of short term antipsychotic treatment
A Sarandol, S Kirli, C Akkaya, N Ocak, E Eroz, E Sarandol
Journal of Psychopharmacology (Oxford, England) 2007
Polymorphisms and Vascular Cognitive Impairment After Ischemic Stroke
L Baum, X Chen, WS Cheung, CK Cheung, LW Cheung, KF Chiu, HM Wen, P Poon, KS Woo, HK Ng, KS Wong
Journal of Geriatric Psychiatry and Neurology 2007
Arylesterase Activity and Antioxidant Status Depend on PON1-Q192R and PON1-L55M Polymorphisms in Subjects with Increased Risk of Cardiovascular Disease Consuming Walnut-Enriched Meat
M Nus, F Frances, J Librelotto, A Canales, D Corella, JM Sánchez-Montero, FJ Sánchez-Muniz
The Journal of nutrition 2007
Age-Related Paraoxonase Activity Changes in Turkish Population
E Saruhan, A Olgun, K Ozturk, S Akman, MK Erbil
Annals of the New York Academy of Sciences 2007
Study of the Relationship between Gene Polymorphisms of Paraoxonase 2 and Stroke in a Chinese Population
HW Xu, N Yuan, Z Zhao, L Zhang, J Xia, KM Zeng, B Xiao, XS Yang, BS Tang
Cerebrovascular Diseases 2007
Accuracy and Biological Variation of Human Serum Paraoxonase 1 Activity and Polymorphism (Q192R) by Kinetic Enzyme Assay
RW Browne, ST Koury, S Marion, G Wilding, P Muti, M Trevisan
Clinical chemistry 2007
High‐Density Lipoproteins: From Basic Biology to Clinical Aspects
CJ Fielding
2007
Low ethanol intake prevents salt-induced hypertension in WKY rats
S Vasdev, V Gill, S Parai, V Gadag
Molecular and Cellular Biochemistry 2006
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
A Kontush, MJ Chapman
Pharmacological reviews 2006
Time-dependent modulation of rat serum paraoxonase 1 activity by fasting
E Thomàs-Moyà, A Nadal-Casellas, M Gianotti, I Lladó, AM Proenza
Pflügers Archiv - European Journal of Physiology 2006
Inhibition of MMP-2 activation and release as a novel mechanism for HDL-induced cardioprotection
S Bellosta, M Gomaraschi, M Canavesi, G Rossoni, M Monetti, G Franceschini, L Calabresi
FEBS Letters 2006
HDL inflammation and atherosclerosis: current and future perspectives
T Sampietro, F Bigazzi, M Puntoni, A Bionda
Future Cardiology 2006
Modified HDL: Biological and physiopathological consequences
GD Norata, A Pirillo, AL Catapano
Nutrition, Metabolism and Cardiovascular Diseases 2006
Probucol Up-Regulates Paraoxonase 1 Expression in Hepatocytes of Hypercholesterolemic Rabbits
S Hong, S Zhao, Z Wu
Journal of Cardiovascular Pharmacology 2006
Paraoxonase-1 activity as a marker of atherosclerosis is not associated with low bone mineral density in healthy postmenopausal women
FF Verit, H Celik, P Yazgan, O Erel, I Geyikli
Archives of Gynecology and Obstetrics 2006
Preferable stimulation of PON1 arylesterase activity by phosphatidylcholines with unsaturated acyl chains or oxidized acyl chains at sn-2 position
SD Nguyen, DE Sok
Biochimica et Biophysica Acta (BBA) - Biomembranes 2006
Hyperbaric oxygen: a new drug in myocardial revascularization and protection?
JZ Yogaratnam, G Laden, LA Madden, AM Seymour, L Guvendik, M Cowen, J Greenman, A Cale, S Griffin
Cardiovascular Revascularization Medicine 2006
A long and winding road: defining the biological role and clinical importance of paraoxonases
RW James
Clinical Chemistry and Laboratory Medicine 2006
Association of Paraoxonase-1 Activity and Concentration With Angiographic Severity and Extent of Coronary Artery Disease
M Granér, RW James, J Kahri, MS Nieminen, M Syvänne, MR Taskinen
Journal of the American College of Cardiology 2006
Postprandial modulation of serum paraoxonase activity and concentration in diabetic and non-diabetic subjects
S Beer, X Moren, J Ruiz, RW James
Nutrition, Metabolism and Cardiovascular Diseases 2006
Paraoxonase and arylesterase activities in coronary artery disease
M Gur, M Aslan, A Yildiz, R Demirbag, R Yilmaz, S Selek, O Erel, I Ozdogru
European Journal of Clinical Investigation 2006
Human serum paraoxonase gene polymorphisms, Q192R and L55M, are not associated with the risk of cerebral infarction in Chinese Han population
Q Huang, YH Liu, QD Yang, B Xiao, L Ge, N Zhang, J Xia, L Zhang, ZJ Liu
Neurological Research 2006
Paraoxonase 1, 2 and 3 DNA variants and susceptibility to childhood inflammatory bowel disease
R Sanchez, E Levy, E Seidman, D Amre, F Costea, D Sinnett
Gut 2006
Beneficial effect of low ethanol intake on the cardiovascular system: possible biochemical mechanisms
S Vasdev, V Gill, PK Singal
Vascular Health and Risk Management 2006
Modulation of oxidative stress-induced changes in hypertension and atherosclerosis by antioxidants
S Vasdev, VD Gill, PK Singal
Experimental and clinical cardiology 2006
A new method for the determination of arylesterase activity in human serum using simulated body fluid
M Nus, FJ Sánchez-Muniz, JM Sánchez-Montero
Atherosclerosis 2006
Sobre los genes paraoxonasa-1 y SR-B1, y su importancia en la aterosclerosis
FR Esparragón, YH Trujillo, AM Reyes, EH Ortega, A Medina, JC Pérez
Revista Española de Cardiología 2006
Postprandial serum triacylglycerols and oxidative stress in mice after consumption of fish oil, soy oil or olive oil: Possible role for paraoxonase-1 triacylglycerol lipase-like activity
B Fuhrman, N Volkova, M Aviram
Nutrition 2006
HDL dysfunction in obstructive sleep apnea
KC Tan, WS Chow, JC Lam, B Lam, WK Wong, S Tam, MS Ip
Atherosclerosis 2006
From Oxidative Stress to Cardiovascular Risk in Obstructive Sleep Apnoea. Vom oxidativen Stress zum kardiovaskularen Risiko bei obstruktiver Schlafapnoe
L Lavie
Somnologie 2006
A biphasic U-shape effect of cellular oxidative stress on the macrophage anti-oxidant paraoxonase 2 (PON2) enzymatic activity
M Shiner, B Fuhrman, M Aviram
Biochemical and Biophysical Research Communications 2006
Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: Relevance to diabetes
M Rosenblat, R Karry, M Aviram
Atherosclerosis 2006
S-Glutathionylation regulates HDL-associated paraoxonase 1 (PON1) activity
O Rozenberg, M Aviram
Biochemical and Biophysical Research Communications 2006
Effects of Intranasal Estradiol Treatment on Serum Paraoxonase and Lipids in Healthy, Postmenopausal Women
IV Fenkci, M Serteser, S Fenkci, AM Akyol
Gynecologic and Obstetric Investigation 2006
Serum Paraoxonase 1 Activity and Lipid Peroxidation Levels in Patients with Age-Related Macular Degeneration
G Baskol, S Karakucuk, AO Oner, M Baskol, D Kocer, E Mirza, R Saraymen, M &Idot;stdal
Ophthalmologica 2006
Oxidation of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in major depressive disorder
A Sarandol, E Sarandol, SS Eker, EU Karaagac, BZ Hizli, M Dirican, S Kirli
Progress in Neuro-Psychopharmacology and Biological Psychiatry 2006
Paraoxonase 1 (PON1) and its relationship to lipid variables, age and gender in healthy volunteers
K Sumegová, P Blažíček, B Fuhrman, I Waczulíková, Z Ďuračková
Biologia 2006
Paraoxonase 1 gene Q192R polymorphism affects stroke and myocardial infarction risk
L Baum, HK Ng, KS Woo, B Tomlinson, TH Rainer, X Chen, WS Cheung, DK Chan, GN Thomas, CS Tong, KS Wong
Clinical Biochemistry 2006
Lipid and protein oxidation and antioxidant status in patients with angiographically proven coronary artery disease
Z Serdar, K Aslan, M Dirican, E Sarandöl, D Yeşilbursa, A Serdar
Clinical Biochemistry 2006
Vitamin C preserves the cardio-protective paraoxonase activity of high-density lipoprotein during oxidant stress
MS Calla, SM Lynch
Archives of Biochemistry and Biophysics 2006
Adenovirus mediated expression of human paraoxonase 2 protects against the development of atherosclerosis in apolipoprotein E-deficient mice
CJ Ng, SY Hama, N Bourquard, M Navab, ST Reddy
Molecular Genetics and Metabolism 2006
HDL: The ‘new’ target of cardiovascular medicine
T Sampietro, F Bigazzi, BD Pino, M Puntoni, A Bionda
International Journal of Cardiology 2006
Concerning the Significance of Paraoxonase-1 and SR-B1 Genes in Atherosclerosis
FR Esparragón, YH Trujillo, AM Reyes, EH Ortega, A Medina, JC Pérez
Revista Española de Cardiología (English Edition) 2006
Influence of chronic exercise on red cell antioxidant defense, plasma malondialdehyde and total antioxidant capacity in hypercholesterolemic rabbits
M Alipour, M Mohammadi, N Zarghami, N Ahmadiasl
Journal of sports science & medicine 2006
The Catalytic Histidine Dyad of High Density Lipoprotein-associated Serum Paraoxonase-1 (PON1) Is Essential for PON1-mediated Inhibition of Low Density Lipoprotein Oxidation and Stimulation of Macrophage Cholesterol Efflux
M Rosenblat, L Gaidukov, O Khersonsky, J Vaya, R Oren, DS Tawfik, M Aviram
The Journal of biological chemistry 2006
Phospholipase Action of Platelet-activating Factor Acetylhydrolase, but Not Paraoxonase-1, on Long Fatty Acyl Chain Phospholipid Hydroperoxides
T Kriska, GK Marathe, JC Schmidt, TM McIntyre, AW Girotti
The Journal of biological chemistry 2006
The age-related paraoxonase 1 response is altered by long-term caloric restriction in male and female rats
E Thomàs-Moyà, M Gianotti, AM Proenza, I Lladó
Journal of lipid research 2006
Isolation and characterization of human apolipoprotein M-containing lipoproteins
C Christoffersen, LB Nielsen, O Axler, A Andersson, AH Johnsen, B Dahlbäck
Journal of lipid research 2006
TagSNP analyses of the PON gene cluster: effects on PON1 activity, LDL oxidative susceptibility, and vascular disease
CS Carlson, PJ Heagerty, TS Hatsukami, RJ Richter, J Ranchalis, J Lewis, TJ Bacus, LA McKinstry, GD Schellenberg, M Rieder, D Nickerson, CE Furlong, A Chait, GP Jarvik
Journal of lipid research 2006
Coding region paraoxonase polymorphisms dictate accentuated neuronal reactions in chronic, sub-threshold pesticide exposure
RO Browne, LB Moyal-Segal, D Zumsteg, Y David, O Kofman, A Berger, H Soreq, A Friedman
The FASEB Journal 2006
Effects of caloric restriction and gender on rat serum paraoxonase 1 activity
E Thomàs-Moyà, M Gianotti, I Lladó, AM Proenza
The Journal of Nutritional Biochemistry 2006
Dyslipidemia and inflammation: an evolutionary conserved mechanism
E Esteve, W Ricart, JM Fernández-Real
Clinical Nutrition 2005
Paraoxonase 1 status in the Thai population
W Phuntuwate, C Suthisisang, B Koanantakul, MI Mackness, B Mackness
Journal of Human Genetics 2005
Effects of Surgical Menopause and Estrogen Replacement Therapy on Serum Paraoxonase Activity and Plasma Malondialdehyde Concentration
S Kumru, S Aydin, A Aras, MF Gursu, F Gulcu
Gynecologic and Obstetric Investigation 2005
Iron-ascorbic acid-induced oxidant stress and its quenching by paraoxonase 1 in HDL and the liver: Comparison between humans and rats
K Trudel, D Sinnett, RW James, E Delvin, D Amre, E Seidman, E Levy
Journal of Cellular Biochemistry 2005
Paraoxonase 1 (PON1) is present in postprandial chylomicrons
B Fuhrman, N Volkova, M Aviram
Atherosclerosis 2005
Paraoxonase 1 (PON1) attenuates macrophage oxidative status: studies in PON1 transfected cells and in PON1 transgenic mice
O Rozenberg, DM Shih, M Aviram
Atherosclerosis 2005
The cardiovascular protective effect of red wine
AC Cordova, LS Jackson, DW Berke-Schlessel, BE Sumpio
Journal of the American College of Surgeons 2005
Inherited and acquired interactions between ACHE and PON1 polymorphisms modulate plasma acetylcholinesterase and paraoxonase activities
B Bryk, L BenMoyal-Segal, E Podoly, O Livnah, A Eisenkraft, S Luria, A Cohen, Y Yehezkelli, A Hourvitz, H Soreq
Journal of Neurochemistry 2005
Effect of pitavastatin on transactivation of human serum paraoxonase 1 gene
K Ota, T Suehiro, K Arii, Y Ikeda, Y Kumon, F Osaki, K Hashimoto
Metabolism 2005
Genetic and other sources of variation in the activity of serum paraoxonase/diazoxonase in humans: consequences for risk from exposure to diazinon
KA OʼLeary, RJ Edwards, MM Town, AR Boobis
Pharmacogenetics and Genomics 2005
Oxidative inactivation of paraoxonase—implications in diabetes mellitus and atherosclerosis
SA Karabina, AN Lehner, E Frank, S Parthasarathy, N Santanam
Biochimica et Biophysica Acta (BBA) - General Subjects 2005
Bovine Paraoxonase 1 Activities in Serum and Distribution in Lipoproteins
T MIYAMOTO, Y TAKAHASHI, T OOHASHI, K SATO, S OIKAWA
Journal of Veterinary Medical Science 2005
Sleep-Disordered Breathing and Cerebrovascular Disease: A Mechanistic Approach
L Lavie
Neurologic Clinics 2005
Intravenöse Sauerstofftherapie erhöht die Aktivität des antioxidativen und antiatherogenetischen Enzyms Paraoxonase-1 im Serum
S Kopprasch, FJ Kreutzer, V Nowak, J Graessler
Forschende Komplementärmedizin und Klassische Naturheilkunde / Research in Complementary and Classical Natural Medicine 2005
The Effect of Hormone Replacement Therapy on Oxidized Low Density Lipoprotein Levels and Paraoxonase Activity in Postmenopausal Women
A Topçuoglu, H Uzun, S Aydin, N Kahraman, S Vehid, G Zeybek, D Topçuoglu
The Tohoku Journal of Experimental Medicine 2005
The effect of statin therapy on plasma high-density lipoprotein cholesterol levels is modified by paraoxonase-1 in patients with familial hypercholesterolaemia
TM Himbergen, LJ Tits, HA Voorbij, J Graaf, AF Stalenhoef, M Roest
Journal of Internal Medicine 2005
Effects of green tea on serum paraoxonase/arylesterase activities in streptozotocin-induced diabetic rats
S Tas, E Sarandol, S Ziyanok, K Aslan, M Dirican
Nutrition Research 2005
Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with rheumatoid arthritis
G Baskol, H Demir, M Baskol, E Kilic, F Ates, D Kocer, S Muhtaroglu
Clinical Biochemistry 2005
Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities
DI Draganov, JF Teiber, A Speelman, Y Osawa, R Sunahara, BN la Du
Journal of lipid research 2005
A role for FXR and human FGF-19 in the repression of paraoxonase-1 gene expression by bile acids
DM Shih, HR Kast-Woelbern, J Wong, YR Xia, PA Edwards, AJ Lusis
Journal of lipid research 2005
Atherosclerosis: Diet and Drugs
A von Eckardstein
2005
Structure−Reactivity Studies of Serum Paraoxonase PON1 Suggest that Its Native Activity Is Lactonase
O Khersonsky, DS Tawfik
Biochemistry 2005
Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine
M Rosenblat, J Vaya, D Shih, M Aviram
Atherosclerosis 2004
Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development
M Aviram, M Rosenblat
Free radical biology & medicine 2004
Statins in atherosclerosis: lipid-lowering agents with antioxidant capabilities
RS Rosenson
Atherosclerosis 2004
Low Serum α-Tocopherol Concentrations in Subjects With Various Coronary Risk Factors
K Miwa, S Okinaga, M Fujita
Circulation Journal 2004
Omapatrilat Decreased Macrophage Oxidative Status and Atherosclerosis Progression in Atherosclerotic Apolipoprotein E-Deficient Mice
T Hayek, S Hamoud, S Keidar, E Pavlotzky, R Coleman, M Aviram, M Kaplan
Journal of Cardiovascular Pharmacology 2004
Effects of intravenous apolipoprotein A-I/phosphatidylcholine discs on paraoxonase and platelet-activating factor acetylhydrolase in human plasma and tissue fluid
T Kujiraoka, H Hattori, M Ito, MN Nanjee, M Ishihara, M Nagano, T Iwasaki, CJ Cooke, WL Olszewski, IP Stepanova, T Egashira, NE Miller
Atherosclerosis 2004
Q192R polymorphism of the paraoxanase 1 gene and its association with serum lipoprotein variables and carotid artery intima-media thickness in young adults from a biracial community
SR Srinivasan, S Li, W Chen, R Tang, MG Bond, E Boerwinkle, GS Berenson
Atherosclerosis 2004
Study of factors influencing the decreased HDL associated PON1 activity with aging
I Seres, G Paragh, E Deschene, T Fulop, A Khalil
Experimental Gerontology 2004
Paraoxonase 1 activity, concentration and genotype in cardiovascular disease
M Mackness, P Durrington, B Mackness
Current Opinion in Lipidology 2004
Interaction between smoking and PON2 Ser311Cys polymorphism as a determinant of the risk of myocardial infarction
N Martinelli, D Girelli, O Olivieri, C Stranieri, E Trabetti, F Pizzolo, S Friso, I Tenuti, S Cheng, MA Grow, PF Pignatti, R Corrocher
European Journal of Clinical Investigation 2004
Smoking is associated with reduced serum levels of the antioxidant enzyme, paraoxonase, in Type 2 diabetic patients
M Boemi, C Sirolla, R Testa, S Cenerelli, P Fumelli, RW James
Diabetic Medicine 2004
Paraoxonase, a cardioprotective enzyme: continuing issues
GS Getz, CA Reardon
Current Opinion in Lipidology 2004
Polygonatum Rhizoma Affects Antioxidant Defense Systems Without Changing mRNA Expression in Diet-Induced Hypercholesterolemic Rabbits
SM Jeon, MK Lee, YB Park, HM Park, MS Choi
Journal of Medicinal Food 2004
Serum paraoxonase activity is decreased in the active stage of Behçet's disease
S Karakucuk, G Baskol, AO Oner, M Baskol, E Mirza, M Ustdal
The British journal of ophthalmology 2004
Acetylcholinesterase/paraoxonase genotype and expression predict anxiety scores in Health, Risk Factors, Exercise Training, and Genetics study
EH Sklan, A Lowenthal, M Korner, Y Ritov, DM Landers, T Rankinen, C Bouchard, AS Leon, T Rice, DC Rao, JH Wilmore, JS Skinner, H Soreq
Proceedings of the National Academy of Sciences 2004
Associations between HDL oxidation and paraoxonase-1 and paraoxonase-1 gene polymorphisms in families affected by familial combined hyperlipidemia
ML Liu, RW James, K Ylitalo, MR Taskinen
Nutrition, Metabolism and Cardiovascular Diseases 2004
Oxidative stress and serum paraoxonase activity in experimental hypothyroidism: effect of vitamin E supplementation
E Sarand�l, S Ta?, M Dirican, Z Serdar
Cell Biochemistry and Function 2004
Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation
M Aviram, M Rosenblat, D Gaitini, S Nitecki, A Hoffman, L Dornfeld, N Volkova, D Presser, J Attias, H Liker, T Hayek
Clinical Nutrition 2004
Acetylcholine esterase protects LDL against oxidation
B Fuhrman, A Partoush, M Aviram
Biochemical and Biophysical Research Communications 2004
Paraoxonase 2 (PON2) expression is upregulated via a reduced-nicotinamide-adenine-dinucleotide-phosphate (NADPH)-oxidase-dependent mechanism during monocytes differentiation into macrophages
M Shiner, B Fuhrman, M Aviram
Free radical biology & medicine 2004
Oxidizability of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in preeclampsia
E Sarandöl, Ö aŞafak, M Dirican, G Uncu
Clinical Biochemistry 2004
Paraoxonase 1 and platelet-activating factor acetylhydrolase activities in patients with low hdl-cholesterol levels with or without primary hypertriglyceridemia
FD Brites, J Verona, LE Schreier, JC Fruchart, GR Castro, RL Wikinski
Archives of Medical Research 2004
A fluorogenic substrate for detection of organophosphatase activity
S Soukharev, DJ Hammond
Analytical Biochemistry 2004
Usefulness of hyperbaric oxygen therapy to inhibit restenosis after percutaneous coronary intervention for acute myocardial infarction or unstable angina pectoris
M Sharifi, W Fares, I Abdel-Karim, JM Koch, J Sopko, D Adler
The American Journal of Cardiology 2004
Paraoxonase 1 Gln/Arg polymorphism is associated with the risk of microangiopathy in Type 2 diabetes mellitus
M Murata, T Maruyama, Y Suzuki, T Saruta, Y Ikeda
Diabetic Medicine 2004
Comprehensive Handbook of Alcohol Related Pathology
J Sastre, JB Miñana, FV Pallardó, J Viña
Comprehensive Handbook of Alcohol Related Pathology 2004
The Antioxidant Function of High Density Lipoproteins: A New Paradigm in Atherosclerosis
M Tomás, G Latorre, M Sentí, J Marrugat
Revista Española de Cardiología (English Edition) 2004
Función antioxidante de las lipoproteínas de alta densidad: un nuevo paradigma en la arteriosclerosis
M Tomás, G Latorre, M Sentí, J Marrugat
Revista Española de Cardiología 2004
PON1 M/L55 mutation protects high-risk patients against coronary artery disease
SA Oliveira, AP Mansur, CC Ribeiro, JA Ramires, JM Annichino-Bizzacchi
International Journal of Cardiology 2004
Preferential inhibition of paraoxonase activity of human paraoxonase 1 by negatively charged lipids
SD Nguyen, DE Sok
Journal of lipid research 2004
Indications that paraoxonase-1 contributes to plasma high density lipoprotein levels in familial hypercholesterolemia
TM van Himbergen, M Roest, J Graaf, EH Jansen, H Hattori, JJ Kastelein, HA Voorbij, AF Stalenhoef, LJ van Tits
Journal of lipid research 2004
Purified human serum PON1 does not protect LDL against oxidation in the in vitro assays initiated with copper or AAPH
JF Teiber, DI Draganov, BN la Du
Journal of lipid research 2004
Oxidative stress in white coat hypertension; role of paraoxonase
H Uzun, Y Karter, S Aydin, A Çurgunlu, G Şimşek, R Yücel, S Vehiyd, N Ertürk, A Kutlu, A Benian, A Yaldiran, E Öztürk, S Erdine
Journal of Human Hypertension 2004
Association of paraoxonase-1 M55L genotype and alcohol consumption with coronary atherosclerosis: the Helsinki Sudden Death Study
R Rontu, T Lehtimki, E Ilveskoski, J Mikkelsson, O Kajander, S Goebeler, M Perola, A Penttil, PJ Karhunen
Pharmacogenetics 2004
Association of Paraoxonase 1 Polymorphism With Beta-Cell Function: A Case of Molecular Heterosis
KC Chiu, LM Chuang, A Chu, J Lu, J Hu, S Fernando
Pancreas 2004
Molekularmedizinische Grundlagen von altersspezifischen Erkrankungen
D Ganten, K Ruckpaul, A Ruiz-Torres
2004
The Role of Paraoxonase 1 Activity in Cardiovascular Disease: Potential for Therapeutic Intervention
MI Mackness, PN Durrington, B Mackness
American Journal Cardiovascular Drugs 2004
Acetylcholinesterase/paraoxonase interactions increase the risk of insecticide‐induced Parkinson's disease
L Benmoyal-Segal, T Vander, S Shifman, B Bryk, R Ebstein, EL Marcus, J Stessman, A Darvasi, Y Herishanu, A Friedman, H Soreq
The FASEB Journal 2004
Dietary Polyphenols Increase Paraoxonase 1 Gene Expression by an Aryl Hydrocarbon Receptor-Dependent Mechanism
C Gouédard, R Barouki, Y Morel
Molecular and cellular biology 2004
HDL: The Metabolism, Function, and Therapeutic Importance
M Wang, MR Briggs
Chemical Reviews 2003
Opposite Regulation of the Human Paraoxonase-1 Gene PON-1 by Fenofibrate and Statins
C Gouédard, N Koum-Besson, R Barouki, Y Morel
Molecular pharmacology 2003
Effect of Eplerenone, a Selective Aldosterone Blocker, on Blood Pressure, Serum and Macrophage Oxidative Stress, and Atherosclerosis in Apolipoprotein E–Deficient Mice
S Keidar, T Hayek, M Kaplan, E Pavlotzky, S Hamoud, R Coleman, M Aviram
Journal of Cardiovascular Pharmacology 2003
RENAL RESEARCH INSTITUTE SYMPOSITUM: Characteristics and Effects of Inflammation in End-Stage Renal Disease
GA Kaysen, JP Eiserich
Seminars in Dialysis 2003
Coronary Artery Disease
Y Okura, K Hayashi, T Shingu, Y Kuga, S Nomura, G Kajiyama, Y Nakashima, K Saku
Coronary Artery Disease 2003
Smoking-dependent association between paraoxonase 1 M/L55 genotype and coronary atherosclerosis in males: an autopsy study
R Rontu, PJ Karhunen, E Ilveskoski, J Mikkelsson, O Kajander, M Perola, A Penttilä, AM Koivisto, T Lehtimäki
Atherosclerosis 2003
Expression of human paraoxonase (PON1) during development
TB Cole, RL Jampsa, BJ Walter, TL Arndt, RJ Richter, DM Shih, A Tward, AJ Lusis, RM Jack, LG Costa, CE Furlong
Pharmacogenetics 2003
Functional Genomics of the Paraoxonase (PON1) Polymorphisms: Effects on Pesticide Sensitivity, Cardiovascular Disease, and Drug Metabolism
LG Costa, TB Cole, GP Jarvik, CE Furlong
Annual Review of Medicine 2003
R/R Genotype of Human Paraoxonase(PON1) is More Protective against Lipoprotein Oxidation and Coronary Artery Disease in Japanese Subjects
K Kuremoto, Y Watanabe, H Ohmura, K Shimada, H Mokuno, H Daida
Journal of Atherosclerosis and Thrombosis 2003
Beneficial effect of oleoylated lipids on paraoxonase 1: protection against oxidative inactivation and stabilization
SD Nguyen, DE Sok
Biochemical Journal 2003
Identification of paraoxonase 3 in rat liver microsomes: purification and biochemical properties
L Rodrigo, F Gil, AF Hernandez, O Lopez, A Pla
Biochemical Journal 2003
Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization
A Aharoni, L Gaidukov, S Yagur, L Toker, I Silman, DS Tawfik
Proceedings of the National Academy of Sciences 2003
Two cinnamate derivatives produce similar alteration in mRNA expression and activity of antioxidant enzymes in rats
MK Lee, EM Park, SH Bok, UJ Jung, JY Kim, YB Park, TL Huh, OS Kwon, MS Choi
Journal of Biochemical and Molecular Toxicology 2003
Cholesteryl ester oxidation products in atherosclerosis
N Leitinger
Molecular Aspects of Medicine 2003
Serum paraoxonase activity decreases in rheumatoid arthritis
N Tanimoto, Y Kumon, T Suehiro, S Ohkubo, Y Ikeda, K Nishiya, K Hashimoto
Life Sciences 2003
Human paraoxonase-1 gene expression by HepG2 cells is downregulated by interleukin-1β and tumor necrosis factor-α, but is upregulated by interleukin-6
Y Kumon, T Suehiro, Y Ikeda, K Hashimoto
Life Sciences 2003
Update on vascular disease in systemic lupus erythematosus
AH Kao, JM Sabatine, S Manzi
Current Opinion in Rheumatology 2003
PON1 activities and oxidative markers of LDL in patients with angiographically proven coronary artery disease
E Azarsız, M Kayıkcıoǧlu, S Payzın, EY Sözmen
International Journal of Cardiology 2003
Effect of homocysteinylation on human high-density lipoproteins: A correlation with paraoxonase activity
G Ferretti, T Bacchetti, E Marotti, G Curatola
Metabolism 2003
Human paraoxonase gene cluster polymorphisms as predictors of coronary heart disease risk in the prospective Northwick Park Heart Study II
Kirsty S Robertson, Emma Hawe, George J Miller, Philippa J Talmud, Steve E Humphries,
Biochimica et Biophysica Acta 2003
Altered Gene Expression in Liver from a Murine Model of Hyperhomocysteinemia
K Robert, JF Chassé, D Santiard-Baron, C Vayssettes, A Chabli, J Aupetit, N Maeda, P Kamoun, J London, N Janel
The Journal of biological chemistry 2003
Increased influence of genetic variation on PON1 activity in neonates
J Chen, M Kumar, W Chan, G Berkowitz, JG Wetmur
Environmental Health Perspectives 2003
Oral Insulin Supplementation Attenuates Atherosclerosis Progression in Apolipoprotein E-Deficient Mice
R Shamir, N Shehadeh, M Rosenblat, O Eshach-Adiv, R Coleman, M Kaplan, S Hamoud, S Lischinsky, T Hayek
Arteriosclerosis, thrombosis, and vascular biology 2003
Antioxidant Paraoxonase 1 Activity in the Metabolic Syndrome
M Sentí, M Tomás, M Fitó, T Weinbrenner, MI Covas, J Sala, R Masiá, J Marrugat
The Journal of clinical endocrinology and metabolism 2003
Paraoxonase gene polymorphisms, oxidative stress, and diseases
HL Li, DP Liu, CC Liang
Journal of Molecular Medicine 2003
Wiley Encyclopedia of Molecular Medicine
WT Morgan
Wiley Encyclopedia of Molecular Medicine 2002
Wine
A Klatsky
Wine 2002
HDL and arteriosclerosis: beyond reverse cholesterol transport
JR Nofer, B Kehrel, M Fobker, B Levkau, G Assmann, A Eckardstein
Atherosclerosis 2002
Wine Flavonoids Protect against LDL Oxidation and Atherosclerosis
M Aviram, B Fuhrman
Annals of the New York Academy of Sciences 2002
Increased macrophage glutathione content reduces cell-mediated oxidation of LDL and atherosclerosis in apolipoprotein E-deficient mice
M Rosenblat, R Coleman, M Aviram
Atherosclerosis 2002
Oxidized lipids as mediators of coronary heart disease
M Navab, SY Hama, ST Ready, CJ Ng, BJ van Lenten, H Laks, AM Fogelman
Current Opinion in Lipidology 2002
Influence of norbixin on plasma cholesterol-associated lipoproteins, plasma arylesterase/paraoxonase activity and hepatic lipid peroxidation of Swiss mice on a high fat diet
AA Santos, MV Silva, LT Guerreiro, MV Alves, VL Bastos, JC Bastos, K Kovary
Food Chemistry 2002
The Arg allele in position 192 of PON1 is associated with carotid atherosclerosis in subjects with elevated HDLs
A Gnasso, C Motti, C Irace, ID Gennaro, A Pujia, E Leto, M Ciamei, A Crivaro, S Bernardini, G Federici, C Cortese
Atherosclerosis 2002
Kinetics of HDL Cholesterol and Paraoxonase Activity in Moderate Alcohol Consumers
A Sierksma, MS van der Gaag, A Tol, RW James, HF Hendriks
Alcoholism: Clinical & Experimental Research 2002
Microarray analysis of altered gene expression in the TM4 Sertoli-like cell line exposed to chromium(III) chloride
RY Cheng, WG Alvord, D Powell, KS Kasprzak, LM Anderson
Reproductive Toxicology 2002
The mechanism of action of antioxidants against lipoprotein peroxidation, evaluation based on kinetic experiments
I Pinchuk, D Lichtenberg
Progress in Lipid Research 2002
Paraoxonase 1 Activity: A New Vascular Marker of Dementia?
TF Dantoine, J Debord, L Merle, H Lacroix-Ramiandrisoa, L Bourzeix, JP Charmes
Annals of the New York Academy of Sciences 2002
Multiple Substrates for Paraoxonase-1 during Oxidation of Phosphatidylcholine by Peroxynitrite
Z Ahmed, A Ravandi, GF Maguire, A Emili, D Draganov, BN la Du, A Kuksis, PW Connelly
Biochemical and Biophysical Research Communications 2002
Detection of oxidized high-density lipoprotein
T Matsunaga, I Koyama, S Hokari, T Komoda
Journal of Chromatography B 2002
Higher antioxidant defences in plasma and low density lipoproteins from rugby players
P Evelson, G Gambino, M Travacio, G Jaita, J Verona, C Maroncelli, R Wikinski, S Llesuy, F Brites
European Journal of Clinical Investigation 2002
Oxidative stress increases the expression of the CD36 scavenger receptor and the cellular uptake of oxidized low-density lipoprotein in macrophages from atherosclerotic mice: protective role of antioxidants and of paraoxonase
B Fuhrman, N Volkova, M Aviram
Atherosclerosis 2002
Paraoxonase 1 Overexpression in Mice and Its Effect on High-Density Lipoproteins
MN Oda, JK Bielicki, TT Ho, T Berger, EM Rubin, TM Forte
Biochemical and Biophysical Research Communications 2002
HDL or not HDL, that is the question
RW James
European Journal of Clinical Investigation 2002
Detoxification of Oxidized LDL by Transferring Its Oxidation Product(s) to Lecithin:Cholesterol Acyltransferase
ZH Howlader, S Kamiyama, H Shirakawa, Y Murakami, M Ito, M Komai, K Muramoto, Y Furukawa
Biochemical and Biophysical Research Communications 2002
Supplementation of naringenin and its synthetic derivative alters antioxidant enzyme activities of erythrocyte and liver in high cholesterol-fed rats
MK Lee, SH Bok, TS Jeong, SS Moon, SE Lee, YB Park, MS Choi
Bioorganic & Medicinal Chemistry 2002
Proinflammatory Cytokines But Not Acute Phase Serum Amyloid A Or C-Reactive Protein, Downregulate Paraoxonase 1 (Pon1) Expression By Hepg2 Cells
Y Kumon, Y Nakauchi, T Suehiro, T Shiinoki, N Tanimoto, M Inoue, T Nakamura, K Hashimoto, JD Sipe
Amyloid 2002
Antiatherosclerotic effects of licorice extract supplementation on hypercholesterolemic patients: increased resistance of LDL to atherogenic modifications, reduced plasma lipid levels, and decreased systolic blood pressure
B Fuhrman, N Volkova, M Kaplan, D Presser, J Attias, T Hayek, M Aviram
Nutrition 2002
Atorvastatin therapy in hypercholesterolemic patients suppresses cellular uptake of oxidized-LDL by differentiating monocytes
B Fuhrman, L Koren, N Volkova, S Keidar, T Hayek, M Aviram
Atherosclerosis 2002
Preservation of Paraoxonase Activity by Wine Flavonoids
B Fuhrman, M Aviram
Annals of the New York Academy of Sciences 2002
Paraoxonase Gln-Arg(192) and Leu-Met(55) gene polymorphisms and enzyme activity in a population with a low rate of coronary heart disease
N Ferré, M Tous, A Paul, A Zamora, JJ Vendrell, A Bardajı́, J Camps, C Richart, J Joven
Clinical Biochemistry 2002
Oxidative stress increases the expression of the angiotensin-II receptor type 1 in mouse peritoneal macrophages
S Keidar, R Heinrich, M Kaplan, M Aviram
Journal of Renin-Angiotensin-Aldosterone System 2002
Paraoxonase and coronary heart disease
MI Mackness, B Mackness, PN Durrington
Atherosclerosis Supplements 2002
Effect of Alcohol on Lipids and Lipoproteins in Relation to Atherosclerosis
ML Hannuksela, MK Liisanantti, MJ Savolainen
Critical Reviews in Clinical Laboratory Sciences 2002
Platelet-activating Factor Acetylhydrolase, and Not Paraoxonase-1, Is the Oxidized Phospholipid Hydrolase of High Density Lipoprotein Particles
GK Marathe, GA Zimmerman, TM McIntyre
The Journal of biological chemistry 2002
Codon 311 (Cys → Ser) polymorphism of paraoxonase-2 gene is associated with apolipoprotein E4 allele in both Alzheimer's and vascular dementias
Z Janka, A Juhász, Á Rimanóczy, K Boda, J Márki-Zay, J Kálmán
Molecular Psychiatry 2002
Further evidence for an association of the Paraoxonase 1 (PON1) Met-54 allele with Parkinson's disease
A Carmine, S Buervenich, O Sydow, M Anvret, L Olson
Movement disorders : official journal of the Movement Disorder Society 2002
Decreased Atherosclerotic Lesion Formation in Human Serum Paraoxonase Transgenic Mice
A Tward, YR Xia, XP Wang, YS Shi, C Park, LW Castellani, AJ Lusis, DM Shih
Circulation 2002
Atorvastatin Preferentially Reduces LDL-Associated Platelet-Activating Factor Acetylhydrolase Activity in Dyslipidemias of Type IIA and Type IIB
V Tsimihodimos, SA Karabina, AP Tambaki, E Bairaktari, JA Goudevenos, MJ Chapman, M Elisaf, AD Tselepis
Arteriosclerosis, thrombosis, and vascular biology 2002
Vitamin C and E Intake Is Associated With Increased Paraoxonase Activity
GP Jarvik, NT Tsai, LA McKinstry, R Wani, VH Brophy, RJ Richter, GD Schellenberg, PJ Heagerty, TS Hatsukami, CE Furlong
Arteriosclerosis, thrombosis, and vascular biology 2002
Paraoxonase (PON1) in Health and Disease
LG Costa, CE Furlong
2002
Grape Seed Proanthocyanidins Prevent Plasma Postprandial Oxidative Stress in Humans
F Natella, F Belelli, V Gentili, F Ursini, C Scaccini
Journal of Agricultural and Food Chemistry 2002
Antioxidant properties of HDL in transgenic mice overexpressing human apolipoprotein A-II
E Boisfer, D Stengel, D Pastier, PM Laplaud, N Dousset, E Ninio, AD Kalopissis
Journal of lipid research 2002
Altered activities of anti-atherogenic enzymes LCAT, paraoxonase, and platelet-activating factor acetylhydrolase in atherosclerosis-susceptible mice
TM Forte, G Subbanagounder, JA Berliner, PJ Blanche, AO Clermont, Z Jia, MN Oda, RM Krauss, JK Bielicki
Journal of lipid research 2002
Oxidized low-density lipoprotein promotes mature dendritic cell transition from differentiating monocyte
L Perrin-Cocon, F Coutant, S Agaugué, S Deforges, P André, V Lotteau
Journal of immunology (Baltimore, Md. : 1950) 2001
Oxidized LDL and HDL: antagonists in atherothrombosis
A Mertens, P Holvoet
The FASEB Journal 2001
Handbook of Antioxidants
K Meissner, W Siems, O Sommerburg, M Leichsenring
Handbook of Antioxidants 2001
Mitogenic Effect of Lipoproteins on Human Vascular Smooth Muscle Cells: The Impact of Hydrolysis by gr II A Phospholipase A2
W Pruzanski, E Stefanski, J Kopilov, A Kuksis
Laboratory Investigation 2001
Relative sensitivities of plasma lecithin:cholesterol acyltransferase, platelet-activating factor acetylhydrolase, and paraoxonase to in vitro gas-phase cigarette smoke exposure
JK Bielicki, LJ Knoff, DL Tribble, TM Forte
Atherosclerosis 2001
Polymorphisms in the human paraoxonase (PON1) promoter
VH Brophy, MD Hastings, JB Clendenning, RJ Richter, GP Jarvik, CE Furlong
Pharmacogenetics 2001
Rabbits possess a serum paraoxonase polymorphism similar to the human Q192R
CE Watson, DI Draganov, SS Billecke, CL Bisgaier, BN la Du
Pharmacogenetics 2001
Effects of 5′ Regulatory-Region Polymorphisms on Paraoxonase-Gene (PON1) Expression
VH Brophy, RL Jampsa, JB Clendenning, LA McKinstry, GP Jarvik, CE Furlong
The American Journal of Human Genetics 2001
Kinetics of lipid peroxidation in mixtures of HDL and LDL, mutual effects
O Raveh, I Pinchuk, M Fainaru, D Lichtenberg
Free radical biology & medicine 2001
Relationship of age-related myocardial infarction risk and Gln/Arg 192 variants of the human paraoxonase1 gene: the REGICOR study
M Sentí
Atherosclerosis 2001
Abnormalities in uremic lipoprotein metabolism and its impact on cardiovascular disease
T Quaschning, V Krane, T Metzger, C Wanner
American Journal of Kidney Diseases 2001
Biotransformation of organophosphorus compounds
M Jokanović
Toxicology 2001
Flavonoids protect LDL from oxidation and attenuate atherosclerosis
B Fuhrman, M Aviram
Current Opinion in Lipidology 2001
Immunohistochemical evidence for the expression and induction of paraoxonase in rat liver, kidney, lung and brain tissue. implications for its physiological role
L Rodrigo, AF Hernández, JJ López-Caballero, F Gil, A Pla
Chemico-Biological Interactions 2001
Analysis of association between the Gln192Arg polymorphism of the paraoxonase gene and schizophrenia in humans
C Matsumoto
Neuroscience Letters 2001
High-density lipoprotein: Epidemiology, metabolism, and antiatherogenic effects
PP Toth
Disease-a-Month 2001
Alcohol in Health and Disease: A Review
M Hannuksela, M Savolainen
Alcohol in Health and Disease 2001
A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids
M Navab, SY Hama, GP Hough, G Subbanagounder, ST Reddy, AM Fogelman
Journal of lipid research 2001
Apolipoprotein A-I Promotes the Formation of Phosphatidylcholine Core Aldehydes That Are Hydrolyzed by Paraoxonase (PON-1) during High Density Lipoprotein Oxidation with a Peroxynitrite Donor
Z Ahmed, A Ravandi, GF Maguire, A Emili, D Draganov, BN la Du, A Kuksis, PW Connelly
The Journal of biological chemistry 2001
Enzymatically Active Paraoxonase-1 Is Located at the External Membrane of Producing Cells and Released by a High Affinity, Saturable, Desorption Mechanism
S Deakin, I Leviev, M Gomaraschi, L Calabresi, G Franceschini, RW James
The Journal of biological chemistry 2001
Pomegranate Juice Supplementation to Atherosclerotic Mice Reduces Macrophage Lipid Peroxidation, Cellular Cholesterol Accumulation and Development of Atherosclerosis
M Kaplan, T Hayek, A Raz, R Coleman, L Dornfeld, J Vaya, M Aviram
The Journal of nutrition 2001
Exploiting the Vascular Protective Effects of High-Density Lipoprotein and Its Apolipoproteins: An Idea Whose Time for Testing Is Coming, Part I
PK Shah, S Kaul, J Nilsson, B Cercek
Circulation 2001
Exploiting the Vascular Protective Effects of High-Density Lipoprotein and its Apolipoproteins: An Idea Whose Time for Testing Is Coming, Part II
PK Shah, S Kaul, J Nilsson, B Cercek
Circulation 2001
Paraoxonase and Atherosclerosis
PN Durrington, B Mackness, MI Mackness
Arteriosclerosis, thrombosis, and vascular biology 2001
HDL and the Inflammatory Response Induced by LDL-Derived Oxidized Phospholipids
M Navab, JA Berliner, G Subbanagounder, S Hama, AJ Lusis, LW Castellani, S Reddy, D Shih, W Shi, AD Watson, BJ Lenten, D Vora, AM Fogelman
Arteriosclerosis, thrombosis, and vascular biology 2001
The effect of meals rich in thermally stressed olive and safflower oils on postprandial serum paraoxonase activity in patients with diabetes
AJ Wallace, WH Sutherland, JI Mann, SM Williams
European Journal of Clinical Nutrition 2001
Is the Oxidation of High-Density Lipoprotein Lipids Different Than the Oxidation of Low-Density Lipoprotein Lipids? ,
MJ Thomas, Q Chen, M Zabalawi, R Anderson, M Wilson, R Weinberg, MG Sorci-Thomas, LL Rudel
Biochemistry 2001
Decreased stability of the M54 isoform of paraoxonase as a contributory factor to variations in human serum paraoxonase concentrations
I Leviev, S Deakin, RW James
Journal of lipid research 2001
Baculovirus-mediated expression and purification of human serum paraoxonase 1A
RJ Brushia, TM Forte, MN Oda, BN Du, JK Bielicki
Journal of lipid research 2001
Focus on HDL: a new treatment paradigm for athero-thrombotic vascular disease
PK Shah
Expert Opinion on Investigational Drugs 2000
Analysis of paraoxonase (PON1) L55M status requires both genotype and phenotype
VH Brophy, GP Jarvik, RJ Richter, LS Rozek, GD Schellenberg, CE Furlong
Pharmacogenetics 2000
The paraoxonase Leu–Met54 and Gln–Arg191 gene polymorphisms are not associated with the risk of coronary heart disease
A Gardemann, M Philipp, K Heß, N Katz, H Tillmanns, W Haberbosch
Atherosclerosis 2000
Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases
Y Imai, H Morita, H Kurihara, T Sugiyama, N Kato, A Ebihara, C Hamada, Y Kurihara, T Shindo, Y Oh-hashi, Y Yazaki
Atherosclerosis 2000
A polymorphism upstream from the human paraoxonase (PON1) gene and its association with PON1 expression
T Suehiro, T Nakamura, M Inoue, T Shiinoki, Y Ikeda, Y Kumon, M Shindo, H Tanaka, K Hashimoto
Atherosclerosis 2000
Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1
M Navab, SY Hama, CJ Cooke, GM Anantharamaiah, M Chaddha, L Jin, G Subbanagounder, KF Faull, ST Reddy, NE Miller, AM Fogelman
Journal of lipid research 2000
Genetic polymorphism in paraoxonase is a risk factor for childhood focal segmental glomerulosclerosis
Y Frishberg, H Toledano, R Becker-Cohen, E Feigin, D Halle
American Journal of Kidney Diseases 2000
How high-density lipoprotein protects against the effects of lipid peroxidation
M I Mackness, P N Durrington, B Mackness
Current Opinion in Lipidology 2000
Combined Serum Paraoxonase Knockout/Apolipoprotein E Knockout Mice Exhibit Increased Lipoprotein Oxidation and Atherosclerosis
DM Shih, YR Xia, XP Wang, E Miller, LW Castellani, G Subbanagounder, H Cheroutre, KF Faull, JA Berliner, JL Witztum, AJ Lusis
The Journal of biological chemistry 2000
Rabbit Serum Paraoxonase 3 (PON3) Is a High Density Lipoprotein-associated Lactonase and Protects Low Density Lipoprotein against Oxidation
DI Draganov, PL Stetson, CE Watson, SS Billecke, BN la Du
The Journal of biological chemistry 2000
Isoflavone phytoestrogens consumed in soy decrease F2-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans
H Wiseman, JD O'Reilly, H Adlercreutz, AI Mallet, EA Bowey, IR Rowland, TA Sanders
The American journal of clinical nutrition 2000
Dietary Fat Modulates Serum Paraoxonase 1 Activity in Rats
BJ Kudchodkar, AG Lacko, L Dory, TV Fungwe
The Journal of nutrition 2000
Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E–deficient mice
M Aviram, L Dornfeld, M Rosenblat, N Volkova, M Kaplan, R Coleman, T Hayek, D Presser, B Fuhrman
The American journal of clinical nutrition 2000
Smoking Is Associated With Reduced Serum Paraoxonase Activity and Concentration in Patients With Coronary Artery Disease
RW James, I Leviev, A Righetti
Circulation 2000
Human Serum Paraoxonases (PON1) Q and R Selectively Decrease Lipid Peroxides in Human Coronary and Carotid Atherosclerotic Lesions: PON1 Esterase and Peroxidase-Like Activities
M Aviram, E Hardak, J Vaya, S Mahmood, S Milo, A Hoffman, S Billicke, D Draganov, M Rosenblat
Circulation 2000
Promoter Polymorphisms of Human Paraoxonase PON1 Gene and Serum Paraoxonase Activities and Concentrations
I Leviev, RW James
Arteriosclerosis, thrombosis, and vascular biology 2000
Infection and Inflammation Induce LDL Oxidation In Vivo
RA Memon, I Staprans, M Noor, WM Holleran, Y Uchida, AH Moser, KR Feingold, C Grunfeld
Arteriosclerosis, thrombosis, and vascular biology 2000
Hyperbaric Oxygen Reduces the Progression and Accelerates the Regression of Atherosclerosis in Rabbits
BJ Kudchodkar, J Wilson, A Lacko, L Dory
Arteriosclerosis, thrombosis, and vascular biology 2000
Effect of Overexpression of Human Apo A-I in C57BL/6 and C57BL/6 Apo E–Deficient Mice on 2 Lipoprotein-Associated Enzymes, Platelet-Activating Factor Acetylhydrolase and Paraoxonase: Comparison of Adenovirus-Mediated Human Apo A-I Gene Transfer and Human Apo A-I Transgenesis
BD Geest, D Stengel, M Landeloos, M Lox, LL Gat, D Collen, P Holvoet, E Ninio
Arteriosclerosis, thrombosis, and vascular biology 2000
Oxidized Cholesterol in the Diet Accelerates the Development of Atherosclerosis in LDL Receptor– and Apolipoprotein E–Deficient Mice
I Staprans, XM Pan, JH Rapp, C Grunfeld, KR Feingold
Arteriosclerosis, thrombosis, and vascular biology 2000
Effect of Simvastatin Therapy on Paraoxonase Activity and Related Lipoproteins in Familial Hypercholesterolemic Patients
M Tomás, M Sentí, F García-Faria, J Vila, A Torrents, M Covas, J Marrugat
Arteriosclerosis, thrombosis, and vascular biology 2000
Impact of Antioxidants and HDL on Glycated LDL–Induced Generation of Fibrinolytic Regulators From Vascular Endothelial Cells
S Ren, GX Shen
Arteriosclerosis, thrombosis, and vascular biology 2000
Cardiology for the primary care Physician
JS Alpert
2000
Phospholipid composition of reconstituted high density lipoproteins influences their ability to inhibit endothelial cell adhesion molecule expression
PW Baker, KA Rye, JR Gamble, MA Vadas, PJ Barter
Journal of lipid research 2000
Comparative analysis of lipid composition of normal and acute-phase high density lipoproteins
W Pruzanski, E Stefanski, FC de Beer, MC de Beer, A Ravandi, A Kuksis
Journal of lipid research 2000
A sandwich enzyme-linked immunosorbent assay for human serum paraoxonase concentration
T Kujiraoka, T Oka, M Ishihara, T Egashira, T Fujioka, E Saito, S Saito, NE Miller, H Hattori
Journal of lipid research 2000
Apo A-I inhibits foam cell formation in apo E–deficient mice after monocyte adherence to endothelium
HM Dansky, SA Charlton, CB Barlow, M Tamminen, JD Smith, JS Frank, JL Breslow
Journal of Clinical Investigation 1999
Remodelling of high density lipoproteins by plasma factors
KA Rye, MA Clay, PJ Barter
Atherosclerosis 1999
Oxidized Low Density Lipoprotein: Atherogenic and Proinflammatory Characteristics during Macrophage Foam Cell Formation. An Inhibitory Role for Nutritional Antioxidants and Serum Paraoxonase
M Kaplan, M Aviram
Clinical Chemistry and Laboratory Medicine 1999
The protective role of high-density lipoproteins in atherosclerosis
S Mingpeng, W Zongli
Experimental Gerontology 1999
High Density Lipoproteins (HDL) and the Oxidative Hypothesis of Atherosclerosis
D Bonnefont-Rousselot, P Thérond, JL Beaudeux, J Peynet, A Le-grand, J Delattre
Clinical Chemistry and Laboratory Medicine 1999
Atheroprotective mechanisms of HDL
O Stein, Y Stein
Atherosclerosis 1999
Paraoxonase Genes and Disease
RA Hegele
Annals of Medicine 1999
Macrophage Foam Cell Formation During Early Atherogenesis Is Determined by the Balance Between Pro-Oxidants and Anti-Oxidants in Arterial Cells and Blood Lipoproteins
M Aviram
Antioxidants & Redox Signaling 1999
Daily moderate alcohol consumption increases serum paraoxonase activity; a diet-controlled, randomised intervention study in middle-aged men
MS van der Gaag, A Tol, LM Scheek, RW James, R Urgert, G Schaafsma, HF Hendriks
Atherosclerosis 1999
Does paraoxonase play a role in susceptibility to cardiovascular disease?
M Aviram
Molecular Medicine Today 1999
Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants
M Aviram, M Rosenblat, S Billecke, J Erogul, R Sorenson, CL Bisgaier, RS Newton, BL Du
Free radical biology & medicine 1999
Serum paraoxonase activity and phenotype distribution in Turkish subjects with coronary heart disease and its relationship to serum lipids and lipoproteins
A Karakaya, S İbiş, T Kural, SK Köse, AE Karakaya
Chemico-Biological Interactions 1999
Isolation and complete covalent structure of liver microsomal paraoxonase
J Ozols
Biochemical Journal 1999
The role of oxidative stress in atherosclerosis: the hope and the hype
MS Runge
Transactions of the American Clinical and Climatological Association 1999
Microsomal cytochromes P450 catalyze the oxidation of low density lipoprotein
M Aviram, UM Kent, PF Hollenberg
Atherosclerosis 1999
On the physiological role(s) of the paraoxonases
BN la Du, M Aviram, S Billecke, M Navab, S Primo-Parmo, RC Sorenson, TJ Standiford
Chemico-Biological Interactions 1999
Properties of the retained N-terminal hydrophobic leader sequence in human serum paraoxonase/arylesterase
RC Sorenson, M Aviram, CL Bisgaier, S Billecke, C Hsu, BN la Du
Chemico-Biological Interactions 1999
Human serum Paraoxonase/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids : apolipoprotein A-I stabilizes activity
RC Sorenson, CL Bisgaier, M Aviram, C Hsu, S Billecke, BN la Du
Arteriosclerosis, thrombosis, and vascular biology 1999
Antioxidant protection of lipoproteins containing estrogens: in vitro evidence for low- and high-density lipoproteins as estrogen carriers
QH Meng, A Höckerstedt, S Heinonen, K Wähälä, H Adlercreutz, MJ Tikkanen
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1999
Role of lecithin-cholesterol acyltransferase in the metabolism of oxidized phospholipids in plasma: studies with platelet-activating factor-acetyl hydrolase-deficient plasma
VS Subramanian, J Goyal, M Miwa, J Sugatami, M Akiyama, M Liu, PV Subbaiah
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1999
Reduced Postprandial Serum Paraoxonase Activity After a Meal Rich in Used Cooking Fat
WH Sutherland, RJ Walker, SA de Jong, AM van Rij, V Phillips, HL Walker
Arteriosclerosis, thrombosis, and vascular biology 1999
Evidence that lipid hydroperoxides inhibit plasma lecithin:cholesterol acyltransferase activity
JK Bielicki, TM Forte
Journal of lipid research 1999
Paraoxonase protection of LDL against peroxidation is independent of its esterase activity towards paraoxon and is unaffected by the Q→R genetic polymorphism
H Cao, A Girard-Globa, F Berthezene, P Moulin
Journal of lipid research 1999
High density associated enzymes: their role in vascular biology
M Navab, SY Hama, GP Hough, CC Hedrick, R Sorenson, BN la Du, JA Kobashigawa, GC Fonarow, JA Berliner, H Laks, AM Fogelman
Current Opinion in Lipidology 1998
Paraoxonase as a Risk Marker for Cardiovascular Disease: Facts and Hypotheses
PM Laplaud, T Dantoine, MJ Chapman
Clinical Chemistry and Laboratory Medicine 1998
An Assessment of the Scientific Basis for Attempting to Define the Dietary Reference Intake for Beta Carotene
GS Omenn
Journal of the American Dietetic Association 1998
Paraoxonase Active Site Required for Protection Against LDL Oxidation Involves Its Free Sulfhydryl Group and Is Different From That Required for Its Arylesterase/Paraoxonase Activities: Selective Action of Human Paraoxonase Allozymes Q and R
M Aviram, S Billecke, R Sorenson, C Bisgaier, R Newton, M Rosenblat, J Erogul, C Hsu, C Dunlop, BL Du
Arteriosclerosis, thrombosis, and vascular biology 1998
Molecular and Cellular Effects of Nutrition on Disease Processes
GN Pierce, T Izumi, H Rupp, A Grynberg
1998
LDL oxidation by arterial wall macrophages depends on the oxidative status in the lipoprotein and in the cells: role of prooxidants vs. antioxidants
M Aviram, B Fuhrman
Molecular and Cellular Biochemistry 1998
Nitric Oxide
RA Schroeder, PC Kuo
Anesthesia & Analgesia 1995
Pharmacogenetics
BM Watson
Anaesthesia 1969

← Previous 1 2 3 … 34 35 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 16 patents
198 readers on Mendeley
See more details